,abstract,author1_last_fm,author1_lastfm,author_list,authors,authors_str,book_abstracts,book_accession_id,book_contribution_date,book_copyright,book_date_revised,book_editors,book_history,book_language,book_medium,book_publication_status,book_publisher,book_sections,book_synonyms,book_title,chemicals,citation,citation_html,content,doi,first_page,grants,history,issn,issue,journal,last_page,mesh,pages,parse_xml,pii,pmc,pmid,pmcid,publication_types,pubmed_type,title,to_dict,url,volume,volume_issue,xml,year
0,"BACKGROUND: No standard treatment guidelines have been established for postpartum hemorrhage (PPH). We aimed to assess the differences in outcomes and prognoses between patients with PPH who underwent surgical and non-surgical treatment.
METHODS: This retrospective study included 230 patients diagnosed with PPH at two referral hospitals between August 2013 and October 2023. The patients were divided into non-surgical (group 1, n = 159) and surgical intervention groups (group 2, n = 71). A subgroup analysis was performed by dividing the surgical intervention group into immediate (n = 45) and delayed surgical intervention groups (n = 26).
RESULTS: Initial lactic acid levels and shock index were significantly higher in group 2 (2.85 ± 1.37 vs. 4.54 ± 3.63 mmol/L, p = 0.001, and 0.83 ± 0.26 vs. 1.10 ± 0.51, p < 0.001, respectively). Conversely, initial heart rate and body temperature were significantly lower in group 2 (92.5 ± 21.0 vs. 109.0 ± 28.1 beat/min, p < 0.001, and 37.3 ± 0.8 °C vs. 37.0 ± 0.9 °C, p = 0.011, respectively). Logistic regression analysis identified low initial body temperature, high lactic acid level, and shock index as independent predictors of surgical intervention (p = 0.029, p = 0.027, and p = 0.049, respectively). Regarding the causes of PPH, tone was significantly more prevalent in group 1 (57.2% vs. 35.2%, p = 0.002), whereas trauma was significantly more prevalent in group 2 (24.5% vs. 39.4%, p = 0.030). Group 2 had worse overall outcomes and prognoses than group 1. The subgroup analysis showed significantly higher rates of uterine atony combined with other causes, hysterectomy, and disseminated intravascular coagulopathy in the delayed surgical intervention group than the immediate surgical intervention group (42.2% vs. 69.2%, p = 0.027; 51.1% vs. 73.1%, p = 0.049; and 17.8% vs. 46.2%, p = 0.018, respectively).
CONCLUSIONS: Patients with PPH presenting with increased lactic acid levels and shock index and decreased body temperature may be surgical candidates. Additionally, immediate surgical intervention in patients with uterine atony combined with other causes of PPH could improve prognosis and reduce postoperative complications.",Jung YW,JungYW,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf1ed0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf1f10>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf1a50>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf25d0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf3f10>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf3f50>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf2a10>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf0890>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf1690>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf2a50>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf3d50>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf3bd0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018fadc250>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018fadcbd0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018fadd9d0>]","['Jung YW', 'Kim J', 'Shin WK', 'Song SY', 'Choi JS', 'Hyun SH', 'Ko YB', 'Lee M', 'Kang BH', 'Kim BY', 'Min JH', 'In YN', 'Jung SM', 'Oh SK', 'Yoo HJ']",Jung YW; Kim J; Shin WK; Song SY; Choi JS; Hyun SH; Ko YB; Lee M; Kang BH; Kim BY; Min JH; In YN; Jung SM; Oh SK; Yoo HJ,,,,,,,,,,,,,,,"{'D019344': {'substance_name': 'Lactic Acid', 'registry_number': '33X04XA5AT'}}","Jung YW, et al. Outcomes and prognosis of postpartum hemorrhage according to management protocol: an 11-year retrospective study from two referral centers. Outcomes and prognosis of postpartum hemorrhage according to management protocol: an 11-year retrospective study from two referral centers. 2024; 19:27. doi: 10.1186/s13017-024-00556-5","Jung YW, <i>et al</i>. Outcomes and prognosis of postpartum hemorrhage according to management protocol: an 11-year retrospective study from two referral centers. Outcomes and prognosis of postpartum hemorrhage according to management protocol: an 11-year retrospective study from two referral centers. 2024; 19:27. doi: 10.1186/s13017-024-00556-5",<Element PubmedArticle at 0x7f018faf1940>,10.1186/s13017-024-00556-5,27.0,[],"{'received': datetime.datetime(2024, 4, 28, 0, 0), 'accepted': datetime.datetime(2024, 7, 22, 0, 0), 'medline': datetime.datetime(2024, 8, 2, 0, 0), 'pubmed': datetime.datetime(2024, 8, 2, 0, 0), 'entrez': datetime.datetime(2024, 8, 1, 0, 0), 'pmc-release': datetime.datetime(2024, 8, 1, 0, 0)}",1749-7922,1,World J Emerg Surg,,"{'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D012189': {'descriptor_name': 'Retrospective Studies', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': True, 'qualifier_name': None, 'qualifier_ui': None}, 'D000328': {'descriptor_name': 'Adult', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D011379': {'descriptor_name': 'Prognosis', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D019344': {'descriptor_name': 'Lactic Acid', 'major_topic': False, 'qualifier_name': 'blood', 'qualifier_ui': 'Q000097'}}",27,<function MetaPubObject.parse_xml at 0x7f01911c1120>,10.1186/s13017-024-00556-5,11293252.0,39090705,,"{'D016428': 'Journal Article', 'D016448': 'Multicenter Study'}",article,Outcomes and prognosis of postpartum hemorrhage according to management protocol: an 11-year retrospective study from two referral centers.,<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018e94b910>>,https://ncbi.nlm.nih.gov/pubmed/39090705,19,19(1),"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Curated""><PMID Version=""1"">39090705</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel=""Electronic""><Journal><ISSN IssnType=""Electronic"">1749-7922</ISSN><JournalIssue CitedMedium=""Internet""><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>World journal of emergency surgery : WJES</Title><ISOAbbreviation>World J Emerg Surg</ISOAbbreviation></Journal><ArticleTitle>Outcomes and prognosis of postpartum hemorrhage according to management protocol: an 11-year retrospective study from two referral centers.</ArticleTitle><Pagination><StartPage>27</StartPage><MedlinePgn>27</MedlinePgn></Pagination><ELocationID EIdType=""pii"" ValidYN=""Y"">27</ELocationID><ELocationID EIdType=""doi"" ValidYN=""Y"">10.1186/s13017-024-00556-5</ELocationID><Abstract><AbstractText Label=""BACKGROUND"">No standard treatment guidelines have been established for postpartum hemorrhage (PPH). We aimed to assess the differences in outcomes and prognoses between patients with PPH who underwent surgical and non-surgical treatment.</AbstractText><AbstractText Label=""METHODS"">This retrospective study included 230 patients diagnosed with PPH at two referral hospitals between August 2013 and October 2023. The patients were divided into non-surgical (group 1, n&#x2009;=&#x2009;159) and surgical intervention groups (group 2, n&#x2009;=&#x2009;71). A subgroup analysis was performed by dividing the surgical intervention group into immediate (n&#x2009;=&#x2009;45) and delayed surgical intervention groups (n&#x2009;=&#x2009;26).</AbstractText><AbstractText Label=""RESULTS"">Initial lactic acid levels and shock index were significantly higher in group 2 (2.85&#x2009;&#xb1;&#x2009;1.37 vs. 4.54&#x2009;&#xb1;&#x2009;3.63 mmol/L, p&#x2009;=&#x2009;0.001, and 0.83&#x2009;&#xb1;&#x2009;0.26 vs. 1.10&#x2009;&#xb1;&#x2009;0.51, p&#x2009;&lt;&#x2009;0.001, respectively). Conversely, initial heart rate and body temperature were significantly lower in group 2 (92.5&#x2009;&#xb1;&#x2009;21.0 vs. 109.0&#x2009;&#xb1;&#x2009;28.1 beat/min, p&#x2009;&lt;&#x2009;0.001, and 37.3&#x2009;&#xb1;&#x2009;0.8&#xa0;&#xb0;C vs. 37.0&#x2009;&#xb1;&#x2009;0.9&#xa0;&#xb0;C, p&#x2009;=&#x2009;0.011, respectively). Logistic regression analysis identified low initial body temperature, high lactic acid level, and shock index as independent predictors of surgical intervention (p&#x2009;=&#x2009;0.029, p&#x2009;=&#x2009;0.027, and p&#x2009;=&#x2009;0.049, respectively). Regarding the causes of PPH, tone was significantly more prevalent in group 1 (57.2% vs. 35.2%, p&#x2009;=&#x2009;0.002), whereas trauma was significantly more prevalent in group 2 (24.5% vs. 39.4%, p&#x2009;=&#x2009;0.030). Group 2 had worse overall outcomes and prognoses than group 1. The subgroup analysis showed significantly higher rates of uterine atony combined with other causes, hysterectomy, and disseminated intravascular coagulopathy in the delayed surgical intervention group than the immediate surgical intervention group (42.2% vs. 69.2%, p&#x2009;=&#x2009;0.027; 51.1% vs. 73.1%, p&#x2009;=&#x2009;0.049; and 17.8% vs. 46.2%, p&#x2009;=&#x2009;0.018, respectively).</AbstractText><AbstractText Label=""CONCLUSIONS"">Patients with PPH presenting with increased lactic acid levels and shock index and decreased body temperature may be surgical candidates. Additionally, immediate surgical intervention in patients with uterine atony combined with other causes of PPH could improve prognosis and reduce postoperative complications.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y"" EqualContrib=""Y""><LastName>Jung</LastName><ForeName>Ye Won</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chungnam National University School of Medicine, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y"" EqualContrib=""Y""><LastName>Kim</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Public Health, Chungnam National University School of Medicine, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Shin</LastName><ForeName>Won Kyo</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Song</LastName><ForeName>Soo Youn</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chungnam National University School of Medicine, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Choi</LastName><ForeName>Jae Sung</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Hyun</LastName><ForeName>Suk Hwan</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Ko</LastName><ForeName>Young Bok</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Chungnam National University Hospital, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chungnam National University School of Medicine, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Lee</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Chungnam National University Hospital, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chungnam National University School of Medicine, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Kang</LastName><ForeName>Byung Hun</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Chungnam National University Hospital, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chungnam National University School of Medicine, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Kim</LastName><ForeName>Bo Young</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Chungnam National University Hospital, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Min</LastName><ForeName>Jin Hong</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>In</LastName><ForeName>Yong Nam</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Jung</LastName><ForeName>Sang Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Oh</LastName><ForeName>Se Kwang</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Yoo</LastName><ForeName>Heon Jong</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Chungnam National University Sejong Hospital, Sejong, Republic of Korea. bell4184@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chungnam National University School of Medicine, Daejeon, Republic of Korea. bell4184@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=""D016428"">Journal Article</PublicationType><PublicationType UI=""D016448"">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType=""Electronic""><Year>2024</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>World J Emerg Surg</MedlineTA><NlmUniqueID>101266603</NlmUniqueID><ISSNLinking>1749-7922</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI=""D019344"">Lactic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D012189"" MajorTopicYN=""N"">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""Y"">Postpartum Hemorrhage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D011379"" MajorTopicYN=""N"">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D019344"" MajorTopicYN=""N"">Lactic Acid</DescriptorName><QualifierName UI=""Q000097"" MajorTopicYN=""N"">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=""NOTNLM""><Keyword MajorTopicYN=""N"">Disseminated intravascular coagulation</Keyword><Keyword MajorTopicYN=""N"">Hemorrhagic shock</Keyword><Keyword MajorTopicYN=""N"">Hysterectomy</Keyword><Keyword MajorTopicYN=""N"">Lactic acid</Keyword><Keyword MajorTopicYN=""N"">Postpartum Hemorrhage</Keyword><Keyword MajorTopicYN=""N"">Uterine Atony</Keyword><Keyword MajorTopicYN=""N"">Uterine artery embolization</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""received""><Year>2024</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=""accepted""><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pubmed""><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=""entrez""><Year>2024</Year><Month>8</Month><Day>1</Day><Hour>23</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pmc-release""><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">39090705</ArticleId><ArticleId IdType=""pmc"">PMC11293252</ArticleId><ArticleId IdType=""doi"">10.1186/s13017-024-00556-5</ArticleId><ArticleId IdType=""pii"">10.1186/s13017-024-00556-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bl&#xe1;ha J, Barto&#x161;ov&#xe1; T. Epidemiology and definition of PPH worldwide. Best Pract Res Clin Anaesthesiol. 2022;36(3&#x2013;4):325&#x2013;39. 10.1016/j.bpa.2022.11.001. 10.1016/j.bpa.2022.11.001</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.bpa.2022.11.001</ArticleId><ArticleId IdType=""pubmed"">36513428</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer MS, Berg C, Abenhaim H, Dahhou M, Rouleau J, Mehrabadi A, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol. 2013;209(5):e4491&#x2013;7. 10.1016/j.ajog.2013.07.007.10.1016/j.ajog.2013.07.007</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ajog.2013.07.007</ArticleId><ArticleId IdType=""pubmed"">23871950</ArticleId></ArticleIdList></Reference><Reference><Citation>Leduc D, Senikas V, Lalonde AB. 235-active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2018;40(12):e841&#x2013;55. 10.1016/j.jogc.2018.09.024. 10.1016/j.jogc.2018.09.024</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.jogc.2018.09.024</ArticleId><ArticleId IdType=""pubmed"">30527079</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath WH. Postpartum hemorrhage&#x2013;update on problems of definitions and diagnosis. Acta Obstet Gynecol Scand. 2011;90(5):421&#x2013;8. 10.1111/j.1600-0412.2011.01107.x. 10.1111/j.1600-0412.2011.01107.x</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1600-0412.2011.01107.x</ArticleId><ArticleId IdType=""pubmed"">21332452</ArticleId></ArticleIdList></Reference><Reference><Citation>Menard MK, Main EK, Currigan SM. Executive summary of the reVITALize initiative: standardizing obstetric data definitions. Obstet Gynecol. 2014;124(1):150&#x2013;3. 10.1097/AOG.0000000000000322. 10.1097/AOG.0000000000000322</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/AOG.0000000000000322</ArticleId><ArticleId IdType=""pubmed"">24901267</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks A. The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next? BJOG. 2015;122(2):202&#x2013;10. 10.1111/1471-0528.13098. 10.1111/1471-0528.13098</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/1471-0528.13098</ArticleId><ArticleId IdType=""pubmed"">25289730</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutomski JE, Byrne BM, Devane D, Greene RA. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG. 2012;119(3):306&#x2013;14. 10.1111/j.1471-0528.2011.03198.x. 10.1111/j.1471-0528.2011.03198.x</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.2011.03198.x</ArticleId><ArticleId IdType=""pubmed"">22168794</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentilhes L, Vayssi&#xe8;re C, Deneux-Tharaux C, Aya AG, Bayoumeu F, Bonnet MP, et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol. 2016;198:12&#x2013;21. 10.1016/j.ejogrb.2015.12.012. 10.1016/j.ejogrb.2015.12.012</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ejogrb.2015.12.012</ArticleId><ArticleId IdType=""pubmed"">26773243</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnar J. Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14(1):1&#x2013;18. 10.1053/beog.1999.0060. 10.1053/beog.1999.0060</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1053/beog.1999.0060</ArticleId><ArticleId IdType=""pubmed"">10789257</ArticleId></ArticleIdList></Reference><Reference><Citation>Said Ali A, Faraag E, Mohammed M, Elmarghany Z, Helaly M, Gadallah A, et al. The safety and effectiveness of Bakri balloon in the management of postpartum hemorrhage: a systematic review. J Matern Fetal Neonatal Med. 2021;34(2):300&#x2013;7. 10.1080/14767058.2019.1605349. 10.1080/14767058.2019.1605349</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1080/14767058.2019.1605349</ArticleId><ArticleId IdType=""pubmed"">30957590</ArticleId></ArticleIdList></Reference><Reference><Citation>Deux JF, Bazot M, Le Blanche AF, Tassart M, Khalil A, Berkane N, et al. Is selective embolization of uterine arteries a safe alternative to hysterectomy in patients with postpartum hemorrhage? AJR Am J Roentgenol. 2001;177(1):145&#x2013;9. 10.2214/ajr.177.1.1770145. 10.2214/ajr.177.1.1770145</Citation><ArticleIdList><ArticleId IdType=""doi"">10.2214/ajr.177.1.1770145</ArticleId><ArticleId IdType=""pubmed"">11418416</ArticleId></ArticleIdList></Reference><Reference><Citation>Stensaeth KH, Sovik E, Haig IN, Skomedal E, Jorgensen A. Fluoroscopy-free resuscitative endovascular balloon occlusion of the aorta (REBOA) for controlling life threatening postpartum hemorrhage. PLoS ONE. 2017;12(3):e0174520. 10.1371/journal.pone.0174520. 10.1371/journal.pone.0174520</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1371/journal.pone.0174520</ArticleId><ArticleId IdType=""pmc"">PMC5371310</ArticleId><ArticleId IdType=""pubmed"">28355242</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;vik E, Stokkeland P, Storm BS, Asheim P, Bol&#xe5;s O. The use of aortic occlusion balloon catheter without fluoroscopy for life-threatening post-partum haemorrhage. Acta Anaesthesiol Scand. 2012;56(3):388&#x2013;93. 10.1111/j.1399-6576.2011.02611.x. 10.1111/j.1399-6576.2011.02611.x</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1399-6576.2011.02611.x</ArticleId><ArticleId IdType=""pubmed"">22260088</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, Shen L, Wang S, Wang H. Retrospective analysis of 586 cases of placenta previa and accreta. J Obstet Gynaecol. 2020;40(5):609&#x2013;13. 10.1080/01443615.2019.1634019. 10.1080/01443615.2019.1634019</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1080/01443615.2019.1634019</ArticleId><ArticleId IdType=""pubmed"">31476941</ArticleId></ArticleIdList></Reference><Reference><Citation>Qatawneh A, Fram KM, Thikerallah F, Mhidat N, Fram FK, Fram RK, et al. Emergency peripartum hysterectomy at Jordan University hospital - a teaching hospital experience. Prz Menopauzalny. 2020;19(2):66&#x2013;71. 10.5114/pm.2020.97840. 10.5114/pm.2020.97840</Citation><ArticleIdList><ArticleId IdType=""doi"">10.5114/pm.2020.97840</ArticleId><ArticleId IdType=""pmc"">PMC7422286</ArticleId><ArticleId IdType=""pubmed"">32802016</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathiraja PDM, Jayawardane A. Evaluation of peripartum hysterectomy in a tertiary care unit and its effect on patients&#x2019; long-term physical and mental wellbeing: quest is not over when you save the life. Obstet Gynecol Int. 2021;2021:5720264. 10.1155/2021/5720264. 10.1155/2021/5720264</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1155/2021/5720264</ArticleId><ArticleId IdType=""pmc"">PMC7906802</ArticleId><ArticleId IdType=""pubmed"">33679986</ArticleId></ArticleIdList></Reference><Reference><Citation>Huque S, Roberts I, Fawole B, Chaudhri R, Arulkumaran S, Shakur-Still H. Risk factors for peripartum hysterectomy among women with postpartum haemorrhage: analysis of data from the WOMAN trial. BMC Pregnancy Childbirth. 2018;18(1):186. 10.1186/s12884-018-1829-7. 10.1186/s12884-018-1829-7</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1186/s12884-018-1829-7</ArticleId><ArticleId IdType=""pmc"">PMC5975404</ArticleId><ArticleId IdType=""pubmed"">29843627</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Zhou Y, Liu A, Pu Z. Relationship between dynamic changes of microcirculation flow, tissue perfusion parameters, and lactate level and mortality of septic shock in ICU. Contrast Media Mol Imaging. 2022;2022:1192902. 10.1155/2022/1192902. 10.1155/2022/1192902</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1155/2022/1192902</ArticleId><ArticleId IdType=""pmc"">PMC9568350</ArticleId><ArticleId IdType=""pubmed"">36277595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Kim SH, Jang JH, Park JH, Jo KM, No TH, et al. Clinical usefulness of biomarkers for diagnosis and prediction of prognosis in sepsis and septic shock. Med (Baltim). 2022;101(48):e31895. 10.1097/MD.0000000000031895.10.1097/MD.0000000000031895</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/MD.0000000000031895</ArticleId><ArticleId IdType=""pmc"">PMC9726295</ArticleId><ArticleId IdType=""pubmed"">36482619</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23(1):98. 10.1186/s13054-019-2347-3. 10.1186/s13054-019-2347-3</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1186/s13054-019-2347-3</ArticleId><ArticleId IdType=""pmc"">PMC6436241</ArticleId><ArticleId IdType=""pubmed"">30917843</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutschler M, Nienaber U, M&#xfc;nzberg M, W&#xf6;lfl C, Schoechl H, Paffrath T, TraumaRegister DGU, et al. The shock index revisited - a fast guide to transfusion requirement? A retrospective analysis on 21,853 patients derived from the TraumaRegister DGU. Crit Care. 2013;17(4):R172. 10.1186/cc12851. 10.1186/cc12851</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1186/cc12851</ArticleId><ArticleId IdType=""pmc"">PMC4057268</ArticleId><ArticleId IdType=""pubmed"">23938104</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan S, Mascha E, Na J, Sessler DI. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology. 2008;108(1):71&#x2013;7. 10.1097/01.anes.0000296719.73450.52. 10.1097/01.anes.0000296719.73450.52</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/01.anes.0000296719.73450.52</ArticleId><ArticleId IdType=""pubmed"">18156884</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienstock JL, Eke AC, Hueppchen NA. Postpartum hemorrhage. N Engl J Med. 2021;384(17):1635&#x2013;45. 10.1056/NEJMra1513247. 10.1056/NEJMra1513247</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1056/NEJMra1513247</ArticleId><ArticleId IdType=""pmc"">PMC10181876</ArticleId><ArticleId IdType=""pubmed"">33913640</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanc J, Courbiere B, Desbriere R, Bretelle F, Boubli L, D&#x2019;Ercole C, et al. Uterine-sparing surgical management of postpartum hemorrhage: is it always effective? Arch Gynecol Obstet. 2012;285(4):925&#x2013;30. 10.1007/s00404-011-2083-7. 10.1007/s00404-011-2083-7</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1007/s00404-011-2083-7</ArticleId><ArticleId IdType=""pubmed"">21932086</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan JY, Zhou ZM, Xu X, Huang XY, Xu RL, Lin SH. Risk factors and surgical interventions associated with primary postpartum haemorrhage unresponsive to first-line therapies. J Obstet Gynaecol. 2014;34(7):588&#x2013;92. 10.3109/01443615.2014.920310. 10.3109/01443615.2014.920310</Citation><ArticleIdList><ArticleId IdType=""doi"">10.3109/01443615.2014.920310</ArticleId><ArticleId IdType=""pubmed"">24911676</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin S, Guzin K, Ero&#x11f;lu M, Kayabasoglu F, Ya&#x15f;artekin MS. Emergency peripartum hysterectomy: our 12-year experience. Arch Gynecol Obstet. 2014;289(5):953&#x2013;8. 10.1007/s00404-013-3079-2. 10.1007/s00404-013-3079-2</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1007/s00404-013-3079-2</ArticleId><ArticleId IdType=""pubmed"">24213098</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J, Mousa HA. Peripartum hysterectomy for primary postpartum haemorrhage: incidence and maternal morbidity. J Obstet Gynaecol. 2007;27(1):44&#x2013;7. 10.1080/01443610601016925. 10.1080/01443610601016925</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1080/01443610601016925</ArticleId><ArticleId IdType=""pubmed"">17365458</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoll W, Phelan R, Hopman WM, Ho AM, Cenkowski M, Mizubuti GB, et al. Retrospective review of time to uterotonic administration and maternal outcomes after postpartum hemorrhage. J Obstet Gynaecol Can. 2022;44(5):490&#x2013;5. 10.1016/j.jogc.2021.11.011. 10.1016/j.jogc.2021.11.011</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.jogc.2021.11.011</ArticleId><ArticleId IdType=""pubmed"">34844004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbakwa MR, Tendongfor N, Ngunyi YL, Ngek ESN, Alemkia F, Egbe TO. Indications and outcomes of emergency obstetric hysterectomy; a 5-year review at the Bafoussam Regional Hospital, Cameroon. BMC Pregnancy Childbirth. 2021;21(1):323. 10.1186/s12884-021-03797-3. 10.1186/s12884-021-03797-3</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1186/s12884-021-03797-3</ArticleId><ArticleId IdType=""pmc"">PMC8067397</ArticleId><ArticleId IdType=""pubmed"">33892626</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurn L, Wikman A, Lindqvist PG. Postpartum blood transfusion and hemorrhage as independent risk factors for venous thromboembolism. Thromb Res. 2018;165:54&#x2013;60. 10.1016/j.thromres.2018.03.002. 10.1016/j.thromres.2018.03.002</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.thromres.2018.03.002</ArticleId><ArticleId IdType=""pubmed"">29573720</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaca Z, Laway BA, Dokmetas HS, Atmaca H, Kelestimur F. Sheehan syndrome. Nat Rev Dis Primers. 2016;2:16092. 10.1038/nrdp.2016.92. 10.1038/nrdp.2016.92</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1038/nrdp.2016.92</ArticleId><ArticleId IdType=""pubmed"">28004764</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>'",2024
1,"INTRODUCTION: Uterine compressive sutures are conservative measures applied in cases of severe postpartum hemorrhage unresponsive to uterotonics. Pereira's suture was introduced in 2005 and consists of two longitudinal and three transverse non-transfixes sutures. Previous studies reported favorable results, highlighting its benefits and value. The aim of this study was to assess the efficacy, complications, and impact on fertility and future pregnancies of Pereira's suture applied in cases of uterine atony and postpartum hemorrhage.
METHODS: An observational retrospective study was performed by consulting the medical records of women treated with Pereira's compressive sutures in a tertiary center between January 2013 and December 2022. We registered demographic data, pregnancy outcomes, short-term complications, and outcomes of subsequent pregnancies.
RESULTS: A total of 50 women were treated with Pereira's suture. The overall success rate was 96% and no hysterectomies were performed. Women who had sutures performed during an intra-cesarean section had better outcomes than those who had an after-cesarean section. Complications were reported in 12% (n = 6) of women, with the most frequent being pelvic infection (n = 3) and abdominal pain (n = 3). Regarding fertility, all women desiring a future pregnancy (n = 5) were able to conceive, resulting in three live births.
CONCLUSION: Pereira's suture is a type of suture that provides numerous advantages and should be considered when first-line medical treatment fails. When applied at an early stage, the sutures may prevent maternal morbidity. The Alcides Pereira's suture is a safe technique and appears to preserve fertility.",Cordeiro Féria B,CordeiroFériaB,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018e9516d0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e953090>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e951c90>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e950190>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e952050>]","['Cordeiro Féria B', 'Nazaré P', 'Figueiredo J', 'Neves Gomes I', 'Pereira A']",Cordeiro Féria B; Nazaré P; Figueiredo J; Neves Gomes I; Pereira A,,,,,,,,,,,,,,,{},"Cordeiro Féria B, et al. Efficacy, Complications and Effects of Alcides Pereira's Sutures in the Management of Uterine Atony: A Retrospective Study. Efficacy, Complications and Effects of Alcides Pereira's Sutures in the Management of Uterine Atony: A Retrospective Study. 2024; 37:518-525. doi: 10.20344/amp.20429","Cordeiro Féria B, <i>et al</i>. Efficacy, Complications and Effects of Alcides Pereira's Sutures in the Management of Uterine Atony: A Retrospective Study. Efficacy, Complications and Effects of Alcides Pereira's Sutures in the Management of Uterine Atony: A Retrospective Study. 2024; 37:518-525. doi: 10.20344/amp.20429",<Element PubmedArticle at 0x7f018e9057c0>,10.20344/amp.20429,518.0,[],"{'received': datetime.datetime(2023, 8, 6, 0, 0), 'accepted': datetime.datetime(2023, 11, 8, 0, 0), 'medline': datetime.datetime(2024, 7, 22, 0, 0), 'pubmed': datetime.datetime(2024, 3, 6, 0, 0), 'entrez': datetime.datetime(2024, 3, 6, 0, 0)}",1646-0758,7-8,Acta Med Port,,"{'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D012189': {'descriptor_name': 'Retrospective Studies', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D000328': {'descriptor_name': 'Adult', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': True, 'qualifier_name': None, 'qualifier_ui': None}, 'D013536': {'descriptor_name': 'Suture Techniques', 'major_topic': True, 'qualifier_name': None, 'qualifier_ui': None}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D014593': {'descriptor_name': 'Uterine Inertia', 'major_topic': True, 'qualifier_name': 'surgery', 'qualifier_ui': 'Q000601'}, 'D016896': {'descriptor_name': 'Treatment Outcome', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D002585': {'descriptor_name': 'Cesarean Section', 'major_topic': False, 'qualifier_name': 'adverse effects', 'qualifier_ui': 'Q000009'}, 'D011256': {'descriptor_name': 'Pregnancy Outcome', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D055815': {'descriptor_name': 'Young Adult', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D013537': {'descriptor_name': 'Sutures', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}}",518-525,<function MetaPubObject.parse_xml at 0x7f01911c1120>,,,38447018,,"{'D016428': 'Journal Article', 'D064888': 'Observational Study'}",article,"Efficacy, Complications and Effects of Alcides Pereira's Sutures in the Management of Uterine Atony: A Retrospective Study.",<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018fa05750>>,https://ncbi.nlm.nih.gov/pubmed/38447018,37,37(7-8),"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Curated""><PMID Version=""1"">38447018</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel=""Electronic-Print""><Journal><ISSN IssnType=""Electronic"">1646-0758</ISSN><JournalIssue CitedMedium=""Internet""><Volume>37</Volume><Issue>7-8</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Acta medica portuguesa</Title><ISOAbbreviation>Acta Med Port</ISOAbbreviation></Journal><ArticleTitle>Efficacy, Complications and Effects of Alcides Pereira\'s Sutures in the Management of Uterine Atony: A Retrospective Study.</ArticleTitle><Pagination><StartPage>518</StartPage><EndPage>525</EndPage><MedlinePgn>518-525</MedlinePgn></Pagination><ELocationID EIdType=""doi"" ValidYN=""Y"">10.20344/amp.20429</ELocationID><Abstract><AbstractText Label=""INTRODUCTION"" NlmCategory=""BACKGROUND"">Uterine compressive sutures are conservative measures applied in cases of severe postpartum hemorrhage unresponsive to uterotonics. Pereira\'s suture was introduced in 2005 and consists of two longitudinal and three transverse non-transfixes sutures. Previous studies reported favorable results, highlighting its benefits and value. The aim of this study was to assess the efficacy, complications, and impact on fertility and future pregnancies of Pereira\'s suture applied in cases of uterine atony and postpartum hemorrhage.</AbstractText><AbstractText Label=""METHODS"" NlmCategory=""METHODS"">An observational retrospective study was performed by consulting the medical records of women treated with Pereira\'s compressive sutures in a tertiary center between January 2013 and December 2022. We registered demographic data, pregnancy outcomes, short-term complications, and outcomes of subsequent pregnancies.</AbstractText><AbstractText Label=""RESULTS"" NlmCategory=""RESULTS"">A total of 50 women were treated with Pereira\'s suture. The overall success rate was 96% and no hysterectomies were performed. Women who had sutures performed during an intra-cesarean section had better outcomes than those who had an after-cesarean section. Complications were reported in 12% (n = 6) of women, with the most frequent being pelvic infection (n = 3) and abdominal pain (n = 3). Regarding fertility, all women desiring a future pregnancy (n = 5) were able to conceive, resulting in three live births.</AbstractText><AbstractText Label=""CONCLUSION"" NlmCategory=""CONCLUSIONS"">Pereira\'s suture is a type of suture that provides numerous advantages and should be considered when first-line medical treatment fails. When applied at an early stage, the sutures may prevent maternal morbidity. The Alcides Pereira\'s suture is a safe technique and appears to preserve fertility.</AbstractText></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Cordeiro F&#xe9;ria</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Ginecologia e Obstetr&#xed;cia. Hospital Garcia de Orta. Almada. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Nazar&#xe9;</LastName><ForeName>Patr&#xed;cia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Ginecologia e Obstetr&#xed;cia. Hospital Garcia de Orta. Almada. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Figueiredo</LastName><ForeName>Joana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Ginecologia e Obstetr&#xed;cia. Hospital Garcia de Orta. Almada. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Neves Gomes</LastName><ForeName>In&#xea;s</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Ginecologia e Obstetr&#xed;cia. Hospital Garcia de Orta. Almada. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Pereira</LastName><ForeName>Alcides</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Ginecologia e Obstetr&#xed;cia. Hospital Garcia de Orta. Almada. Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=""D016428"">Journal Article</PublicationType><PublicationType UI=""D064888"">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType=""Electronic""><Year>2024</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Portugal</Country><MedlineTA>Acta Med Port</MedlineTA><NlmUniqueID>7906803</NlmUniqueID><ISSNLinking>0870-399X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D012189"" MajorTopicYN=""N"">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""Y"">Postpartum Hemorrhage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D013536"" MajorTopicYN=""Y"">Suture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D014593"" MajorTopicYN=""Y"">Uterine Inertia</DescriptorName><QualifierName UI=""Q000601"" MajorTopicYN=""N"">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D016896"" MajorTopicYN=""N"">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D002585"" MajorTopicYN=""N"">Cesarean Section</DescriptorName><QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D011256"" MajorTopicYN=""N"">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D055815"" MajorTopicYN=""N"">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D013537"" MajorTopicYN=""N"">Sutures</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=""NOTNLM""><Keyword MajorTopicYN=""N"">Postpartum Hemorrhage/surgery</Keyword><Keyword MajorTopicYN=""N"">Postpartum Period</Keyword><Keyword MajorTopicYN=""N"">Suture Techniques</Keyword><Keyword MajorTopicYN=""N"">Uterine Inertia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""received""><Year>2023</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=""accepted""><Year>2023</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2024</Year><Month>7</Month><Day>22</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pubmed""><Year>2024</Year><Month>3</Month><Day>6</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=""entrez""><Year>2024</Year><Month>3</Month><Day>6</Day><Hour>15</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">38447018</ArticleId><ArticleId IdType=""doi"">10.20344/amp.20429</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>'",2024
2,"OBJECTIVES: To describe the use of the B-Lynch suture in a case of postpartum hemorrhage of a woman with bicornuate uterus, and to carry out a review of the literature on PPH control strategies in patients with müllerian anomalies, maternal outcomes in terms of hemorrhage control, as well as early and late complications.
MATERIAL AND METHODS: Case report of a patient with bicornuate uterus who presented to a regional referral hospital with postpartum hemorrhage following a cesarean section, which was successfully controlled using the B-Lynch suture. A search was conducted in the PubMed, Embase, Medline, Google Scholar and LILACS databases. The MeSh terms used were: “Uterine Atony,” “Postpartum Hemorrhage,” “Immediate Postpartum Hemorrhage,” “Bicornuate Uterus,” “Müllerian Anomalies,” “Müllerian Duct Abnormalities”. Case reports and case series of patients with müllerian malformations and PPH not responding to initial pharmacological management in whom conservative surgical procedures were used to control bleeding were included. A narrative analysis of the findings was carried out based on study characteristics, techniques used and complications.
RESULTS: Five studies were selected, 4 case reports and 1 case series which included 12 women with uterine malformations who developed PPH and in whom surgical management (uterine compression sutures) or devices (intrauterine balloon) were used for hemorrhage control. Bleeding was successfully controlled in 11 cases, with hysterectomy required only in one case (8.3 %). No long-term complications were reported.
CONCLUSIONS: The literature on PPH management in women with müllerian uterine malformations is limited to case reports in which either compression sutures or medical devices such as intrauterine balloons were used. The B-Lynch-type compression suture appears to be a good option for controlling PPH in these women in order to preserve fertility, with a low rate of complications. Further documentation of these types of cases is needed in order to build the evidence regarding the usefulness of this technique for controlling postpartum uterine bleeding in this population.",Rueda-Monsalbe A,Rueda-MonsalbeA,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf5890>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf5f10>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faf4150>]","['Rueda-Monsalbe A', 'Sanabria-Castelblanco JE', 'Montañez-Aldana MÁ']",Rueda-Monsalbe A; Sanabria-Castelblanco JE; Montañez-Aldana MÁ,,,,,,,,,,,,,,,{},"Rueda-Monsalbe A, et al. Management of postpartum hemorrhage in a patient with bicornuate uterus using the B-Lynch suture. Case report and review of the literature. Management of postpartum hemorrhage in a patient with bicornuate uterus using the B-Lynch suture. Case report and review of the literature. 2023; 74:153-162. doi: 10.18597/rcog.3989","Rueda-Monsalbe A, <i>et al</i>. Management of postpartum hemorrhage in a patient with bicornuate uterus using the B-Lynch suture. Case report and review of the literature. Management of postpartum hemorrhage in a patient with bicornuate uterus using the B-Lynch suture. Case report and review of the literature. 2023; 74:153-162. doi: 10.18597/rcog.3989",<Element PubmedArticle at 0x7f018faf53c0>,10.18597/rcog.3989,153.0,[],"{'received': datetime.datetime(2022, 12, 27, 0, 0), 'accepted': datetime.datetime(2023, 6, 5, 0, 0), 'medline': datetime.datetime(2023, 8, 2, 0, 0), 'pubmed': datetime.datetime(2023, 7, 31, 0, 0), 'entrez': datetime.datetime(2023, 7, 31, 0, 0), 'pmc-release': datetime.datetime(2023, 6, 30, 0, 0)}",2463-0225,2,Rev Colomb Obstet Ginecol,,"{'D014599': {'descriptor_name': 'Uterus', 'major_topic': False, 'qualifier_name': 'abnormalities', 'qualifier_ui': 'Q000002'}, 'D002585': {'descriptor_name': 'Cesarean Section', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': True, 'qualifier_name': None, 'qualifier_ui': None}, 'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D014564': {'descriptor_name': 'Urogenital Abnormalities', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D000093663': {'descriptor_name': 'Bicornuate Uterus', 'major_topic': True, 'qualifier_name': None, 'qualifier_ui': None}, 'D016896': {'descriptor_name': 'Treatment Outcome', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D013536': {'descriptor_name': 'Suture Techniques', 'major_topic': False, 'qualifier_name': 'adverse effects', 'qualifier_ui': 'Q000009'}, 'D013537': {'descriptor_name': 'Sutures', 'major_topic': False, 'qualifier_name': 'adverse effects', 'qualifier_ui': 'Q000009'}}",153-162,<function MetaPubObject.parse_xml at 0x7f01911c1120>,,10419877.0,37523684,,"{'D016454': 'Review', 'D002363': 'Case Reports', 'D016428': 'Journal Article'}",article,Management of postpartum hemorrhage in a patient with bicornuate uterus using the B-Lynch suture. Case report and review of the literature.,<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018e94c5d0>>,https://ncbi.nlm.nih.gov/pubmed/37523684,74,74(2),"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Automated""><PMID Version=""1"">37523684</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel=""Electronic""><Journal><ISSN IssnType=""Electronic"">2463-0225</ISSN><JournalIssue CitedMedium=""Internet""><Volume>74</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Revista colombiana de obstetricia y ginecologia</Title><ISOAbbreviation>Rev Colomb Obstet Ginecol</ISOAbbreviation></Journal><ArticleTitle>Management of postpartum hemorrhage in a patient with bicornuate uterus using the B-Lynch suture. Case report and review of the literature.</ArticleTitle><Pagination><StartPage>153</StartPage><EndPage>162</EndPage><MedlinePgn>153-162</MedlinePgn></Pagination><ELocationID EIdType=""doi"" ValidYN=""Y"">10.18597/rcog.3989</ELocationID><Abstract><AbstractText Label=""OBJECTIVES"">To describe the use of the B-Lynch suture in a case of postpartum hemorrhage of a woman with bicornuate uterus, and to carry out a review of the literature on PPH control strategies in patients with m&#xfc;llerian anomalies, maternal outcomes in terms of hemorrhage control, as well as early and late complications.</AbstractText><AbstractText Label=""MATERIAL AND METHODS"">Case report of a patient with bicornuate uterus who presented to a regional referral hospital with postpartum hemorrhage following a cesarean section, which was successfully controlled using the B-Lynch suture. A search was conducted in the PubMed, Embase, Medline, Google Scholar and LILACS databases. The MeSh terms used were: &#x201c;Uterine Atony,&#x201d; &#x201c;Postpartum Hemorrhage,&#x201d; &#x201c;Immediate Postpartum Hemorrhage,&#x201d; &#x201c;Bicornuate Uterus,&#x201d; &#x201c;M&#xfc;llerian Anomalies,&#x201d; &#x201c;M&#xfc;llerian Duct Abnormalities&#x201d;. Case reports and case series of patients with m&#xfc;llerian malformations and PPH not responding to initial pharmacological management in whom conservative surgical procedures were used to control bleeding were included. A narrative analysis of the findings was carried out based on study characteristics, techniques used and complications.</AbstractText><AbstractText Label=""RESULTS"">Five studies were selected, 4 case reports and 1 case series which included 12 women with uterine malformations who developed PPH and in whom surgical management (uterine compression sutures) or devices (intrauterine balloon) were used for hemorrhage control. Bleeding was successfully controlled in 11 cases, with hysterectomy required only in one case (8.3 %). No long-term complications were reported.</AbstractText><AbstractText Label=""CONCLUSIONS"">The literature on PPH management in women with m&#xfc;llerian uterine malformations is limited to case reports in which either compression sutures or medical devices such as intrauterine balloons were used. The B-Lynch-type compression suture appears to be a good option for controlling PPH in these women in order to preserve fertility, with a low rate of complications. Further documentation of these types of cases is needed in order to build the evidence regarding the usefulness of this technique for controlling postpartum uterine bleeding in this population.</AbstractText></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Rueda-Monsalbe</LastName><ForeName>Amanecer</ForeName><Initials>A</Initials><Identifier Source=""ORCID"">0000-0002-0520-8228</Identifier><AffiliationInfo><Affiliation>ESE San Rafael de Rond&#xf3;n, Rond&#xf3;n (Colombia).. amanecer.rueda@uptc.edu.co.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Sanabria-Castelblanco</LastName><ForeName>Jhon Edison</ForeName><Initials>JE</Initials><Identifier Source=""ORCID"">0000-0002-8192-7208</Identifier><AffiliationInfo><Affiliation>Hospital Universitario San Rafael de Tunja, Tunja (Colombia).. jhonesanabria24@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Monta&#xf1;ez-Aldana</LastName><ForeName>Miguel &#xc1;ngel</ForeName><Initials>M&#xc1;</Initials><Identifier Source=""ORCID"">0000-0003-3618-1790</Identifier><AffiliationInfo><Affiliation>Universidad Pedag&#xf3;gica y Tecnol&#xf3;gica de Colombia, Tunja (Colombia).. miguel.montanez03@uptc.edu.co.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI=""D016454"">Review</PublicationType><PublicationType UI=""D002363"">Case Reports</PublicationType><PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Manejo de la hemorragia posparto en una paciente con &#xfa;tero bicorne con la sutura B-Lynch. Reporte de caso y revisi&#xf3;n de la literatura.</VernacularTitle><ArticleDate DateType=""Electronic""><Year>2023</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Colombia</Country><MedlineTA>Rev Colomb Obstet Ginecol</MedlineTA><NlmUniqueID>0404263</NlmUniqueID><ISSNLinking>0034-7434</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type=""Disease"" UI=""C562565"">Uterine Anomalies</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=""D014599"" MajorTopicYN=""N"">Uterus</DescriptorName><QualifierName UI=""Q000002"" MajorTopicYN=""N"">abnormalities</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D002585"" MajorTopicYN=""N"">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""Y"">Postpartum Hemorrhage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D014564"" MajorTopicYN=""N"">Urogenital Abnormalities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D000093663"" MajorTopicYN=""Y"">Bicornuate Uterus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D016896"" MajorTopicYN=""N"">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D013536"" MajorTopicYN=""N"">Suture Techniques</DescriptorName><QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D013537"" MajorTopicYN=""N"">Sutures</DescriptorName><QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type=""Publisher"" Language=""spa""><AbstractText Label=""OBJETIVOS"">describir un caso de manejo con sutura de B-Lynch en una mujer con &#xfa;tero bicorne que presenta hemorragia posparto (HPP), y realizar una revisi&#xf3;n de la literatura acerca de las estrategias de control quir&#xfa;rgico de la HPP en pacientes con malformaciones m&#xfc;llerianas, los resultados maternos en t&#xe9;rminos de control de la hemorragia, as&#xed; como las complicaciones tempranas y tard&#xed;as.</AbstractText><AbstractText Label=""MATERIALES Y M&#xc9;TODOS"">se reporta el caso de una paciente con &#xfa;tero bicorne, atendida en un hopsital de referencia regional, que, posterior a parto por ces&#xe1;rea, presenta hemorragia posparto, la cual es controlada con &#xe9;xito empleando la sutura de B-Lynch. Se realiz&#xf3; una b&#xfa;squeda en las siguientes bases de datos: PubMed, Embase, Medline, Google Scholar y LILACS. Se emplearon los t&#xe9;rminos MeSh: &#x201c;Uterine Atony&#x201d;, &#x201c;Postpartum Hemorrhage&#x201d;, &#x201c;Immediate Postpartum Hemorrhage&#x201d;, &#x201c;Bicornuate Uterus&#x201d;, &#x201c;Mullerian Anomalies&#x201d;, &#x201c;Mullerian Ducts Abnormalities&#x201d;, &#x201c;Uterine Compression Suture&#x201d;. Se incluyeron reportes y series de casos que hubieran incluido pacientes con malformaciones m&#xfc;llerianas con HPP que no respondieran al manejo farmacol&#xf3;gico inicial, con uso de procedimientos quir&#xfa;rgicos conservadores para el control de la hemorragia. Se hace an&#xe1;lisis narrativo de los hallazgos respecto a las caracter&#xed;sticas de los estudios, t&#xe9;cnicas utilizadas y complicaciones.</AbstractText><AbstractText Label=""RESULTADOS"">se seleccionaron 5 estudios, 4 de tipo reporte de caso y 1 serie de casos, que corresponden a 12 mujeres con malformaci&#xf3;n uterina que desarrollaron HPP, en las cuales se emple&#xf3; manejo quir&#xfa;rgico (suturas de compresi&#xf3;n uterina), y con dispositivo (tipo bal&#xf3;n intrauterino) para el control de la hemorragia, logrando controlar el sangrado en 11 casos, solo una (8,3 %) requiri&#xf3; histerectom&#xed;a. No se reportan complicaciones a largo plazo.</AbstractText><AbstractText Label=""CONCLUSIONES"">el manejo de la HPP en mujeres con malformaciones uterinas m&#xfc;llerianas cuenta con una literatura limitada a reportes de casos, con uso tanto de suturas compresivas como dispositivos m&#xe9;dicos tipo balones intrauterinos. La sutura compresiva tipo B-Lynch parece ser una buena alternativa en el control de la HPP en estas mujeres con el fin de preservar la fertilidad, con baja tasa de complicaciones. Se requiere continuar documentando este tipo de casos con el fin de consolidar evidencia de la utilidad de esta t&#xe9;cnica en el control del sangrado uterino posparto en esta poblaci&#xf3;n.</AbstractText></OtherAbstract><OtherAbstract Type=""Publisher"" Language=""eng""><AbstractText Label=""OBJECTIVES:"">To describe the use of the B-Lynch suture in a case of postpartum hemorrhage of a woman with bicornuate uterus, and to carry out a review of the literature on PPH control strategies in patients with m&#xfc;llerian anomalies, maternal outcomes in terms of hemorrhage control, as well as early and late complications.</AbstractText><AbstractText Label=""MATERIAL AND METHODS:"">Case report of a patient with bicornuate uterus who presented to a regional referral hospital with postpartum hemorrhage following a cesarean section, which was successfully controlled using the B-Lynch suture. A search was conducted in the PubMed, Embase, Medline, Google Scholar and LILACS databases. The MeSh terms used were: ""Uterine Atony,"" ""Postpartum Hemorrhage,"" ""Immediate Postpartum Hemorrhage,"" ""Bicornuate Uterus,"" ""M&#xfc;llerian Anomalies,"" ""M&#xfc;llerian Duct Abnormalities"". Case reports and case series of patients with m&#xfc;llerian malformations and PPH not responding to initial pharmacological management in whom conservative surgical procedures were used to control bleeding were included. A narrative analysis of the findings was carried out based on study characteristics, techniques used and complications.</AbstractText><AbstractText Label=""RESULTS:"">Five studies were selected, 4 case reports and 1 case series which included 12 women with uterine malformations who developed PPH and in whom surgical management (uterine compression sutures) or devices (intrauterine balloon) were used for hemorrhage control. Bleeding was successfully controlled in 11 cases, with hysterectomy required only in one case (8.3 %). No long-term complications were reported.</AbstractText><AbstractText Label=""CONCLUSIONS:"">The literature on PPH management in women with m&#xfc;llerian uterine malformations is limited to case reports in which either compression sutures or medical devices such as intrauterine balloons were used. The B-Lynch-type compression suture appears to be a good option for controlling PPH in these women in order to preserve fertility, with a low rate of complications. Further documentation of these types of cases is needed in order to build the evidence regarding the usefulness of this technique for controlling postpartum uterine bleeding in this population.</AbstractText></OtherAbstract><KeywordList Owner=""NOTNLM""><Keyword MajorTopicYN=""N"">Case reports</Keyword><Keyword MajorTopicYN=""N"">postpartum hemorrhage</Keyword><Keyword MajorTopicYN=""N"">uterus</Keyword><Keyword MajorTopicYN=""N"">uterine duplication anomalies</Keyword><Keyword MajorTopicYN=""N"">uterine inertia</Keyword></KeywordList><CoiStatement><b>Conflicto de intereses:</b> los autores declaran no tener ning&#xfa;n conflicto de intereses.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""received""><Year>2022</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=""accepted""><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pubmed""><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus=""entrez""><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>16</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pmc-release""><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">37523684</ArticleId><ArticleId IdType=""pmc"">PMC10419877</ArticleId><ArticleId IdType=""doi"">10.18597/rcog.3989</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Safier LZ, Rackow BW. Congenital mullerian anomalies: Diagnosis and management. Springer; 2016. pp. 95&#x2013;104.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1007/978-3-319-27231-3_8</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YY, Jayaprakasan K, Zamora J, Thornton JG, Raine-Fenning N, Coomarasamy A. The prevalence of congenital uterine anomalies in unselected and high-risk populations: A systematic review. Hum Reprod Update. 2011;17(6):761&#x2013;771. doi: 10.1093/humupd/dmr028.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1093/humupd/dmr028</ArticleId><ArticleId IdType=""pmc"">PMC3191936</ArticleId><ArticleId IdType=""pubmed"">21705770</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes E, Vitale SG, Alvarado D, Iyune E, Vitagliano A, Lohmeyer FM, et al. M&#xfc;llerian anomalies prevalence diagnosed by hysteroscopy and laparoscopy in Mexican infertile women: Results from a cohort study. Diagnostics. 2019;9(4):149&#x2013;149. doi: 10.3390/diagnostics9040149.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.3390/diagnostics9040149</ArticleId><ArticleId IdType=""pmc"">PMC6963274</ArticleId><ArticleId IdType=""pubmed"">31627332</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez CA, De los R&#xed;os LF, Ibat&#xe1; JM. Preval encia de anomal&#xed;as m&#xfc;llerianas en un centro de medicina reproductiva. CES Medicina. 2012;26(2):155&#x2013;164. https://www.redalyc.org/articulo.oa?id=261125094002</Citation></Reference><Reference><Citation>Metin G&#xfc;lmezoglu A, Souza JP, Chou D, Mathai M, Hill S, Abalos E. WHO guidelines for the management of postpartum haemorrhage and retained placenta. World Health Organization. 2009</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23844453</ArticleId></ArticleIdList></Reference><Reference><Citation>Say L, Chou D, Gemmill A, Tun&#xe7;alp O, Moller AB, Daniels J, et al. Global causes of maternal death: A WHO systematic analysis. Lancet Glob Health. 2014;2(6):323&#x2013;333. doi: 10.1016/S2214-109X(14)70227-X.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/S2214-109X(14)70227-X</ArticleId><ArticleId IdType=""pubmed"">25103301</ArticleId></ArticleIdList></Reference><Reference><Citation>Instituto Nacional de Salud  . Bolet&#xed;n Epidemiol&#xf3;gico Semanal: Semana epidemiol&#xf3;gica 52, 25 al 31 de diciembre de 2022. 2022. pp. 7&#x2013;8.https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2022 Bolet%C3%ADnepidemiologico_semana_52.pdf</Citation></Reference><Reference><Citation>V&#xe9;lez GA, Agudelo B, G&#xf3;mez JG, Zuleta JJ. C&#xf3;digo rojo: gu&#xed;a para el manejo de la hemorragia obst&#xe9;trica. Rev Colomb Obstet Ginecol. 2023;60(1):34&#x2013;48. doi: 10.18S97/rcog.352.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.18S97/rcog.352</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010;110(5):1368&#x2013;1373. doi: 10.1213/ANE.0b013e3181d74898.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1213/ANE.0b013e3181d74898</ArticleId><ArticleId IdType=""pubmed"">20237047</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on Practice Bulletins-Obstetrics Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168&#x2013;e186. doi: 10.1097/AOG.0000000000002351.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/AOG.0000000000002351</ArticleId><ArticleId IdType=""pubmed"">28937571</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy CR, Moore JL, Saleem S, Tshefu A, Bose CL, Chomba E, et al. Malpresentation in low- and middle-income countries: Associations with perinatal and maternal outcomes in the Global Network. Acta Obstet Gynecol Scand. 2019;98(3):300&#x2013;308. doi: 10.1111/aogs.13502.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/aogs.13502</ArticleId><ArticleId IdType=""pmc"">PMC6422525</ArticleId><ArticleId IdType=""pubmed"">30414270</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Yu F, Xu Y, Li J, Guan Z, Sun M, et al. Prevalence and risk factors of severe postpartum hemorrhage: A retrospective cohort study. BMC Pregnancy Childbirth. 2021;21(332) doi: 10.1186/s12884-021-03818-1.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1186/s12884-021-03818-1</ArticleId><ArticleId IdType=""pmc"">PMC8077797</ArticleId><ArticleId IdType=""pubmed"">33902475</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano D, Mashiach S, Seidman DS. A prospective cohort study of oxytocin plus ergometrine compared with oxytocin alone for prevention of postpartum haemorrhage. BJOG. 1996;103(11):1068&#x2013;1073. doi: 10.1111/j.1471-0528.1996.tb09584.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.1996.tb09584.x</ArticleId><ArticleId IdType=""pubmed"">8916990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tungalp O, Hofmeyr GJ, G&#xfc;lmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews. 2012;8:CD000494&#x2013;CD000494. doi: 10.1002/14651858.cd000494.pub4.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1002/14651858.cd000494.pub4</ArticleId><ArticleId IdType=""pmc"">PMC7043277</ArticleId><ArticleId IdType=""pubmed"">22895917</ArticleId></ArticleIdList></Reference><Reference><Citation>Butwick AJ, Carvalho B, Blumenfeld YJ, El-Sayed YY, Nelson LM, Bateman BT. Second-line uterotonics and the risk of hemorrhage-related morbidity. Am J Obstet Gynecol. 2015;212(5):642.e1&#x2013;642.e7. doi: 10.1016/j.ajog.2015.01.008.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ajog.2015.01.008</ArticleId><ArticleId IdType=""pmc"">PMC4416982</ArticleId><ArticleId IdType=""pubmed"">25582104</ArticleId></ArticleIdList></Reference><Reference><Citation>Aibar L, Aguilar MT, Puertas A, Valverde M. Bakri balloon for the management of postpartum hemorrhage. Acta Obstet Gynecol Scand. 2013;92(4):465&#x2013;467. doi: 10.1111/j.1600-0412.2012.01497.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1600-0412.2012.01497.x</ArticleId><ArticleId IdType=""pubmed"">22762694</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves ALL, Francisco AA, Osanan GC, Vieira LB. Postpartum hemorrhage: Prevention, diagnosis and non-surgical management. Rev Bras Ginecol Obstet. 2020;42(11):776&#x2013;784. doi: 10.1055/s-0040-1721882.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1055/s-0040-1721882</ArticleId><ArticleId IdType=""pmc"">PMC10416182</ArticleId><ArticleId IdType=""pubmed"">33254276</ArticleId></ArticleIdList></Reference><Reference><Citation>B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: An alternative to hysterectomy? Five cases reported. BJOG. 1997;104(3):372&#x2013;375. doi: 10.1111/j.1471-0528.1997.tb11471.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.1997.tb11471.x</ArticleId><ArticleId IdType=""pubmed"">9091019</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwabara M, Takahashi Y, Iwagaki S, Imai N, Asai K, Matsui M, et al. Effectiveness of preventive B-Lynch sutures in patients at a high risk of postpartum hemorrhage. J Obstet Gynaecol Res. 2022;48(12):3111&#x2013;3118. doi: 10.1111/jog.15415.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/jog.15415</ArticleId><ArticleId IdType=""pubmed"">36089573</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Guerra R, Assaf-Balut M, El-Bakkali S, P&#xe9;rez de Avila-Benavides I, Huertas-Fern&#xe1;ndez MA. Necrosis uterina tras sutura de compresi&#xf3;n hemost&#xe1;tica: reporte de caso y revisi&#xf3;n de la literatura. Rev Colomb Obstet Ginecol. 2022;73(4):378&#x2013;387. doi: 10.18597/rcog.3856.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.18597/rcog.3856</ArticleId><ArticleId IdType=""pmc"">PMC9856609</ArticleId><ArticleId IdType=""pubmed"">36637386</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Obstetricians and Gynecologists ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: Nomenclature, interpretation, and general management principles. ACOG. 2009;114(1):192&#x2013;202. doi: 10.1097/AOG.0b013e3181aef106.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/AOG.0b013e3181aef106</ArticleId><ArticleId IdType=""pubmed"">19546798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplanoglu M. The uterine sandwich method for placenta previa accreta in mullerian anomaly: Combining the B-Lynch compression suture and an intrauterine Gauze tampon. Case Rep Obstet Gynecol. 2013;2013:236069&#x2013;236069. doi: 10.1155/2013/236069.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1155/2013/236069</ArticleId><ArticleId IdType=""pmc"">PMC3626387</ArticleId><ArticleId IdType=""pubmed"">23607012</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyar IH, Boynukalin FK, Boyar N, Vural M. Uterin anomali olgusunda postpartum kanama kontrol&#xfc;nde B-Lynch s&#xfc;t&#xfc;r teknigi. J Turk Ger Gynecol Assoc. 2011;12(1):47&#x2013;49. doi: 10.5152/jtgga.2011.10.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.5152/jtgga.2011.10</ArticleId><ArticleId IdType=""pmc"">PMC3939291</ArticleId><ArticleId IdType=""pubmed"">24591957</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan ES, Basharat A. Successful use of balloon tamponade in the management of postpartum hemorrhage in a case of bicornuate uterus. SAGE Open Med Case Rep. 2018;6:2050313X1877617&#x2013;2050313X1877617. doi: 10.1177/2050313x18776174.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1177/2050313x18776174</ArticleId><ArticleId IdType=""pmc"">PMC5960844</ArticleId><ArticleId IdType=""pubmed"">29796270</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham C. Bakri balloon placement in the successful management of postpartum hemorrhage in a bicornuate uterus: A case report. Int J Surg Case Rep. 2017;(31):218&#x2013;220. doi: 10.1016/j.ijscr.2017.01.055.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijscr.2017.01.055</ArticleId><ArticleId IdType=""pmc"">PMC5302184</ArticleId><ArticleId IdType=""pubmed"">28189983</ArticleId></ArticleIdList></Reference><Reference><Citation>Halder A. A new uterine suture technique to control PPH in congenitally malformed uterus during caesar-ean section. J Obstet Gynaecol. 2009;29(5):402&#x2013;404. doi: 10.1080/01443610902898195.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1080/01443610902898195</ArticleId><ArticleId IdType=""pubmed"">19603317</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>'",2023
3,"OBJECTIVES: To present a case of uterine necrosis following hemostatic suturing to control postpartum bleeding, and to review the literature in order to identify the suture techniques employed, clinical findings, diagnostics and treatment in the clinical cases described.
MATERIAL AND METHODS: A 34-year-old woman presenting with abdominal pain eight days after cesarean delivery due to placenta previa who required B-Lynch compression suture due to uterine atony, and who was diagnosed with uterine necrosis. The patient underwent total abdominal hysterectomy with a satisfactory recovery. A systematic literature search was conducted in the Medline vía Pubmed, Embase and Web of Science databases. The search included case series and reports, and cohorts of women with uterine necrosis following the use of uterine compression sutures for postpartum bleeding. The analysis included sociodemographic and clinical variables at the time of diagnosis, suturing technique, diagnostic tests and treatment.
RESULTS: Overall, 23 studies with 24 patients were included. Of all necrosis cases, 83% occurred following cesarean section. B-Lynch was the suturing technique most frequently used (66 %), followed by the Cho suture (25 %). The most frequent symptoms were fever and abdominal pain. The most commonly used diagnostic test was computed tomography (9/24 cases). Hysterectomy was performed in the majority of cases (75 %).
CONCLUSIONS: Although rare, uterine wall necrosis is a serious complication. It would be advisable to design follow-up cohort studies of women undergoing these procedures in order to determine the incidence of associated complications.",García-Guerra R,García-GuerraR,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018e918e90>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e9187d0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e91ac90>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e91bb90>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e91a690>]","['García-Guerra R', 'Assaf-Balut M', 'El-Bakkali S', 'Pérez de Ávila-Benavides I', 'Huertas-Fernández MÁ']",García-Guerra R; Assaf-Balut M; El-Bakkali S; Pérez de Ávila-Benavides I; Huertas-Fernández MÁ,,,,,,,,,,,,,,,"{'D006490': {'substance_name': 'Hemostatics', 'registry_number': '0'}}","García-Guerra R, et al. Uterine necrosis following hemostatic compression suture: case report and review of the literature. Uterine necrosis following hemostatic compression suture: case report and review of the literature. 2022; 73:378-387. doi: 10.18597/rcog.3856","García-Guerra R, <i>et al</i>. Uterine necrosis following hemostatic compression suture: case report and review of the literature. Uterine necrosis following hemostatic compression suture: case report and review of the literature. 2022; 73:378-387. doi: 10.18597/rcog.3856",<Element PubmedArticle at 0x7f018e909a40>,10.18597/rcog.3856,378.0,[],"{'received': datetime.datetime(2022, 4, 7, 0, 0), 'accepted': datetime.datetime(2022, 8, 10, 0, 0), 'entrez': datetime.datetime(2023, 1, 13, 0, 0), 'pubmed': datetime.datetime(2023, 1, 14, 0, 0), 'medline': datetime.datetime(2023, 1, 18, 0, 0), 'pmc-release': datetime.datetime(2022, 12, 30, 0, 0)}",2463-0225,4,Rev Colomb Obstet Ginecol,,"{'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D000328': {'descriptor_name': 'Adult', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D002585': {'descriptor_name': 'Cesarean Section', 'major_topic': False, 'qualifier_name': 'adverse effects', 'qualifier_ui': 'Q000009'}, 'D006490': {'descriptor_name': 'Hemostatics', 'major_topic': True, 'qualifier_name': None, 'qualifier_ui': None}, 'D005500': {'descriptor_name': 'Follow-Up Studies', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': True, 'qualifier_name': 'etiology', 'qualifier_ui': 'Q000209'}, 'D013537': {'descriptor_name': 'Sutures', 'major_topic': False, 'qualifier_name': 'adverse effects', 'qualifier_ui': 'Q000009'}, 'D009336': {'descriptor_name': 'Necrosis', 'major_topic': False, 'qualifier_name': 'complications', 'qualifier_ui': 'Q000150'}}",378-387,<function MetaPubObject.parse_xml at 0x7f01911c1120>,,9856609.0,36637386,,"{'D016454': 'Review', 'D002363': 'Case Reports', 'D016428': 'Journal Article'}",article,Uterine necrosis following hemostatic compression suture: case report and review of the literature.,<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018e904550>>,https://ncbi.nlm.nih.gov/pubmed/36637386,73,73(4),"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Automated""><PMID Version=""1"">36637386</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel=""Electronic""><Journal><ISSN IssnType=""Electronic"">2463-0225</ISSN><JournalIssue CitedMedium=""Internet""><Volume>73</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>30</Day></PubDate></JournalIssue><Title>Revista colombiana de obstetricia y ginecologia</Title><ISOAbbreviation>Rev Colomb Obstet Ginecol</ISOAbbreviation></Journal><ArticleTitle>Uterine necrosis following hemostatic compression suture: case report and review of the literature.</ArticleTitle><Pagination><StartPage>378</StartPage><EndPage>387</EndPage><MedlinePgn>378-387</MedlinePgn></Pagination><ELocationID EIdType=""doi"" ValidYN=""Y"">10.18597/rcog.3856</ELocationID><Abstract><AbstractText Label=""OBJECTIVES"">To present a case of uterine necrosis following hemostatic suturing to control postpartum bleeding, and to review the literature in order to identify the suture techniques employed, clinical findings, diagnostics and treatment in the clinical cases described.</AbstractText><AbstractText Label=""MATERIAL AND METHODS"">A 34-year-old woman presenting with abdominal pain eight days after cesarean delivery due to placenta previa who required B-Lynch compression suture due to uterine atony, and who was diagnosed with uterine necrosis. The patient underwent total abdominal hysterectomy with a satisfactory recovery. A systematic literature search was conducted in the Medline v&#xed;a Pubmed, Embase and Web of Science databases. The search included case series and reports, and cohorts of women with uterine necrosis following the use of uterine compression sutures for postpartum bleeding. The analysis included sociodemographic and clinical variables at the time of diagnosis, suturing technique, diagnostic tests and treatment.</AbstractText><AbstractText Label=""RESULTS"">Overall, 23 studies with 24 patients were included. Of all necrosis cases, 83% occurred following cesarean section. B-Lynch was the suturing technique most frequently used (66 %), followed by the Cho suture (25 %). The most frequent symptoms were fever and abdominal pain. The most commonly used diagnostic test was computed tomography (9/24 cases). Hysterectomy was performed in the majority of cases (75 %).</AbstractText><AbstractText Label=""CONCLUSIONS"">Although rare, uterine wall necrosis is a serious complication. It would be advisable to design follow-up cohort studies of women undergoing these procedures in order to determine the incidence of associated complications.</AbstractText></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Garc&#xed;a-Guerra</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><Identifier Source=""ORCID"">0000-0003-1881-5921</Identifier><AffiliationInfo><Affiliation>Hospital Universitario de Getafe, Madrid (Espa&#xf1;a).. raquelgague@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Assaf-Balut</LastName><ForeName>Myrna</ForeName><Initials>M</Initials><Identifier Source=""ORCID"">0000-0002-3955-0363</Identifier><AffiliationInfo><Affiliation>Hospital Universitario de Getafe, Madrid (Espa&#xf1;a).. autor@contacto.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>El-Bakkali</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source=""ORCID"">0000-0002-6365-2378</Identifier><AffiliationInfo><Affiliation>Hospital Universitario Ibn Sina, Rabat (Marruecos).. autor@contacto.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>P&#xe9;rez de &#xc1;vila-Benavides</LastName><ForeName>Irene</ForeName><Initials>I</Initials><Identifier Source=""ORCID"">0000-0002-6222-7345</Identifier><AffiliationInfo><Affiliation>Hospital Universitario de Getafe, Madrid (Espa&#xf1;a).. autor@contacto.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Huertas-Fern&#xe1;ndez</LastName><ForeName>Miguel &#xc1;ngel</ForeName><Initials>M&#xc1;</Initials><Identifier Source=""ORCID"">0000-0002-0627-1595</Identifier><AffiliationInfo><Affiliation>Hospital Universitario de Getafe, Madrid (Espa&#xf1;a).. autor@contacto.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI=""D016454"">Review</PublicationType><PublicationType UI=""D002363"">Case Reports</PublicationType><PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Necrosis uterina tras sutura de compresi&#xf3;n hemost&#xe1;tica: reporte de caso y revisi&#xf3;n de la literatura.</VernacularTitle><ArticleDate DateType=""Electronic""><Year>2022</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Colombia</Country><MedlineTA>Rev Colomb Obstet Ginecol</MedlineTA><NlmUniqueID>0404263</NlmUniqueID><ISSNLinking>0034-7434</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=""D006490"">Hemostatics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D002585"" MajorTopicYN=""N"">Cesarean Section</DescriptorName><QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D006490"" MajorTopicYN=""Y"">Hemostatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D005500"" MajorTopicYN=""N"">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""Y"">Postpartum Hemorrhage</DescriptorName><QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName><QualifierName UI=""Q000601"" MajorTopicYN=""N"">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D013537"" MajorTopicYN=""N"">Sutures</DescriptorName><QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D009336"" MajorTopicYN=""N"">Necrosis</DescriptorName><QualifierName UI=""Q000150"" MajorTopicYN=""N"">complications</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type=""Publisher"" Language=""spa""><AbstractText Label=""OBJETIVOS"">presentar un caso de necrosis uterina tras t&#xe9;cnica de sutura hemost&#xe1;tica por hemorragia posparto y hacer una revisi&#xf3;n de la literatura para determinar la t&#xe9;cnica de sutura utilizada, los hallazgos cl&#xed;nicos, la t&#xe9;cnica diagn&#xf3;stica y el tratamiento realizado en los casos cl&#xed;nicos descritos.</AbstractText><AbstractText Label=""MATERIALES Y M&#xc9;TODOS"">se presenta el caso de una mujer de 34 a&#xf1;os que consult&#xf3; por dolor abdominal al octavo d&#xed;a tras ces&#xe1;rea por placenta previa, que precis&#xf3; sutura de B-Lynch por aton&#xed;a uterina y cuyo diagn&#xf3;stico fue necrosis uterina. La paciente requiri&#xf3; histerectom&#xed;a abdominal total, con evoluci&#xf3;n satisfactoria. Se realiz&#xf3; una b&#xfa;squeda sistem&#xe1;tica de la literatura en las bases de datos Medline v&#xed;a Pubmed, Embase y Web of Science. Se buscaron series y reportes de casos y cohortes de mujeres con necrosis uterina posterior al uso de suturas de compresi&#xf3;n uterina para control de hemorragia posparto. Se analizaron variables sociodemogr&#xe1;ficas y cl&#xed;nicas al diagn&#xf3;stico, t&#xe9;cnica de sutura, pruebas diagn&#xf3;sticas y tratamiento.</AbstractText><AbstractText Label=""RESULTADOS"">se incluyeron 23 estudios con 24 pacientes. El 83&#x2009;% de las necrosis ocurrieron tras ces&#xe1;rea. La t&#xe9;cnica m&#xe1;s utilizada fue B-Lynch (66&#x2009;%), seguida de Cho (25&#x2009;%). Los s&#xed;ntomas m&#xe1;s frecuentes fueron fiebre y dolor abdominal. La prueba diagn&#xf3;stica m&#xe1;s utilizada fue la tomograf&#xed;a computarizada (9 de 24 casos). En la mayor&#xed;a de casos se realiz&#xf3; histerectom&#xed;a (75&#x2009;%).</AbstractText><AbstractText Label=""CONCLUSIONES"">la necrosis de la pared uterina es una complicaci&#xf3;n infrecuente pero grave. Ser&#xed;a recomendable el dise&#xf1;o de cohortes de seguimiento de mujeres sometidas a estos procedimientos para determinar la incidencia de complicaciones asociadas.</AbstractText></OtherAbstract><OtherAbstract Type=""Publisher"" Language=""eng""><AbstractText Label=""OBJECTIVES:"">To present a case of uterine necrosis following hemostatic suturing to control postpartum bleeding, and to review the literature in order to identify the suture techniques employed, clinical findings, diagnostics and treatment in the clinical cases described.</AbstractText><AbstractText Label=""MATERIAL AND METHODS:"">A 34-year-old woman presenting with abdominal pain eight days after cesarean delivery due to placenta previa who required B-Lynch compression suture due to uterine atony, and who was diagnosed with uterine necrosis. The patient underwent total abdominal hysterectomy with a satisfactory recovery. A systematic literature search was conducted in the Medline v&#xed;a Pubmed, Embase and Web of Science databases. The search included case series and reports, and cohorts of women with uterine necrosis following the use of uterine compression sutures for postpartum bleeding. The analysis included sociodemographic and clinical variables at the time of diagnosis, suturing technique, diagnostic tests and treatment.</AbstractText><AbstractText Label=""RESULTS:"">Overall, 23 studies with 24 patients were included. Of all necrosis cases, 83% occurred following cesarean section. B-Lynch was the suturing technique most frequently used (66 %), followed by the Cho suture (25 %). The most frequent symptoms were fever and abdominal pain. The most commonly used diagnostic test was computed tomography (9/24 cases). Hysterectomy was performed in the majority of cases (75 %).</AbstractText><AbstractText Label=""CONCLUSIONS:"">Although rare, uterine wall necrosis is a serious complication. It would be advisable to design follow-up cohort studies of women undergoing these procedures in order to determine the incidence of associated complications.</AbstractText></OtherAbstract><KeywordList Owner=""NOTNLM""><Keyword MajorTopicYN=""N"">Cesarean section</Keyword><Keyword MajorTopicYN=""N"">postpartum hemorrhage</Keyword><Keyword MajorTopicYN=""N"">necrosis</Keyword><Keyword MajorTopicYN=""N"">suture techniques</Keyword><Keyword MajorTopicYN=""N"">uterus</Keyword></KeywordList><CoiStatement><b>Conflicto de intereses:</b> ninguno declarado.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""received""><Year>2022</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=""accepted""><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=""entrez""><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>9</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pubmed""><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pmc-release""><Year>2022</Year><Month>12</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">36637386</ArticleId><ArticleId IdType=""pmc"">PMC9856609</ArticleId><ArticleId IdType=""doi"">10.18597/rcog.3856</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO . Trends in maternal mortality: 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva: World Health Organization; 2019.</Citation></Reference><Reference><Citation>Deneux-Tharaux C, Bonnet MP, Tort J. Epidemiologie de l\'hemorragie du post-partum. J Gynecol Obstet Biol Reprod (Paris) 2014;43(10):936&#x2013;950. doi: 10.1016/j.jgyn.2014.09.023.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.jgyn.2014.09.023</ArticleId><ArticleId IdType=""pubmed"">25447386</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar MF, Nassar AH, Theron G, Barnea ER, Nicholson W, Ramasauskaite D, et al. FIGO Safe Motherhood and Newborn Health Committee. FIGO recommendations on the management of postpartum hemorrhage 2022. Int J Gynaecol Obstet. 2022;157(1):3&#x2013;50. doi: 10.1002/ijgo.14116.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1002/ijgo.14116</ArticleId><ArticleId IdType=""pmc"">PMC9313855</ArticleId><ArticleId IdType=""pubmed"">35297039</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores VM, Garcia JA. Uso de suturas de compresi&#xf3;n uterina para el tratamiento de la hemorragia obstetrica. Rev Hosp Jua Mex. 2014;81(2):104&#x2013;109. https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=52051</Citation></Reference><Reference><Citation>B-Lynch C. Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: An alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol. 1997;(104):372&#x2013;375. doi: 10.1111/j.1471-0528.1997.tb11471.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.1997.tb11471.x</ArticleId><ArticleId IdType=""pubmed"">9091019</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayman RG, Arulkumaran S, Steer PJ. Uterine compression sutures: Surgical management of postpartum hemorrhage. Obstet Gynecol. 2002;(99):502&#x2013;506. doi: 10.1016/S0029-7844(01)01643-X.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/S0029-7844(01)01643-X</ArticleId><ArticleId IdType=""pubmed"">11864681</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JH, Jun HS, Lee CN. Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstet Gynecol. 2000;(96):129&#x2013;131. doi: 10.1097/00006250-200007000-00026.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/00006250-200007000-00026</ArticleId><ArticleId IdType=""pubmed"">10928901</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira A, Nunes F, Pedroso S, Saraiva J, Retto H, Meirinho M. Compressive uterine sutures to treat postpartum bleeding secondary to uterine atony. Obstet Gynecol. 2005;(106):569&#x2013;572. doi: 10.1097/01.AOG.0000168434.28222.d3.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/01.AOG.0000168434.28222.d3</ArticleId><ArticleId IdType=""pubmed"">16135589</ArticleId></ArticleIdList></Reference><Reference><Citation>Steer PJ. The surgical approach to postpartum haemorrhage. Obst Gynaecol. 2009;(11):231&#x2013;238. doi: 10.1576/toag.11.4.231.27525.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1576/toag.11.4.231.27525</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallappa Saroja CS, Nankani A, El-Hamamy E. Uterine compression sutures, an update: Review of efficacy, safety and complications of B-Lynch suture and other uterine compression techniques for postpartum haemorrhage. Arch Gynecol Obstet. 2010;(281):581&#x2013;588. doi: 10.1007/s00404-009-1249-z.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1007/s00404-009-1249-z</ArticleId><ArticleId IdType=""pubmed"">19834719</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubara S, Yano H, Ohkuchi A, Kuwata T, Usui R, Suzuki M. Uterine compression sutures for postpartum hemorrhage: An overview. Acta Obstet Gynecol Scand. 2013;92(4):378&#x2013;385. doi: 10.1111/aogs.12077.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/aogs.12077</ArticleId><ArticleId IdType=""pubmed"">23330882</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S, Aggarwal K, Chaudhary V, Satija B, Rajagopalan I, Sethi A. Ischemic uterine necrosis following Hayman suture for postpartum hemorrhage. Int J Gynaecol Obstet. 2021;152(2):277&#x2013;279. doi: 10.1002/ijgo.13343.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1002/ijgo.13343</ArticleId><ArticleId IdType=""pubmed"">32783188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ploteau S, Renou M, Lopes P. Uterine necrosis and pyometra following surgical hemostatic Cho suture for postpartum haemorrhage: Two cases. Eur J Obstet Gynecol Reprod Biol. 2012;161(2):233&#x2013;234. doi: 10.1016/j.ejogrb.2011.12.015.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ejogrb.2011.12.015</ArticleId><ArticleId IdType=""pubmed"">22261469</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkirane S, Saadi H, Serji B, Mimouni A. Uterine necrosis following a combination of uterine compression sutures and vascular ligation during a postpartum hemorrhage: A case report. Int J Surg Case Rep. 2017;(38):5&#x2013;7. doi: 10.1016/j.ijscr.2017.07.005.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijscr.2017.07.005</ArticleId><ArticleId IdType=""pmc"">PMC5516088</ArticleId><ArticleId IdType=""pubmed"">28728102</ArticleId></ArticleIdList></Reference><Reference><Citation>Akoury H, Sherman C. Uterine wall partial thickness necrosis following combined B-Lynch and Cho square sutures for the treatment of primary postpartum hemorrhage. J Obstet Gynaecol Can. 2008;(30):421&#x2013;424. doi: 10.1016/S1701-2163(16)32827-4.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/S1701-2163(16)32827-4</ArticleId><ArticleId IdType=""pubmed"">18505666</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi VM, Shrivastava M. Partial ischaemic necrosis of the uterus following a uterine brace compression suture. BJOG. 2004;(111):279&#x2013;280. doi: 10.1111/j.1471-0528.2004.00056.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.2004.00056.x</ArticleId><ArticleId IdType=""pubmed"">14961893</ArticleId></ArticleIdList></Reference><Reference><Citation>Treloar EJ, Anderson RS, Andrews HS, Bailey JL. Uterine necrosis following B-Lynch suture for primary postpartum haemorrhage. BJOG. 2006;(4):486&#x2013;488. doi: 10.1111/j.1471-0528.2006.00890.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.2006.00890.x</ArticleId><ArticleId IdType=""pubmed"">16553658</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb AG, Pandipati S, Davis KM, Gibbs RS. Uterine necrosis: A complication of uterine compression sutures. Obstet Gynecol. 2008;2(112):429&#x2013;431. doi: 10.1097/AOG.0b013e31817b0781.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/AOG.0b013e31817b0781</ArticleId><ArticleId IdType=""pubmed"">18669752</ArticleId></ArticleIdList></Reference><Reference><Citation>Moussaoui KE, Zraidi N, Baidada A, Kharbach A. Necrose uterine suite a une combinaison de compressions uterines et de ligature vasculaire lors d\'une hemorragie post-partum: a propos d&#x2019;un cas. Pan Afr Med J. 2020;(37):279&#x2013;279. doi: 10.11604/pamj.2020.37.279.26788.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.11604/pamj.2020.37.279.26788</ArticleId><ArticleId IdType=""pmc"">PMC7864268</ArticleId><ArticleId IdType=""pubmed"">33598093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A, Dash S, Rath SK. B-Lynch resulting in total uterine necrosis leading to obstetric hysterectomy. J Obstet Gynaecol India. 2019;69(1):4&#x2013;6. doi: 10.1007/s13224-017-1068-2.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1007/s13224-017-1068-2</ArticleId><ArticleId IdType=""pmc"">PMC6431710</ArticleId><ArticleId IdType=""pubmed"">30956480</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowat A, Minuzzo L, Wilson J. A necrotic uterus after a B-Lynch Suture: Fertility sparing surgery. Aust N Z J Obstet Gynaecol. 2013;53(4):408&#x2013;409. doi: 10.1111/ajo.12096.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/ajo.12096</ArticleId><ArticleId IdType=""pubmed"">23647460</ArticleId></ArticleIdList></Reference><Reference><Citation>Alaoui FZ, Jayi S, Bouguern H, Melhouf M, El Fatemi H, Amarti A. Necrose parietale uterine partielle apres capitonnage hemostatique au cours d\'une hemorragie de la delivrance. Pan Afr Med J. 2013;15(32):23&#x2013;27. doi: 10.11604/pamj.2013.15.32.2327.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.11604/pamj.2013.15.32.2327</ArticleId><ArticleId IdType=""pmc"">PMC3758845</ArticleId><ArticleId IdType=""pubmed"">24009808</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodhi W, Golara M, Karangaokar V, Yoong W. Uterine necrosis following application of combined uterine compression suture with intrauterine balloon tamponade. J Obstet Gynaecol. 2012;32(1):30&#x2013;31. doi: 10.11604/pamj.2013.15.32.2327.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.11604/pamj.2013.15.32.2327</ArticleId><ArticleId IdType=""pubmed"">22185530</ArticleId></ArticleIdList></Reference><Reference><Citation>Somalwar SA, Joshi SA, Bhalerao AV, Kawthalkar AS, Jain S, Mahore S. Total uterine necrosis: A complication of b-lynch suture. J SAFOG. 2012;4(1):61&#x2013;63. doi: 10.5005/jp-journals-10006-1176.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.5005/jp-journals-10006-1176</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyftmann L, Nguyen A, Ristic V, Rouleau C, Mazet N, Dechaud H. Partial uterine wall necrosis following Cho hemostatic sutures for the treatment of postpartum hemorrhage. Gynecol Obstet Fertil. 2009;(37):579&#x2013;582. doi: 10.1016/j.gyobfe.2008.09.025.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.gyobfe.2008.09.025</ArticleId><ArticleId IdType=""pubmed"">19477674</ArticleId></ArticleIdList></Reference><Reference><Citation>Satia MN, More VS. Uterine necrosis in a case of B lynch brace suture. Int J Reprod Contracept Obstet Gynecol. 2016;5(7):2466&#x2013;2469. doi: 10.18203/2320-1770.ijrcog20162153.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.18203/2320-1770.ijrcog20162153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratna Bulusu R, Dharma Vijaya MN, Chandra Mouli A, et al. Total uterine necrosis: A case report with review of literature. J Clin Biomed Sci. 2016;(6):33&#x2013;35.</Citation></Reference><Reference><Citation>Rashmi MD, Lokeshchandra HC, Chaitra TM. Uteroumbilical fistula with myometrial necrosis following compression suture for atonic PPH: A rare case. Arch Gynecol Obstet. 2013;287(5):1045&#x2013;1046. doi: 10.1007/s00404-012-2606-x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1007/s00404-012-2606-x</ArticleId><ArticleId IdType=""pubmed"">23179795</ArticleId></ArticleIdList></Reference><Reference><Citation>Saman Kumara YV, Marasinghe JP, Condous G, Marasinghe U. Pregnancy complicated by a uterine fundal defect resulting from a previous B-Lynch suture. Br J Obstet Gynaecol. 2009;(116):1815&#x2013;1817. doi: 10.1111/j.1471-0528.2009.02375.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.2009.02375.x</ArticleId><ArticleId IdType=""pubmed"">19832829</ArticleId></ArticleIdList></Reference><Reference><Citation>Pechtor K, Richards B, Paterson H. Antenatal catastrophic uterine rupture at 32 weeks of gestation after previous B-Lynch suture. Br J Obstet Gynaecol. 2010;(117):889&#x2013;891. doi: 10.1111/j.1471-0528.2010.02554.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.2010.02554.x</ArticleId><ArticleId IdType=""pubmed"">20406231</ArticleId></ArticleIdList></Reference><Reference><Citation>Friederich L, Roman H, Marpeau L. A dangerous development. Am J Obstet Gynecol. 2007;(196):92.e1&#x2013;92.e1. doi: 10.1016/j.ajog.2006.10.869.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ajog.2006.10.869</ArticleId><ArticleId IdType=""pubmed"">17240250</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur M, Rathore SS, Jindal A, Mahajan K. Uterocutaneous fistula following B-Lynch suture for primary postpartum haemorrhage. BMJ Case Rep. 2018;(bcr2017):223518&#x2013;223518. doi: 10.1136/bcr-2017-223518.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1136/bcr-2017-223518</ArticleId><ArticleId IdType=""pmc"">PMC5775789</ArticleId><ArticleId IdType=""pubmed"">29305372</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraswathi DB. Avascular necrosis of uterus: A s&#xe9;quela of B-Lynch Sutures. Res J Pharm Biol Chem Sci. 2014;5(6):274&#x2013;277.</Citation></Reference><Reference><Citation>Reyna-Villasmil E, Torres-Cepeda D, Rondon-Tapia M. Rotura uterina en el segundo trimestre por acretismo placentario, en gestante con sutura compresiva uterina previa. Rev Peru Ginecol Obstet. 2019;65(4):533&#x2013;536. doi: 10.31403/rpgo.v65i2217.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.31403/rpgo.v65i2217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>'",2022
4,"BACKGROUND: Postpartum hemorrhage is a main cause of maternal mortality worldwide, with rising incidence, thus demanding new treatment approaches. Intrauterine balloon systems with application of intrauterine vacuum are a promising new method.
METHOD: All women treated with vacuum-induced tamponade using a modified balloon system were included in this single-center study. Aiming to reduce uterine size for control of postpartum hemorrhage, the intrauterine balloon was filled to 50-100 mL and connected to a vacuum device. Success rate of vacuum-induced tamponade, defined as no need for additional interventional treatment, was analyzed by etiology of postpartum hemorrhage and time period of use.
EXPERIENCE: Vacuum-induced tamponade was applied in 66 women. Success rate was 86% in women with uterine atony (n=44) and 73% in women with postpartum hemorrhage due to placental pathology (n=22). Success rate improved over the study period, culminating in a success rate of 100% in women with postpartum hemorrhage due to uterine atony in the second half of the observation period (n=22).
CONCLUSION: This observational study supports our pathophysiologic understanding of uterine atony: to treat an atonic uterus, uterine volume must be reduced, leading to coiling of the uterine spiral arteries and, hence, reduced blood loss.",Haslinger C,HaslingerC,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018e96b750>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e96a590>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e968f90>]","['Haslinger C', 'Weber K', 'Zimmermann R']",Haslinger C; Weber K; Zimmermann R,,,,,,,,,,,,,,,{},"Haslinger C, et al. Vacuum-Induced Tamponade for Treatment of Postpartum Hemorrhage. Vacuum-Induced Tamponade for Treatment of Postpartum Hemorrhage. 2021; 138:361-365. doi: 10.1097/AOG.0000000000004510","Haslinger C, <i>et al</i>. Vacuum-Induced Tamponade for Treatment of Postpartum Hemorrhage. Vacuum-Induced Tamponade for Treatment of Postpartum Hemorrhage. 2021; 138:361-365. doi: 10.1097/AOG.0000000000004510",<Element PubmedArticle at 0x7f018e96af40>,10.1097/AOG.0000000000004510,361.0,[],"{'received': datetime.datetime(2021, 4, 6, 0, 0), 'accepted': datetime.datetime(2021, 6, 10, 0, 0), 'pubmed': datetime.datetime(2021, 8, 6, 0, 0), 'medline': datetime.datetime(2021, 10, 5, 0, 0), 'entrez': datetime.datetime(2021, 8, 5, 0, 0), 'pmc-release': datetime.datetime(2021, 8, 16, 0, 0)}",1873-233X,3,Obstet Gynecol,,"{'D000328': {'descriptor_name': 'Adult', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D015331': {'descriptor_name': 'Cohort Studies', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': False, 'qualifier_name': 'therapy', 'qualifier_ui': 'Q000628'}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D013557': {'descriptor_name': 'Switzerland', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D016896': {'descriptor_name': 'Treatment Outcome', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D058738': {'descriptor_name': 'Uterine Balloon Tamponade', 'major_topic': True, 'qualifier_name': None, 'qualifier_ui': None}, 'D014593': {'descriptor_name': 'Uterine Inertia', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D014618': {'descriptor_name': 'Vacuum', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}}",361-365,<function MetaPubObject.parse_xml at 0x7f01911c1120>,00006250-202109000-00007,8366764.0,34352848,,"{'D016428': 'Journal Article', 'D064888': 'Observational Study'}",article,Vacuum-Induced Tamponade for Treatment of Postpartum Hemorrhage.,<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018e975fd0>>,https://ncbi.nlm.nih.gov/pubmed/34352848,138,138(3),"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Manual""><PMID Version=""1"">34352848</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel=""Print""><Journal><ISSN IssnType=""Electronic"">1873-233X</ISSN><JournalIssue CitedMedium=""Internet""><Volume>138</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Obstetrics and gynecology</Title><ISOAbbreviation>Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Vacuum-Induced Tamponade for Treatment of Postpartum Hemorrhage.</ArticleTitle><Pagination><StartPage>361</StartPage><EndPage>365</EndPage><MedlinePgn>361-365</MedlinePgn></Pagination><ELocationID EIdType=""doi"" ValidYN=""Y"">10.1097/AOG.0000000000004510</ELocationID><Abstract><AbstractText Label=""BACKGROUND"">Postpartum hemorrhage is a main cause of maternal mortality worldwide, with rising incidence, thus demanding new treatment approaches. Intrauterine balloon systems with application of intrauterine vacuum are a promising new method.</AbstractText><AbstractText Label=""METHOD"">All women treated with vacuum-induced tamponade using a modified balloon system were included in this single-center study. Aiming to reduce uterine size for control of postpartum hemorrhage, the intrauterine balloon was filled to 50-100 mL and connected to a vacuum device. Success rate of vacuum-induced tamponade, defined as no need for additional interventional treatment, was analyzed by etiology of postpartum hemorrhage and time period of use.</AbstractText><AbstractText Label=""EXPERIENCE"">Vacuum-induced tamponade was applied in 66 women. Success rate was 86% in women with uterine atony (n=44) and 73% in women with postpartum hemorrhage due to placental pathology (n=22). Success rate improved over the study period, culminating in a success rate of 100% in women with postpartum hemorrhage due to uterine atony in the second half of the observation period (n=22).</AbstractText><AbstractText Label=""CONCLUSION"">This observational study supports our pathophysiologic understanding of uterine atony: to treat an atonic uterus, uterine volume must be reduced, leading to coiling of the uterine spiral arteries and, hence, reduced blood loss.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Haslinger</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source=""ORCID"">0000-0003-3344-9480</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics, University Hospital Zurich, and the University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Weber</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials></Author><Author ValidYN=""Y""><LastName>Zimmermann</LastName><ForeName>Roland</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=""D016428"">Journal Article</PublicationType><PublicationType UI=""D064888"">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Obstet Gynecol</MedlineTA><NlmUniqueID>0401101</NlmUniqueID><ISSNLinking>0029-7844</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D015331"" MajorTopicYN=""N"">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""N"">Postpartum Hemorrhage</DescriptorName><QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D013557"" MajorTopicYN=""N"" Type=""Geographic"">Switzerland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D016896"" MajorTopicYN=""N"">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D058738"" MajorTopicYN=""Y"">Uterine Balloon Tamponade</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D014593"" MajorTopicYN=""N"">Uterine Inertia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D014618"" MajorTopicYN=""N"">Vacuum</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Financial Disclosure The authors did not report any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""received""><Year>2021</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=""accepted""><Year>2021</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=""pubmed""><Year>2021</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""entrez""><Year>2021</Year><Month>8</Month><Day>5</Day><Hour>20</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pmc-release""><Year>2021</Year><Month>8</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">34352848</ArticleId><ArticleId IdType=""pmc"">PMC8366764</ArticleId><ArticleId IdType=""doi"">10.1097/AOG.0000000000004510</ArticleId><ArticleId IdType=""pii"">00006250-202109000-00007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Accessed February 13, 2019. http://www.ncbi.nlm.nih.gov/books/NBK131942/</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23586122</ArticleId></ArticleIdList></Reference><Reference><Citation>Say L, Chou D, Gemmill A, Tun&#x4ab;alp &#x4e6;, Moller AB, Daniels J, et al. . Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014;2:e323&#x2013;33. doi: 10.1016/S2214-109X(14)70227-X</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/S2214-109X(14)70227-X</ArticleId><ArticleId IdType=""pubmed"">25103301</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 [published erratum appears in Lancet 2017;389:e1]. Lancet 2016;388:1775&#x2013;812. doi: 10.1016/S0140-6736(16)31470-2</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/S0140-6736(16)31470-2</ArticleId><ArticleId IdType=""pmc"">PMC5224694</ArticleId><ArticleId IdType=""pubmed"">27733286</ArticleId></ArticleIdList></Reference><Reference><Citation>Reale SC, Easter SR, Xu X, Bateman BT, Farber MK. Trends in postpartum hemorrhage in the United States from 2010 to 2014. Anesth Analg 2020;130:e119&#x2013;22. doi: 10.1213/ANE.0000000000004424</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1213/ANE.0000000000004424</ArticleId><ArticleId IdType=""pubmed"">31567319</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks A. The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next? BJOG 2015;122:202&#x2013;10. doi: 10.1111/1471-0528.13098</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/1471-0528.13098</ArticleId><ArticleId IdType=""pubmed"">25289730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer MS, Berg C, Abenhaim H, Dahhou M, Rouleau J, Mehrabadi A, et al. . Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol 2013;209:449.e1&#x2013;7. doi: 10.1016/j.ajog.2013.07.007</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ajog.2013.07.007</ArticleId><ArticleId IdType=""pubmed"">23871950</ArticleId></ArticleIdList></Reference><Reference><Citation>Purwosunu Y, Sarkoen W, Arulkumaran S, Segnitz J. Control of postpartum hemorrhage using vacuum-induced uterine tamponade. Obstet Gynecol 2016;128:33&#x2013;6. doi: 10.1097/AOG.0000000000001473</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/AOG.0000000000001473</ArticleId><ArticleId IdType=""pubmed"">27275795</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahr MK, Brun R, Zimmermann R, Franke D, Haslinger C. Validation of a quantitative system for real-time measurement of postpartum blood loss. Arch Gynecol Obstet 2018;298:1071&#x2013;7. doi: 10.1007/s00404-018-4896-0</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1007/s00404-018-4896-0</ArticleId><ArticleId IdType=""pubmed"">30225686</ArticleId></ArticleIdList></Reference><Reference><Citation>D\'Alton ME, Rood KM, Smid MC, Simhan HN, Skupski DW, Subramaniam A, et al. . Intrauterine vacuum-induced hemorrhage-control device for rapid treatment of postpartum hemorrhage. Obstet Gynecol 2020;136:882&#x2013;91. doi: 10.1097/AOG.0000000000004138</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/AOG.0000000000004138</ArticleId><ArticleId IdType=""pmc"">PMC7575019</ArticleId><ArticleId IdType=""pubmed"">32909970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>'",2021
5,"OBJECTIVES: To evaluate uterine tamponade devices' effectiveness for atonic refractory postpartum haemorrhage (PPH) after vaginal birth and the effect of including them in institutional protocols.
SEARCH STRATEGY: PubMed, EMBASE, CINAHL, LILACS, POPLINE, from inception to January 2021.
STUDY SELECTION: Randomised and non-randomised comparative studies.
OUTCOMES: Composite outcome including surgical interventions (artery ligations, compressive sutures or hysterectomy) or maternal death, and hysterectomy.
RESULTS: All included studies were at high risk of bias. The certainty of the evidence was rated as very low to low. One randomised study measured the effect of the condom-catheter balloon compared with standard care and found unclear results for the composite outcome (relative risk [RR] 2.33, 95% CI 0.76-7.14) and hysterectomy (RR 4.14, 95% CI 0.48-35.93). Three comparative studies assessed the effect of including uterine balloon tamponade in institutional protocols. A stepped wedge cluster randomised controlled trial suggested an increase in the composite outcome (RR 4.08, 95% CI 1.07-15.58) and unclear results for hysterectomy (RR 4.38, 95% CI 0.47-41.09) with the use of the condom-catheter or surgical glove balloon. One non-randomised study showed unclear effects on the composite outcome (RR 0.33, 95% CI 0.11-1.03) and hysterectomy (RR 0.49, 95% CI 0.04-5.38) after the inclusion of the Bakri balloon. The second non-randomised study found unclear effects on the composite outcome (RR 0.95, 95% CI 0.32-2.81) and hysterectomy (RR 1.84, 95% CI 0.44-7.69) after the inclusion of Ebb or Bakri balloon.
CONCLUSIONS: The effect of uterine tamponade devices for the management of atonic refractory PPH after vaginal delivery is unclear, as is the role of the type of device and the setting.
TWEETABLE ABSTRACT: Unclear effects of uterine tamponade devices and their inclusion in institutional protocols for atonic refractory PPH after vaginal delivery.",Pingray V,PingrayV,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018faee790>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faec590>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faefe50>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faed4d0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faed350>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faec110>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faef710>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faef550>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faecb50>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faed210>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faeca50>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faeee50>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faecdd0>]","['Pingray V', 'Widmer M', 'Ciapponi A', 'Hofmeyr GJ', 'Deneux C', 'Gülmezoglu M', 'Bloemenkamp K', 'Oladapo OT', 'Comandé D', 'Bardach A', 'Vázquez P', 'Cormick G', 'Althabe F']",Pingray V; Widmer M; Ciapponi A; Hofmeyr GJ; Deneux C; Gülmezoglu M; Bloemenkamp K; Oladapo OT; Comandé D; Bardach A; Vázquez P; Cormick G; Althabe F,,,,,,,,,,,,,,,{},"Pingray V, et al. Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review. Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review. 2021; 128:1732-1743. doi: 10.1111/1471-0528.16819","Pingray V, <i>et al</i>. Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review. Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review. 2021; 128:1732-1743. doi: 10.1111/1471-0528.16819",<Element PubmedArticle at 0x7f018fada480>,10.1111/1471-0528.16819,1732.0,[],"{'accepted': datetime.datetime(2021, 4, 16, 0, 0), 'pubmed': datetime.datetime(2021, 6, 25, 0, 0), 'medline': datetime.datetime(2021, 9, 29, 0, 0), 'entrez': datetime.datetime(2021, 6, 24, 0, 0), 'pmc-release': datetime.datetime(2022, 7, 18, 0, 0)}",1471-0528,11,BJOG,,"{'D000328': {'descriptor_name': 'Adult', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D036861': {'descriptor_name': 'Delivery, Obstetric', 'major_topic': False, 'qualifier_name': 'adverse effects', 'qualifier_ui': 'Q000009'}, 'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006489': {'descriptor_name': 'Hemostatic Techniques', 'major_topic': False, 'qualifier_name': 'instrumentation', 'qualifier_ui': 'Q000295'}, 'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D007044': {'descriptor_name': 'Hysterectomy', 'major_topic': False, 'qualifier_name': 'mortality', 'qualifier_ui': 'Q000401'}, 'D008026': {'descriptor_name': 'Ligation', 'major_topic': False, 'qualifier_name': 'instrumentation', 'qualifier_ui': 'Q000295'}, 'D008428': {'descriptor_name': 'Maternal Mortality', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': False, 'qualifier_name': 'mortality', 'qualifier_ui': 'Q000401'}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D016896': {'descriptor_name': 'Treatment Outcome', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D055988': {'descriptor_name': 'Uterine Artery', 'major_topic': False, 'qualifier_name': 'surgery', 'qualifier_ui': 'Q000601'}, 'D055357': {'descriptor_name': 'Uterine Artery Embolization', 'major_topic': False, 'qualifier_name': 'instrumentation', 'qualifier_ui': 'Q000295'}, 'D058738': {'descriptor_name': 'Uterine Balloon Tamponade', 'major_topic': False, 'qualifier_name': 'instrumentation', 'qualifier_ui': 'Q000295'}, 'D014621': {'descriptor_name': 'Vagina', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}}",1732-1743,<function MetaPubObject.parse_xml at 0x7f01911c1120>,,9292664.0,34165867,,"{'D016428': 'Journal Article', 'D000078182': 'Systematic Review'}",article,Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review.,<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018e90b190>>,https://ncbi.nlm.nih.gov/pubmed/34165867,128,128(11),"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Manual""><PMID Version=""1"">34165867</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel=""Print-Electronic""><Journal><ISSN IssnType=""Electronic"">1471-0528</ISSN><JournalIssue CitedMedium=""Internet""><Volume>128</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>BJOG : an international journal of obstetrics and gynaecology</Title><ISOAbbreviation>BJOG</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review.</ArticleTitle><Pagination><StartPage>1732</StartPage><EndPage>1743</EndPage><MedlinePgn>1732-1743</MedlinePgn></Pagination><ELocationID EIdType=""doi"" ValidYN=""Y"">10.1111/1471-0528.16819</ELocationID><Abstract><AbstractText Label=""OBJECTIVES"">To evaluate uterine tamponade devices\' effectiveness for atonic refractory postpartum haemorrhage (PPH) after vaginal birth and the effect of including them in institutional protocols.</AbstractText><AbstractText Label=""SEARCH STRATEGY"">PubMed, EMBASE, CINAHL, LILACS, POPLINE, from inception to January 2021.</AbstractText><AbstractText Label=""STUDY SELECTION"">Randomised and non-randomised comparative studies.</AbstractText><AbstractText Label=""OUTCOMES"">Composite outcome including surgical interventions (artery ligations, compressive sutures or hysterectomy) or maternal death, and hysterectomy.</AbstractText><AbstractText Label=""RESULTS"">All included studies were at high risk of bias. The certainty of the evidence was rated as very low to low. One randomised study measured the effect of the condom-catheter balloon compared with standard care and found unclear results for the composite outcome (relative risk [RR] 2.33, 95% CI 0.76-7.14) and hysterectomy (RR 4.14, 95% CI 0.48-35.93). Three comparative studies assessed the effect of including uterine balloon tamponade in institutional protocols. A stepped wedge cluster randomised controlled trial suggested an increase in the composite outcome (RR 4.08, 95% CI 1.07-15.58) and unclear results for hysterectomy (RR 4.38, 95% CI 0.47-41.09) with the use of the condom-catheter or surgical glove balloon. One non-randomised study showed unclear effects on the composite outcome (RR 0.33, 95% CI 0.11-1.03) and hysterectomy (RR 0.49, 95% CI 0.04-5.38) after the inclusion of the Bakri balloon. The second non-randomised study found unclear effects on the composite outcome (RR 0.95, 95% CI 0.32-2.81) and hysterectomy (RR 1.84, 95% CI 0.44-7.69) after the inclusion of Ebb or Bakri balloon.</AbstractText><AbstractText Label=""CONCLUSIONS"">The effect of uterine tamponade devices for the management of atonic refractory PPH after vaginal delivery is unclear, as is the role of the type of device and the setting.</AbstractText><AbstractText Label=""TWEETABLE ABSTRACT"">Unclear effects of uterine tamponade devices and their inclusion in institutional protocols for atonic refractory PPH after vaginal delivery.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Pingray</LastName><ForeName>V</ForeName><Initials>V</Initials><Identifier Source=""ORCID"">0000-0002-7889-2825</Identifier><AffiliationInfo><Affiliation>Instituto de Efectividad Cl&#xed;nica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Widmer</LastName><ForeName>M</ForeName><Initials>M</Initials><Identifier Source=""ORCID"">0000-0002-4866-109X</Identifier><AffiliationInfo><Affiliation>UNDP-UNFPA-UNICEF-WHO-World Bank Special Program of Research, Development, and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Ciapponi</LastName><ForeName>A</ForeName><Initials>A</Initials><Identifier Source=""ORCID"">0000-0001-5142-6122</Identifier><AffiliationInfo><Affiliation>Instituto de Efectividad Cl&#xed;nica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Hofmeyr</LastName><ForeName>G J</ForeName><Initials>GJ</Initials><Identifier Source=""ORCID"">0000-0002-3080-1007</Identifier><AffiliationInfo><Affiliation>University of Botswana, Gaborone, Botswana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Effective Care Research Unit, University of the Witwatersrand/Walter Sisulu University, Mthatha, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Deneux</LastName><ForeName>C</ForeName><Initials>C</Initials><Identifier Source=""ORCID"">0000-0002-6561-3321</Identifier><AffiliationInfo><Affiliation>Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOP&#xe9;, INSERM, INRA, U1153 Centre for Epidemiology and Statistics Sorbonne Paris Cit&#xe9; (CRESS), Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>G&#xfc;lmezoglu</LastName><ForeName>M</ForeName><Initials>M</Initials><Identifier Source=""ORCID"">0000-0003-4674-0998</Identifier><AffiliationInfo><Affiliation>UNDP-UNFPA-UNICEF-WHO-World Bank Special Program of Research, Development, and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Concept Foundation, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Bloemenkamp</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Birth Centre Wilhelmina\'s Children Hospital, Division Woman and Baby, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Oladapo</LastName><ForeName>O T</ForeName><Initials>OT</Initials><AffiliationInfo><Affiliation>UNDP-UNFPA-UNICEF-WHO-World Bank Special Program of Research, Development, and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Comand&#xe9;</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Instituto de Efectividad Cl&#xed;nica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Bardach</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto de Efectividad Cl&#xed;nica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>V&#xe1;zquez</LastName><ForeName>P</ForeName><Initials>P</Initials><Identifier Source=""ORCID"">0000-0003-0206-6452</Identifier><AffiliationInfo><Affiliation>Instituto de Efectividad Cl&#xed;nica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Cormick</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Instituto de Efectividad Cl&#xed;nica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Althabe</LastName><ForeName>F</ForeName><Initials>F</Initials><Identifier Source=""ORCID"">0000-0002-7024-8701</Identifier><AffiliationInfo><Affiliation>UNDP-UNFPA-UNICEF-WHO-World Bank Special Program of Research, Development, and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=""Y""><Grant><Agency>UNICEF</Agency><Country/></Grant><Grant><Agency>World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, WHO</Agency><Country/></Grant><Grant><Agency>UNFPA</Agency><Country/></Grant><Grant><Agency>WHO</Agency><Country/></Grant><Grant><Agency>UNDP</Agency><Country/></Grant><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=""D016428"">Journal Article</PublicationType><PublicationType UI=""D000078182"">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType=""Electronic""><Year>2021</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJOG</MedlineTA><NlmUniqueID>100935741</NlmUniqueID><ISSNLinking>1470-0328</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType=""CommentIn""><RefSource>BJOG. 2021 Oct;128(11):1744. doi: 10.1111/1471-0528.16818.</RefSource><PMID Version=""1"">34165874</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D036861"" MajorTopicYN=""N"">Delivery, Obstetric</DescriptorName><QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName><QualifierName UI=""Q000379"" MajorTopicYN=""N"">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006489"" MajorTopicYN=""N"">Hemostatic Techniques</DescriptorName><QualifierName UI=""Q000295"" MajorTopicYN=""Y"">instrumentation</QualifierName><QualifierName UI=""Q000401"" MajorTopicYN=""N"">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D007044"" MajorTopicYN=""N"">Hysterectomy</DescriptorName><QualifierName UI=""Q000401"" MajorTopicYN=""N"">mortality</QualifierName><QualifierName UI=""Q000706"" MajorTopicYN=""N"">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D008026"" MajorTopicYN=""N"">Ligation</DescriptorName><QualifierName UI=""Q000295"" MajorTopicYN=""N"">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D008428"" MajorTopicYN=""N"">Maternal Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""N"">Postpartum Hemorrhage</DescriptorName><QualifierName UI=""Q000401"" MajorTopicYN=""N"">mortality</QualifierName><QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D016896"" MajorTopicYN=""N"">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D055988"" MajorTopicYN=""N"">Uterine Artery</DescriptorName><QualifierName UI=""Q000601"" MajorTopicYN=""N"">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D055357"" MajorTopicYN=""N"">Uterine Artery Embolization</DescriptorName><QualifierName UI=""Q000295"" MajorTopicYN=""N"">instrumentation</QualifierName><QualifierName UI=""Q000401"" MajorTopicYN=""N"">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D058738"" MajorTopicYN=""N"">Uterine Balloon Tamponade</DescriptorName><QualifierName UI=""Q000295"" MajorTopicYN=""Y"">instrumentation</QualifierName><QualifierName UI=""Q000401"" MajorTopicYN=""N"">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D014621"" MajorTopicYN=""N"">Vagina</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=""NOTNLM""><Keyword MajorTopicYN=""N"">Bakri balloon</Keyword><Keyword MajorTopicYN=""N"">condom uterine balloon tamponade</Keyword><Keyword MajorTopicYN=""N"">hysterectomy</Keyword><Keyword MajorTopicYN=""N"">maternal death</Keyword><Keyword MajorTopicYN=""N"">postpartum haemorrhage</Keyword><Keyword MajorTopicYN=""N"">uterine atony</Keyword><Keyword MajorTopicYN=""N"">vaginal delivery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""accepted""><Year>2021</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=""pubmed""><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""entrez""><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>12</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pmc-release""><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">34165867</ArticleId><ArticleId IdType=""pmc"">PMC9292664</ArticleId><ArticleId IdType=""doi"">10.1111/1471-0528.16819</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et&#xa0;al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014;2:e323&#x2013;33.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">25103301</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. Geneva, Switzerland: World Health Organization; 2012.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23586122</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmer M, Piaggio G, Hofmeyr GJ, Carroli G, Coomarasamy A, Gallos I, et&#xa0;al. Maternal characteristics and causes associated with refractory postpartum haemorrhage after vaginal birth: a secondary&#xa0;analysis of the WHO CHAMPION trial data. BJOG 2020;127:628&#x2013;34.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC7078998</ArticleId><ArticleId IdType=""pubmed"">31808245</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmer M, Piaggio G, Nguyen TMH, Osoti A, Owa OO, Misra S, et&#xa0;al. Heat&#x2010;stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth. N Engl J Med 2018;379:743&#x2013;52.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">29949473</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousa HA, Cording V, Alfirevic Z. Risk factors and interventions associated with major primary postpartum hemorrhage unresponsive to first&#x2010;line conventional therapy. Acta Obstet Gynecol Scand 2008;87:652&#x2013;61.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">18568465</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . WHO Recommendation on Tranexamic Acid for the Treatment of Postpartum Haemorrhage. Geneva, Switzerland: World Health Organization; 2017.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">29630190</ArticleId></ArticleIdList></Reference><Reference><Citation>\nTolosa J, Bakri Y, Arulkumaran S. Intrauterine balloon tamponade for control of postpartum hemorrhage\n. 2018.  [https://www.uptodate.com/contents/intrauterine&#x2010;balloon&#x2010;tamponade&#x2010;for&#x2010;control&#x2010;of&#x2010;postpartum&#x2010;hemorrhage?search=postpartum%20hemorrhage%20balloon%20tamponade&amp;source=search_result&amp;selectedTitle=1~150&amp;usage_type=default&amp;display_rank=1]. Accessed 17 July 2019.</Citation></Reference><Reference><Citation>Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG: Int J Obstet Gynaecol 2009;116:748&#x2013;57.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">19432563</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiou C. A review of current practice in using Balloon Tamponade Technology in the management of postpartum haemorrhage. Hypertens Res Pregnancy 2014;2:1&#x2013;10.</Citation></Reference><Reference><Citation>Ayres&#x2010;de&#x2010;Campos D, Stones W, Theron G; FIGO Safe Motherhood and Newborn Health Commitee . Affordable and low&#x2010;maintenance obstetric devices. Int J Gynaecol Obstet 2019;146:25&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">31055829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tindell K, Garfinkel R, Abu&#x2010;Haydar E, Ahn R, Burke T, Conn K, et&#xa0;al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource&#x2010;poor settings: a systematic review. BJOG: Int J Obstet Gynaecol 2013;120:5&#x2013;14.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">22882240</ArticleId></ArticleIdList></Reference><Reference><Citation>Purwosunu Y, Sarkoen W, Arulkumaran S, Segnitz J. Control of postpartum hemorrhage using vacuum&#x2010;induced uterine tamponade. Obstet Gynecol 2016;128:33&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">27275795</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmeyr GJ, Singata&#x2010;Madliki M. Novel suction tube uterine tamponade for treating intractable postpartum haemorrhage: description of technique and report of three cases. BJOG 2020;127:1280&#x2013;3.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">32043686</ArticleId></ArticleIdList></Reference><Reference><Citation>Meher S, Cuthbert A, Kirkham JJ, Williamson P, Abalos E, Aflaifel N, et&#xa0;al. Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study. BJOG 2019;126:83&#x2013;93.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">29920912</ArticleId></ArticleIdList></Reference><Reference><Citation>\nCovidence Systematic Review Software. Melbourne, Australia: Veritas Health Innovation. www.covidence.org\n</Citation></Reference><Reference><Citation>\nHiggins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Chapter 8: assessing risk of bias in a randomized trial. In: Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane; 2021. https://training.cochrane.org/handbook\n</Citation><ArticleIdList><ArticleId IdType=""pubmed"">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M, et&#xa0;al. ROBINS&#x2010;I: a tool for assessing risk of bias in non&#x2010;randomised studies of interventions. BMJ 2016;12:i4919.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC5062054</ArticleId><ArticleId IdType=""pubmed"">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck&#x2010;Ytter Y, Alonso&#x2010;Coello P, et&#xa0;al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC2335261</ArticleId><ArticleId IdType=""pubmed"">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.</Citation></Reference><Reference><Citation>Anger HA, Dabash R, Durocher J, Hassanein N, Ononge S, Frye LJ, et&#xa0;al. The effectiveness and safety of introducing condom&#x2010;catheter uterine balloon tamponade for postpartum haemorrhage at secondary level hospitals in Uganda, Egypt and Senegal: a stepped wedge, cluster&#x2010;randomised trial. BJOG 2019;126:1612&#x2013;21.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC6899652</ArticleId><ArticleId IdType=""pubmed"">31410966</ArticleId></ArticleIdList></Reference><Reference><Citation>Laas E, Bui C, Popowski T, Mbaku OM, Rozenberg P. Trends in the rate of invasive procedures after the addition of the intrauterine tamponade test to a protocol for management of severe postpartum hemorrhage. Am J Obstet Gynecol 2012;207:281.e1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23021688</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumont A, Bodin C, Hounkpatin B, Popowski T, Traore M, Perrin R, et&#xa0;al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and Mali. BMJ Open 2017;7:e016590.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC5589006</ArticleId><ArticleId IdType=""pubmed"">28864699</ArticleId></ArticleIdList></Reference><Reference><Citation>Revert M, Cottenet J, Raynal P, Cibot E, Quantin C, Rozenberg P. Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study. BJOG: Int J Obstet Gynaecol 2017;124:1255&#x2013;62.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">27781401</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwish AM, Abdallah MM, Shaaban OM, Ali MK, Khalaf M, Sabra AMA. Bakri balloon versus condom&#x2010;loaded Foley\'s catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. J Maternal&#x2010;Fetal Neonatal Med 2018;31:747&#x2013;53.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28274173</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks AD. Does balloon tamponade really make postpartum haemorrhage worse? BJOG 2019;126:1622.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC6899763</ArticleId><ArticleId IdType=""pubmed"">31529662</ArticleId></ArticleIdList></Reference><Reference><Citation>Houlihan C, Virk K, Lowe W, Dhillon P, Guzman E. The impact of the Bakri Balloon on the rate of cesarean hysterectomy at a single university hospital. Obstet Gynecol 2013;208:S59.</Citation></Reference><Reference><Citation>Von Beckerath AK, Maul H, Elmohandes AM, Shaaban M, Habib DM, Nasr A, et&#xa0;al. Comparison of celox and bakri balloon in management of primary atonic postpartum hemorrhage. Am J Obstet Gynecol 2016;214:S335.</Citation></Reference><Reference><Citation>Patane L, Cavalli G, Mandelli V, Strobelt N, Frigerio L, Pirola S, et&#xa0;al. Bakri balloon tamponade and uterine packing with gauze in post partum hemorrhage management: Any differences? Obstet Gynecol 2014;210:S322.</Citation></Reference><Reference><Citation>Loh YL, Lim C, Soon R. Bakri postpartum balloon in the management of postpartum haemorrhage in Sabah Women\'s And Children\'s Hospital (SWACH): A Sabah Experience. BJOG: Int J Obstet Gynaecol 2012;119:41.</Citation></Reference><Reference><Citation>Cornelissen L, Woodd S, Shakur&#x2010;Still H, Fawole B, Noor S, Etuk S, et&#xa0;al. Secondary analysis of the WOMAN trial to explore the risk of sepsis after invasive treatments for postpartum hemorrhage. Int J Gynaecol Obstet 2019;146:231&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC7814887</ArticleId><ArticleId IdType=""pubmed"">31081140</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra N, Gulabani K, Agrawal S, Shrivastava C. Efficacy and feasibility of chhattisgarh balloon and conventional condom balloon tamponade: a 2&#x2010;year prospective study. J Obstet Gynaecol India 2019;69:133&#x2013;41.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC6801252</ArticleId><ArticleId IdType=""pubmed"">31686746</ArticleId></ArticleIdList></Reference><Reference><Citation>Dueckelmann AM, Hinkson L, Nonnenmacher A, Siedentopf JP, Schoenborn I, Weizsaecker K, et&#xa0;al. Uterine packing with chitosan&#x2010;covered gauze compared to balloon tamponade for managing postpartum hemorrhage. Eur J Obstet Gynecol Reprod Biol 2019;240:151&#x2013;5.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">31284089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong MCW, To WWK. Balloon tamponade for postpartum haemorrhage: case series and literature review. Hong Kong Med J 2013;19:484&#x2013;90.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23650196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramler PI, Henriquez DDCA, van den Akker T, Caram&#x2010;Deelder C, Groenwold RHH, Bloemenkamp KWM, et&#xa0;al. Comparison of outcome between intrauterine balloon tamponade and uterine artery embolization in the management of persistent postpartum hemorrhage: a propensity score&#x2010;matched cohort study. Acta Obstet Gynecol Scand 2019;98:1473&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">31240693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauchotte E, Torre DL, Perdriolle&#x2010;Galet E, Lamy C, Gauchotte G, Morel O. Impact of uterine balloon tamponade on the use of invasive procedures in severe postpartum hemorrhage. Acta Obstet Gynecol Scand 2017;96:877&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28295136</ArticleId></ArticleIdList></Reference><Reference><Citation>Seasely AR, Szychowski JM, Saxon N, Casey BM, Tita A, Subramaniam A. 805 Vacuum&#x2010;induced hemorrhage control versus balloon tamponade for management of postpartum hemorrhage (PPH): single center experience. Obstet Gynecol 2021;224:S501.</Citation></Reference><Reference><Citation>Barinov S, Medyannikova I, Borisova A, Tyrskaya Y, Savelieva I, Shamina I, et&#xa0;al. The usefulness of zhukovsky double balloon in obstetric hemorrhage. Maternal&#x2010;Fetal Medicine 2019;1:1.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozenberg P, Sentilhes L, Winer N, Goffinet F, Vayssiere C, Senat M, et&#xa0;al. 485 Efficacy of early versus late intrauterine balloon tamponade in the management of severe postpartum hemorrhage. Obstet Gynecol 2021;224:S308.</Citation></Reference><Reference><Citation>El Gelany SAA, Soltan MH. External aortic compression device, manual aortic compression &amp; El Minya air inflated balloon: simple, cost&#x2010;effective, and saving many lives in low resource settings. Int J Gynaecol Obstet 2012;119:S335.</Citation></Reference><Reference><Citation>Mattern J, Sibiude J, Picone O, Mandelbrot L. Efficacit&#xe9; de l&#x2019;utilisation du ballonnet de tamponnement intra&#x2010;ut&#xe9;rin dans l&#x2019;h&#xe9;morragie du post&#x2010;partum. &#xc9;tude r&#xe9;trospective monocentrique avant/apr&#xe8;s [Efficiency of Bakri intra uterine tamponade balloon use in postpartum hemorrhage: Before and after study]. Gynecol Obstet Fertil Senol 2021;49:239&#x2013;45.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">33227496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya B, Tuten A, Daglar K, Misirlioglu M, Polat M, Yildirim Y, et&#xa0;al. Balloon tamponade for the management of postpartum uterine hemorrhage. J Perinat Med 2014;42:745&#x2013;53.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">24663227</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar MF, Suso JP, Hincapi&#xe9; MA, Echavarr&#xed;a MP, Fern&#xe1;ndez P, Carvajal J. Experience of combined use of a Bakri uterine balloon and a non&#x2010;pneumatic anti&#x2010;shock garment in a university hospital in Colombia. Int J Gynaecol Obstet 2019;146:244&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">31131884</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltan MH, Mohamed A, Ibrahim E, Gohar A, Ragab H. El&#x2010;menia air inflated balloon in controlling atonic post partum hemorrhage. Int J Health Sci 2007;1:53&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC3068654</ArticleId><ArticleId IdType=""pubmed"">21475452</ArticleId></ArticleIdList></Reference><Reference><Citation>\nAshraf N, Ashraf A, Khursheed K. Efficacy and safety of intrauterine balloon Tamponade versus uterovaginal roll gauze packing in patient presenting with primary postpartum hemorrhage after normal vaginal delivery. Annals KEMU [Internet] 2018;24:889&#x2010;92. [https://annalskemu.org/journal/index.php/annals/article/view/2581]. Accessed 9 July 2021.</Citation></Reference><Reference><Citation>Dalia Y, Agrawal M, Sharma A. Various modifications of condom balloon tamponade and their method, efficacy, outcomes in management of atonic postpartum hemorrhage in tertiary care centre&#x2010; a observational study. JMSCR 2018;06:482&#x2013;9.</Citation></Reference><Reference><Citation>Kong CW, To WWK. Menstrual and reproductive outcome after use of balloon tamponade for severe postpartum haemorrhage. J Perinat Med 2017;45:361.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC6249747</ArticleId><ArticleId IdType=""pubmed"">30463522</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez S, Conde&#x2010;Agudelo A, Borovac&#x2010;Pinheiro A, Suarez&#x2010;Rebling D, Eckardt M, Theron G, et&#xa0;al. Uterine balloon tamponade for the&#xa0;treatment of postpartum hemorrhage: a systematic review and meta&#x2010;analysis. Am J Obstet Gynecol 2020;222:293.e1&#x2013;293.e52.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">31917139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellie FJ, Wandabwa JN, Mousa HA, Weeks AD. Mechanical and surgical interventions for treating primary postpartum haemorrhage. Cochrane Database Syst Rev 2020;7:CD013663.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC8407481</ArticleId><ArticleId IdType=""pubmed"">32609374</ArticleId></ArticleIdList></Reference><Reference><Citation>Said Ali A, Faraag E, Mohammed M, Elmarghany Z, Helaly M, Gadallah A, et&#xa0;al. The safety and effectiveness of Bakri balloon in the management of postpartum hemorrhage: a systematic review. J Maternal&#x2010;Fetal &amp; Neonatal Med 2021;34:300&#x2013;07.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">30957590</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke TF, Thapa K, Shivkumar P, Tarimo V, Oguttu M, Garg L, et&#xa0;al. Time for global scale&#x2010;up, not randomized trials, of uterine balloon tamponade for postpartum hemorrhage. Int J Gynaecol Obstet 2018;142:115&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">29569396</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>'",2021
6,"Objective-to overview, compare and generalize results of randomized clinical trials analyzing different oxytocin doses to prevent postpartum hemorrhage, initiate and maintain uterine contraction after Caesarean delivery. Methods-'PubMed', 'EMBASE', 'CENTRAL', and 'CINAHL' electronic databases were searched for clinical trials analyzing the effectiveness of different dose of oxytocin given intravenously during surgery for uterine contraction and to reduce postpartum hemorrhage. A systematic review of relevant literature sources was performed. Results-our search revealed 813 literature sources. A total of 15 randomized clinical trials, comparing different doses of oxytocin bolus and infusion used after caesarean delivery have met the selection criteria. Conclusion-oxytocin bolus 0.5-3 UI is considered an effective prophylactic dose. Recommended effective prophylactic oxytocin infusion dose is 7.72 IU/h, but it is unanswered whether we really need a prophylactic infusion of oxytocin if we choose effective bolus dose size and rate. Adverse hemodynamic effects were observed when a 5 UI oxytocin bolus was used. However, topics such as bolus dose size, infusion dose size and requirement as well as bolus injection rate, still remain unanswered. The doses that are recommended in the guidelines of peripartum hemorrhage prophylaxis are not confirmed by randomized controlled double-blind trials and more research should cover this topic.",Baliuliene V,BaliulieneV,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018faee8d0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faef7d0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018faee910>]","['Baliuliene V', 'Vitartaite M', 'Rimaitis K']",Baliuliene V; Vitartaite M; Rimaitis K,,,,,,,,,,,,,,,"{'D010120': {'substance_name': 'Oxytocics', 'registry_number': '0'}, 'D010121': {'substance_name': 'Oxytocin', 'registry_number': '50-56-6'}}","Baliuliene V, et al. Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review. Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review. 2021; 18:(unknown pages). doi: 10.3390/ijerph18095029","Baliuliene V, <i>et al</i>. Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review. Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review. 2021; 18:(unknown pages). doi: 10.3390/ijerph18095029",<Element PubmedArticle at 0x7f018e9517c0>,10.3390/ijerph18095029,,[],"{'received': datetime.datetime(2021, 4, 8, 0, 0), 'revised': datetime.datetime(2021, 4, 28, 0, 0), 'accepted': datetime.datetime(2021, 5, 6, 0, 0), 'entrez': datetime.datetime(2021, 6, 2, 0, 0), 'pubmed': datetime.datetime(2021, 6, 3, 0, 0), 'medline': datetime.datetime(2021, 6, 22, 0, 0), 'pmc-release': datetime.datetime(2021, 5, 10, 0, 0)}",1660-4601,9,Int J Environ Res Public Health,,"{'D002585': {'descriptor_name': 'Cesarean Section', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D010120': {'descriptor_name': 'Oxytocics', 'major_topic': True, 'qualifier_name': 'therapeutic use', 'qualifier_ui': 'Q000627'}, 'D010121': {'descriptor_name': 'Oxytocin', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': True, 'qualifier_name': 'prevention & control', 'qualifier_ui': 'Q000517'}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D016032': {'descriptor_name': 'Randomized Controlled Trials as Topic', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D014593': {'descriptor_name': 'Uterine Inertia', 'major_topic': True, 'qualifier_name': None, 'qualifier_ui': None}}",,<function MetaPubObject.parse_xml at 0x7f01911c1120>,ijerph18095029,8126197.0,34068723,,"{'D016428': 'Journal Article', 'D016454': 'Review', 'D000078182': 'Systematic Review'}",article,Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review.,<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018e90c790>>,https://ncbi.nlm.nih.gov/pubmed/34068723,18,18(9),"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Automated""><PMID Version=""1"">34068723</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel=""Electronic""><Journal><ISSN IssnType=""Electronic"">1660-4601</ISSN><JournalIssue CitedMedium=""Internet""><Volume>18</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review.</ArticleTitle><ELocationID EIdType=""pii"" ValidYN=""Y"">5029</ELocationID><ELocationID EIdType=""doi"" ValidYN=""Y"">10.3390/ijerph18095029</ELocationID><Abstract><AbstractText>Objective-to overview, compare and generalize results of randomized clinical trials analyzing different oxytocin doses to prevent postpartum hemorrhage, initiate and maintain uterine contraction after Caesarean delivery. Methods-\'PubMed\', \'EMBASE\', \'CENTRAL\', and \'CINAHL\' electronic databases were searched for clinical trials analyzing the effectiveness of different dose of oxytocin given intravenously during surgery for uterine contraction and to reduce postpartum hemorrhage. A systematic review of relevant literature sources was performed. Results-our search revealed 813 literature sources. A total of 15 randomized clinical trials, comparing different doses of oxytocin bolus and infusion used after caesarean delivery have met the selection criteria. Conclusion-oxytocin bolus 0.5-3 UI is considered an effective prophylactic dose. Recommended effective prophylactic oxytocin infusion dose is 7.72 IU/h, but it is unanswered whether we really need a prophylactic infusion of oxytocin if we choose effective bolus dose size and rate. Adverse hemodynamic effects were observed when a 5 UI oxytocin bolus was used. However, topics such as bolus dose size, infusion dose size and requirement as well as bolus injection rate, still remain unanswered. The doses that are recommended in the guidelines of peripartum hemorrhage prophylaxis are not confirmed by randomized controlled double-blind trials and more research should cover this topic.</AbstractText></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Baliuliene</LastName><ForeName>Vilda</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Lithuanian University of Health Sciences, Eiveniu str. 2, LT-50009 Kaunas, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Vitartaite</LastName><ForeName>Migle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, A. Mickeviciaus str. 9, LT-44307 Kaunas, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Rimaitis</LastName><ForeName>Kestutis</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Lithuanian University of Health Sciences, Eiveniu str. 2, LT-50009 Kaunas, Lithuania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=""D016428"">Journal Article</PublicationType><PublicationType UI=""D016454"">Review</PublicationType><PublicationType UI=""D000078182"">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType=""Electronic""><Year>2021</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=""D010120"">Oxytocics</NameOfSubstance></Chemical><Chemical><RegistryNumber>50-56-6</RegistryNumber><NameOfSubstance UI=""D010121"">Oxytocin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=""D002585"" MajorTopicYN=""N"">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D010120"" MajorTopicYN=""Y"">Oxytocics</DescriptorName><QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D010121"" MajorTopicYN=""N"">Oxytocin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""Y"">Postpartum Hemorrhage</DescriptorName><QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D016032"" MajorTopicYN=""N"">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D014593"" MajorTopicYN=""Y"">Uterine Inertia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=""NOTNLM""><Keyword MajorTopicYN=""N"">caesarean delivery</Keyword><Keyword MajorTopicYN=""N"">hemorrhage</Keyword><Keyword MajorTopicYN=""N"">oxytocin</Keyword><Keyword MajorTopicYN=""N"">uterine contraction</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""received""><Year>2021</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=""revised""><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=""accepted""><Year>2021</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=""entrez""><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pubmed""><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pmc-release""><Year>2021</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">34068723</ArticleId><ArticleId IdType=""pmc"">PMC8126197</ArticleId><ArticleId IdType=""doi"">10.3390/ijerph18095029</ArticleId><ArticleId IdType=""pii"">ijerph18095029</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American College of Obstetricians and Gynecologists  Obstetric Data Definitions (Version 1.0)  [(accessed on 30 March 2021)];Revitalize. 2014  Available online:  https://www.acog.org/-/media/project/acog/acogorg/files/pdfs/publications/revitalize-ob.pdf?la=en&amp;hash=D9ECE1577C2A0B535F42C1B8DC492070.</Citation></Reference><Reference><Citation>Prevention and Management of Postpartum Haemorrhage: Green-Top Guideline No. 52. Bjog Int. J. Obstet. Gynaecol. 2017;124:e106&#x2013;e149. doi: 10.1111/1471-0528.14178.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/1471-0528.14178</ArticleId><ArticleId IdType=""pubmed"">27981719</ArticleId></ArticleIdList></Reference><Reference><Citation>Niino Y. The Increasing Cesarean Rate Globally and What We Can Do about It. Biosci. Trends. 2011;5:139&#x2013;150. doi: 10.5582/bst.2011.v5.4.139.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.5582/bst.2011.v5.4.139</ArticleId><ArticleId IdType=""pubmed"">21914948</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambo I., Bedi N., Dhillon B.S., Saxena N.C. A Critical Appraisal of Cesarean Section Rates at Teaching Hospitals in India. Int. J. Gynecol. Obstet. 2002;79:151&#x2013;158. doi: 10.1016/S0020-7292(02)00226-6.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/S0020-7292(02)00226-6</ArticleId><ArticleId IdType=""pubmed"">12427402</ArticleId></ArticleIdList></Reference><Reference><Citation>Othman E.R., Fayez M.F., el Aal D.E.M.A., El-Dine Mohamed H.S., Abbas A.M., Ali M.K. Sublingual Misoprostol versus Intravenous Oxytocin in Reducing Bleeding during and after Cesarean Delivery: A Randomized Clinical Trial. Taiwan. J. Obstet. Gynecol. 2016;55:791&#x2013;795. doi: 10.1016/j.tjog.2016.02.019.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.tjog.2016.02.019</ArticleId><ArticleId IdType=""pubmed"">28040121</ArticleId></ArticleIdList></Reference><Reference><Citation>Evensen A., Anderson J.M. Postpartum Hemorrhage: Prevention and Treatment. Am. Fam. Physician. 2017;95:442&#x2013;449.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28409600</ArticleId></ArticleIdList></Reference><Reference><Citation>Feduniw S., Warzecha D., Szymusik I., Wielgos M. Epidemiology, Prevention and Management of Early Postpartum Hemorrhage&#x2014;A Systematic Review. Ginekol. Pol. 2020;91:38&#x2013;44. doi: 10.5603/GP.2020.0009.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.5603/GP.2020.0009</ArticleId><ArticleId IdType=""pubmed"">32039467</ArticleId></ArticleIdList></Reference><Reference><Citation>Butwick A.J., Coleman L., Cohen S.E., Riley E.T., Carvalho B. Minimum Effective Bolus Dose of Oxytocin during Elective Caesarean Delivery. Br. J. Anaesth. 2010;104:338&#x2013;343. doi: 10.1093/bja/aeq004.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1093/bja/aeq004</ArticleId><ArticleId IdType=""pubmed"">20150347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartain J.B., Barry J.J., Howat P.W., McCormack D.I., Bryant M. Intravenous Oxytocin Bolus of 2 Units Is Superior to 5 Units during Elective Caesarean Section. Br. J. Anaesth. 2008;101:822&#x2013;826. doi: 10.1093/bja/aen273.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1093/bja/aen273</ArticleId><ArticleId IdType=""pubmed"">18845650</ArticleId></ArticleIdList></Reference><Reference><Citation>Somjit M., Surojananon J., Kongwattanakul K., Kasemsiri C., Sirisom M., Prawannoa K., Thepsuthammarat K., Komwilaisak R. Comparison of Low Dose versus High Dose of Oxytocin for Initiating Uterine Contraction during Cesarean Delivery: A Randomized, Controlled, Non-Inferiority Trial. Int. J. Women&#x2019;s Health. 2020;12:667&#x2013;673. doi: 10.2147/IJWH.S260073.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.2147/IJWH.S260073</ArticleId><ArticleId IdType=""pmc"">PMC7455765</ArticleId><ArticleId IdType=""pubmed"">32904472</ArticleId></ArticleIdList></Reference><Reference><Citation>King K.J., Douglas M.J., Unger W., Wong A., King R.A.R. Five Unit Bolus Oxytocin at Cesarean Delivery in Women at Risk of Atony: A Randomized, Double-Blind, Controlled Trial. Anesth. Analg. 2010;111:1460&#x2013;1466. doi: 10.1213/ANE.0b013e3181f8930a.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1213/ANE.0b013e3181f8930a</ArticleId><ArticleId IdType=""pubmed"">20889945</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson M., Hanson U., Lidell C., Nord&#xe9;n-Lindeberg S. ST Depression at Caesarean Section and the Relation to Oxytocin Dose. A Randomised Controlled Trial. Bjog Int. J. Obstet. Gynaecol. 2010;117:76&#x2013;83. doi: 10.1111/j.1471-0528.2009.02356.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.2009.02356.x</ArticleId><ArticleId IdType=""pubmed"">19781043</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacheva V.P., Soens M.A., Tsen L.C. A Randomized, Double-Blinded Trial of a &#x201c;Rule of Threes&#x201d; Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery. Anesthesiology. 2015;123:92&#x2013;100. doi: 10.1097/ALN.0000000000000682.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/ALN.0000000000000682</ArticleId><ArticleId IdType=""pubmed"">25909969</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecilia M., Vijayaselvi R., Bansal R., Lakshmi L., Jose R. Ten Units Intravenous Oxytocin over 2&#x2013;4 h Is as Effective as 30 Units over 8&#x2013;12 h in Preventing Postpartum Hemorrhage after Cesarean Section: A Randomized Controlled Trial. Indian J. Pharm. 2018;50:279&#x2013;283.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC6302697</ArticleId><ArticleId IdType=""pubmed"">30636832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghulmiyyah L.M., Usta I.M., Ghazeeri G., Taher N., Abu-Ghannam G., Tamim H., Nassar A.H. Intravenous Oxytocin Use to Decrease Blood Loss during Scheduled Cesarean Delivery: A Randomized Double-Blinded Controlled Trial (OXYTRIAL) Am. J. Perinatol. 2017;34:379&#x2013;387. doi: 10.1055/s-0036-1592130.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1055/s-0036-1592130</ArticleId><ArticleId IdType=""pubmed"">27588932</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffield A., McKenzie C., Carvalho B., Ramachandran B., Yin V., El-Sayed Y.Y., Riley E.T., Butwick A.J. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility during Elective Cesarean Delivery: A Prospective Randomized Clinical Trial. Anesth. Analg. 2017;124:857&#x2013;862. doi: 10.1213/ANE.0000000000001658.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1213/ANE.0000000000001658</ArticleId><ArticleId IdType=""pmc"">PMC5319709</ArticleId><ArticleId IdType=""pubmed"">28212181</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xdc;ng&#xd6;rd&#xdc;k K., Asicioglu O., Celikkol O., Olgac Y., Ark C. Use of Additional Oxytocin to Reduce Blood Loss at Elective Caesarean Section A Randomised Control Trial. Aust. N. Zealand J. Obstet. Gynaecol. 2010;50:36&#x2013;39. doi: 10.1111/j.1479-828X.2009.01106.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1479-828X.2009.01106.x</ArticleId><ArticleId IdType=""pubmed"">20218995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajendran J., Silva G.R.C., Ranaraja S.K. Effects of 5 IU Oxytocin Bolus and 20 IU Oxytocin Infusion Compared to 5 IU Oxytocin Bolus and Normal Saline Infusion in the Control of Blood Loss during and after Ante-Partum Lower Segment Caesarean Section: A Randomized Controlled Trial. Ceylon Med. J. 2017;62:121. doi: 10.4038/cmj.v62i3.8515.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.4038/cmj.v62i3.8515</ArticleId><ArticleId IdType=""pubmed"">29072051</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod G., Munishankar B., MacGregor H., Murphy D.J. Maternal Haemodynamics at Elective Caesarean Section: A Randomised Comparison of Oxytocin 5-Unit Bolus and Placebo Infusion with Oxytocin 5-Unit Bolus and 30-Unit Infusion. Int. J. Obstet. Anesth. 2010;19:155&#x2013;160. doi: 10.1016/j.ijoa.2009.08.005.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijoa.2009.08.005</ArticleId><ArticleId IdType=""pubmed"">20194013</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy D.J., MacGregor H., Munishankar B., McLeod G. A Randomised Controlled Trial of Oxytocin 5IU and Placebo Infusion versus Oxytocin 5IU and 30IU Infusion for the Control of Blood Loss at Elective Caesarean Section-Pilot Study. ISRCTN 40302163. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009;142:30&#x2013;33. doi: 10.1016/j.ejogrb.2008.09.004.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ejogrb.2008.09.004</ArticleId><ArticleId IdType=""pubmed"">18977579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan S.R., Montgomery A.A., Carey M., McAuliffe F.M., Gleeson R., Geary M., Murphy D.J. Oxytocin Bolus versus Oxytocin Bolus and Infusion for Control of Blood Loss at Elective Caesarean Section: Double Blind, Placebo Controlled, Randomised Trial. BMJ. 2011;343:46&#x2013;61. doi: 10.1136/bmj.d4661.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1136/bmj.d4661</ArticleId><ArticleId IdType=""pmc"">PMC3148015</ArticleId><ArticleId IdType=""pubmed"">21807773</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian X.W., Drzymalski D.M., Lv C.C., Guo F.H., Wang L.Y., Chen X.Z. The ED50 and ED95 of Oxytocin Infusion Rate for Maintaining Uterine Tone during Elective Caesarean Delivery: A Dose-Finding Study. BMC Pregnancy Childbirth. 2020;20:6. doi: 10.1186/s12884-019-2692-x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1186/s12884-019-2692-x</ArticleId><ArticleId IdType=""pmc"">PMC6937915</ArticleId><ArticleId IdType=""pubmed"">31892352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallos I.D., Williams H.M., Price M.J., Merriel A., Gee H., Lissauer D., Moorthy V., Tobias A., Deeks J.J., Widmer M., et al. Uterotonic agents for preventing postpartum haemorrhage: A network meta-analysis. Cochrane Database Syst. Rev. 2018;12 doi: 10.1002/14651858.CD011689.pub3.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1002/14651858.CD011689.pub3</ArticleId><ArticleId IdType=""pmc"">PMC6494487</ArticleId><ArticleId IdType=""pubmed"">29693726</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . WHO Recommendations: Uterotonics for the Prevention of Postpartum Haemorrhage. World Health Organization; Geneva, Switzerland: 2018. WHO recommendations: Uterotonics for the prevention of postpartum haemorrhage; pp. 1&#x2013;53.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">30645062</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorneloe B., Carvalho J.C.A., Downey K., Balki M. Uterotonic Drug Usage in Canada: A Snapshot of the Practice in Obstetric Units of University-Affiliated Hospitals. Int. J. Obstet. Anesth. 2019;37:45&#x2013;51. doi: 10.1016/j.ijoa.2018.09.002.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijoa.2018.09.002</ArticleId><ArticleId IdType=""pubmed"">30396679</ArticleId></ArticleIdList></Reference><Reference><Citation>Leduc D., Senikas V., Lalonde A.B., Ballerman C., Biringer A., Delaney M., Duperron L., Girard I., Jones D., Lee L.S.Y., et al. Active Management of the Third Stage of Labour: Prevention and Treatment of Postpartum Hemorrhage. J. Obstet. Gynaecol. Can. 2009;31:980&#x2013;993. doi: 10.1016/S1701-2163(16)34329-8.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/S1701-2163(16)34329-8</ArticleId><ArticleId IdType=""pubmed"">19941729</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Obstetricians and Gynecologists Postpartum Hemorrhage. Obs. Gynecol. 2017;130:e168&#x2013;e186. doi: 10.1097/AOG.0000000000002351.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/AOG.0000000000002351</ArticleId><ArticleId IdType=""pubmed"">28937571</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz M., Stensballe J., Ducloy-Bouthors A.S., Bonnet M.P., de Robertis E., Fornet I., Goffinet F., Hofer S., Holzgreve W., Manrique S., et al. Patient Blood Management in Obstetrics: Prevention and Treatment of Postpartum Haemorrhage. A NATA Consensus Statement: A Multidisciplinary Consensus Statement. Blood Transfus. 2019;17:112&#x2013;136. doi: 10.2450/2019.0245-18.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.2450/2019.0245-18</ArticleId><ArticleId IdType=""pmc"">PMC6476742</ArticleId><ArticleId IdType=""pubmed"">30865585</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentilhes L., Vayssi&#xe8;re C., Deneux-Tharaux C., Aya A.G., Bayoumeu F., Bonnet M.P., Djoudi R., Dolley P., Dreyfus M., Ducroux-Schouwey C., et al. Postpartum Hemorrhage: Guidelines for Clinical Practice from the French College of Gynaecologists and Obstetricians (CNGOF): In Collaboration with the French Society of Anesthesiology and Intensive Care (SFAR) Eur. J. Obstet. Gynecol. Reprod. Biol. 2016;198:12&#x2013;21. doi: 10.1016/j.ejogrb.2015.12.012.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ejogrb.2015.12.012</ArticleId><ArticleId IdType=""pubmed"">26773243</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho J.C.A., Balki M., Kingdom J., Windrim R. Oxytocin Requirements at Elective Cesarean Delivery: A Dose-Finding Study. Am. Coll. Obstet. Gynecol. 2004;104:1005&#x2013;1010. doi: 10.1097/01.AOG.0000142709.04450.bd.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/01.AOG.0000142709.04450.bd</ArticleId><ArticleId IdType=""pubmed"">15516392</ArticleId></ArticleIdList></Reference><Reference><Citation>Balki M., Ronayne M., Davies S., Fallah S., Kingdom J., Windrim R., Carvalho J. Minimum Oxytocin Dose Requirement After Cesarean Delivery for Labor Arrest. Obstet. Gynecol. 2006;107:45&#x2013;50. doi: 10.1097/01.AOG.0000191529.52596.c0.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/01.AOG.0000191529.52596.c0</ArticleId><ArticleId IdType=""pubmed"">16394038</ArticleId></ArticleIdList></Reference><Reference><Citation>Beiranvand S., Karimi A., Vahabi S., Amin-Bidokhti A. Comparison of the Mean Minimum Dose of Bolus Oxytocin for Proper Uterine Contraction during Cesarean Section. Curr. Clin. Pharmacol. 2019;14:208&#x2013;213. doi: 10.2174/1574884714666190524100214.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.2174/1574884714666190524100214</ArticleId><ArticleId IdType=""pubmed"">31124424</ArticleId></ArticleIdList></Reference><Reference><Citation>Svanstr&#xf6;m M.C., Biber B., Hanes M., Johansson G., N&#xe4;slund U., B&#xe5;lfors E.M. Signs of Myocardial Ischaemia after Injection of Oxytocin: A Randomized Double-Blind Comparison of Oxytocin and Methylergometrine during Caesarean Section. Br. J. Anaesth. 2008;100:683&#x2013;689. doi: 10.1093/bja/aen071.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1093/bja/aen071</ArticleId><ArticleId IdType=""pubmed"">18385263</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson C., Schumann R., Zhang P., Young R.C. Oxytocin-Induced Desensitization of the Oxytocin Receptor. Am. J. Obstet. Gynecol. 2003;188:497&#x2013;502. doi: 10.1067/mob.2003.22.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1067/mob.2003.22</ArticleId><ArticleId IdType=""pubmed"">12592262</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesen M., Carvalho B., Carvalho J.C.A., Duvekot J.J., Dyer R.A., Lucas D.N., McDonnell N., Orbach-Zinger S., Kinsella S.M. International Consensus Statement on the Use of Uterotonic Agents during Caesarean Section. Anaesthesia. 2019;74:1305&#x2013;1319. doi: 10.1111/anae.14757.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/anae.14757</ArticleId><ArticleId IdType=""pubmed"">31347151</ArticleId></ArticleIdList></Reference><Reference><Citation>Japund&#x17e;i&#x107;-&#x17d;igon N., Lozi&#x107; M., &#x160;arenac O., Murphy D. Vasopressin &amp; Oxytocin in Control of the Cardiovascular System: An Updated Review. Curr. Neuropharmacol. 2019;18:14&#x2013;33. doi: 10.2174/1570159x17666190717150501.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.2174/1570159x17666190717150501</ArticleId><ArticleId IdType=""pmc"">PMC7327933</ArticleId><ArticleId IdType=""pubmed"">31544693</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas J.S., Koh S.H., Cooper G.M. Haemodynamic Effects of Oxytocin given as i.v. Bolus or Infusion on Women Undergoing Caesarean Section. Br. J. Anaesth. 2007;98:116&#x2013;119. doi: 10.1093/bja/ael302.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1093/bja/ael302</ArticleId><ArticleId IdType=""pubmed"">17142825</ArticleId></ArticleIdList></Reference><Reference><Citation>Langes&#xe6;ter E., Rosseland L.A., Stubhaug A. Hemodynamic Effects of Oxytocin during Cesarean Delivery. Int. J. Gynecol. Obstet. 2006;95:46&#x2013;47. doi: 10.1016/j.ijgo.2006.05.032.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijgo.2006.05.032</ArticleId><ArticleId IdType=""pubmed"">16920118</ArticleId></ArticleIdList></Reference><Reference><Citation>Langes&#xe6;ter E., Rosseland L.A., Stubhaug A. Haemodynamic Effects of Oxytocin in Women with Severe Preeclampsia. Int. J. Obstet. Anesth. 2011;20:26&#x2013;29. doi: 10.1016/j.ijoa.2010.10.004.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijoa.2010.10.004</ArticleId><ArticleId IdType=""pubmed"">21224021</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer T.L., Knape K., Liles D., Wheeler A.S., Carter B. The Hemodynamics of Oxytocin and Other Vasoactive Agents during Neuraxial Anesthesia for Cesarean Delivery: Findings in Six Cases. Int. J. Obstet. Anesth. 2008;17 doi: 10.1016/j.ijoa.2008.03.003.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijoa.2008.03.003</ArticleId><ArticleId IdType=""pubmed"">18513945</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>'",2021
7,"IMPORTANCE: Postpartum hemorrhage (PPH) is an emergent obstetric complication and the leading cause of maternal mortality. Pelvic arterial embolization (PAE) is an effective treatment for intractable PPH. However, a unique protocol has not been accepted in obstetrical practice.
OBJECTIVE: To evaluate its efficiency, safety, complications, and outcomes, we conducted a systematic review and meta-analysis of PAE for PPH in the literature.
EVIDENCE ACQUISITION: The Medline, the database of abstract of reviews, the index to allied health literature, and the Chinese database Sino-Med were searched on March 31, 2020, for studies on PAE for PPH. The data for PAE indication, agents, arteries, success rate, complications, and outcomes were extracted and syncretized for meta-analysis.
RESULTS: From 1075 identified articles, 113 abstracts or full articles were retrieved and 43 studies were finally identified as meeting the including criteria. The results demonstrated that the indications for PAE were as follows: uterine atony, placental abnormality, delivery tract injury, disseminated intravascular coagulation, arteriovenous malformation, and vaginal hematoma. The embolization agents mostly in order were gelatin sponge particles, polyvinyl alcohol particles, Gelfoam, N-butyl cyanoacrylate, microcoil, and glue; for arteries, they were mostly uterine artery and internal iliac artery. The clinical success rate was 90.5%, whereas the technical success rate was 99.3%. The most common complications of PAE were postembolization syndrome and menstrual abnormality.
CONCLUSIONS AND RELEVANCE: The emergent PAE is a safe and effective method with high success rate in life-threatening PPH management. Gelatin sponge granules measuring 500 to 1000 μm in diameter have safe results. Pelvic arterial embolization may affect the recovery of menses and increase PPH in the subsequent pregnancy, but there was no noted correlation with fetal growth restriction.",Zhang XQ,ZhangXQ,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018e95d190>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018fad14d0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018fad06d0>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018fad3850>]","['Zhang XQ', 'Chen XT', 'Zhang YT', 'Mai CX']",Zhang XQ; Chen XT; Zhang YT; Mai CX,,,,,,,,,,,,,,,{},"Zhang XQ, et al. The Emergent Pelvic Artery Embolization in the Management of Postpartum Hemorrhage: A Systematic Review and Meta-analysis. The Emergent Pelvic Artery Embolization in the Management of Postpartum Hemorrhage: A Systematic Review and Meta-analysis. 2021; 76:234-244. doi: 10.1097/OGX.0000000000000887","Zhang XQ, <i>et al</i>. The Emergent Pelvic Artery Embolization in the Management of Postpartum Hemorrhage: A Systematic Review and Meta-analysis. The Emergent Pelvic Artery Embolization in the Management of Postpartum Hemorrhage: A Systematic Review and Meta-analysis. 2021; 76:234-244. doi: 10.1097/OGX.0000000000000887",<Element PubmedArticle at 0x7f018e934980>,10.1097/OGX.0000000000000887,234.0,[],"{'entrez': datetime.datetime(2021, 4, 28, 0, 0), 'pubmed': datetime.datetime(2021, 4, 29, 0, 0), 'medline': datetime.datetime(2021, 10, 7, 0, 0), 'pmc-release': datetime.datetime(2021, 4, 28, 0, 0)}",1533-9866,4,Obstet Gynecol Surv,,"{'D000328': {'descriptor_name': 'Adult', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D004621': {'descriptor_name': 'Embolization, Therapeutic', 'major_topic': False, 'qualifier_name': 'methods', 'qualifier_ui': 'Q000379'}, 'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D007083': {'descriptor_name': 'Iliac Artery', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D010388': {'descriptor_name': 'Pelvis', 'major_topic': False, 'qualifier_name': 'blood supply', 'qualifier_ui': 'Q000098'}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': False, 'qualifier_name': 'therapy', 'qualifier_ui': 'Q000628'}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D016896': {'descriptor_name': 'Treatment Outcome', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D055988': {'descriptor_name': 'Uterine Artery', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}}",234-244,<function MetaPubObject.parse_xml at 0x7f01911c1120>,,8081441.0,33908615,,"{'D016428': 'Journal Article', 'D017418': 'Meta-Analysis', 'D000078182': 'Systematic Review'}",article,The Emergent Pelvic Artery Embolization in the Management of Postpartum Hemorrhage: A Systematic Review and Meta-analysis.,<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018e931790>>,https://ncbi.nlm.nih.gov/pubmed/33908615,76,76(4),"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Manual""><PMID Version=""1"">33908615</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel=""Print""><Journal><ISSN IssnType=""Electronic"">1533-9866</ISSN><JournalIssue CitedMedium=""Internet""><Volume>76</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Obstetrical &amp; gynecological survey</Title><ISOAbbreviation>Obstet Gynecol Surv</ISOAbbreviation></Journal><ArticleTitle>The Emergent Pelvic Artery Embolization in the Management of Postpartum Hemorrhage: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>234</StartPage><EndPage>244</EndPage><MedlinePgn>234-244</MedlinePgn></Pagination><ELocationID EIdType=""doi"" ValidYN=""Y"">10.1097/OGX.0000000000000887</ELocationID><Abstract><AbstractText Label=""IMPORTANCE"" NlmCategory=""OBJECTIVE"">Postpartum hemorrhage (PPH) is an emergent obstetric complication and the leading cause of maternal mortality. Pelvic arterial embolization (PAE) is an effective treatment for intractable PPH. However, a unique protocol has not been accepted in obstetrical practice.</AbstractText><AbstractText Label=""OBJECTIVE"" NlmCategory=""OBJECTIVE"">To evaluate its efficiency, safety, complications, and outcomes, we conducted a systematic review and meta-analysis of PAE for PPH in the literature.</AbstractText><AbstractText Label=""EVIDENCE ACQUISITION"" NlmCategory=""METHODS"">The Medline, the database of abstract of reviews, the index to allied health literature, and the Chinese database Sino-Med were searched on March 31, 2020, for studies on PAE for PPH. The data for PAE indication, agents, arteries, success rate, complications, and outcomes were extracted and syncretized for meta-analysis.</AbstractText><AbstractText Label=""RESULTS"" NlmCategory=""RESULTS"">From 1075 identified articles, 113 abstracts or full articles were retrieved and 43 studies were finally identified as meeting the including criteria. The results demonstrated that the indications for PAE were as follows: uterine atony, placental abnormality, delivery tract injury, disseminated intravascular coagulation, arteriovenous malformation, and vaginal hematoma. The embolization agents mostly in order were gelatin sponge particles, polyvinyl alcohol particles, Gelfoam, <i>N</i>-butyl cyanoacrylate, microcoil, and glue; for arteries, they were mostly uterine artery and internal iliac artery. The clinical success rate was 90.5%, whereas the technical success rate was 99.3%. The most common complications of PAE were postembolization syndrome and menstrual abnormality.</AbstractText><AbstractText Label=""CONCLUSIONS AND RELEVANCE"" NlmCategory=""CONCLUSIONS"">The emergent PAE is a safe and effective method with high success rate in life-threatening PPH management. Gelatin sponge granules measuring 500 to 1000 &#x3bc;m in diameter have safe results. Pelvic arterial embolization may affect the recovery of menses and increase PPH in the subsequent pregnancy, but there was no noted correlation with fetal growth restriction.</AbstractText></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Zhang</LastName><ForeName>Xiu Quan</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Professor, Director of Research Laboratory of Reproductive Genetics.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Chen</LastName><ForeName>Xi Ting</ForeName><Initials>XT</Initials><AffiliationInfo><Affiliation>Resident Doctor.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Zhang</LastName><ForeName>Yu Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Research Assistant.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Mai</LastName><ForeName>Cai Xiu</ForeName><Initials>CX</Initials><AffiliationInfo><Affiliation>Assistant Professor, Department of Obstetrics and Gynecology, Shunde Hospital of Southern Medical University (The First People\'s Hospital of Shunde), Foshan, Guangdong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=""D016428"">Journal Article</PublicationType><PublicationType UI=""D017418"">Meta-Analysis</PublicationType><PublicationType UI=""D000078182"">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Obstet Gynecol Surv</MedlineTA><NlmUniqueID>0401007</NlmUniqueID><ISSNLinking>0029-7828</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D004621"" MajorTopicYN=""N"">Embolization, Therapeutic</DescriptorName><QualifierName UI=""Q000379"" MajorTopicYN=""Y"">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D007083"" MajorTopicYN=""N"">Iliac Artery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D010388"" MajorTopicYN=""N"">Pelvis</DescriptorName><QualifierName UI=""Q000098"" MajorTopicYN=""Y"">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""N"">Postpartum Hemorrhage</DescriptorName><QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D016896"" MajorTopicYN=""N"">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D055988"" MajorTopicYN=""N"">Uterine Artery</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""entrez""><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>8</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pubmed""><Year>2021</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2021</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pmc-release""><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">33908615</ArticleId><ArticleId IdType=""pmc"">PMC8081441</ArticleId><ArticleId IdType=""doi"">10.1097/OGX.0000000000000887</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Say L Chou D Gemmill A, et al. . Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323&#x2013;e333.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">25103301</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division . Trends in Maternal Mortality: 2000 to 2017. Geneva, Switzerland: World Health Organization; 2019.</Citation></Reference><Reference><Citation>Borovac-Pinheiro A Pacagnella RC Cecatti JG, et al. . Postpartum hemorrhage: new insights for definition and diagnosis. Am J Obstet Gynecol. 2018;219:162&#x2013;168.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">29660298</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath WH. Postpartum hemorrhage-update on problems of definitions and diagnosis. Acta Obstet Gynecol Scand. 2011;90:421&#x2013;428.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">21332452</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on Practice Bulletins-Obstetrics . Practice Bulletin No. 183: postpartum hemorrhage. Obstet Gynecol. 2017;130:e168&#x2013;e186.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28937571</ArticleId></ArticleIdList></Reference><Reference><Citation>James AH, Cooper DL, Paidas MJ. A global quantitative survey of hemostatic assessment in postpartum hemorrhage and experience with associated bleeding disorders. Int J Womens Health. 2017;9:477&#x2013;485.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC5503669</ArticleId><ArticleId IdType=""pubmed"">28740434</ArticleId></ArticleIdList></Reference><Reference><Citation>James AH, Cooper DL, Paidas MJ. Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists. Int J Womens Health. 2015;7:873&#x2013;881.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC4639551</ArticleId><ArticleId IdType=""pubmed"">26604829</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccone G Caissutti C Ciardulli A, et al. . Uterine massage as part of active management of the third stage of labour for preventing postpartum haemorrhage during vaginal delivery: a systematic review and meta-analysis of randomised trials. BJOG. 2018;125:778&#x2013;781.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28881415</ArticleId></ArticleIdList></Reference><Reference><Citation>Prata N, Weidert K. Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning. Int J Womens Health. 2016;8:341&#x2013;349.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC4973720</ArticleId><ArticleId IdType=""pubmed"">27536161</ArticleId></ArticleIdList></Reference><Reference><Citation>Revert M Rozenberg P Cottenet J, et al. . Intrauterine balloon tamponade for severe postpartum hemorrhage. Obstet Gynecol. 2018;131:143&#x2013;149.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">29215522</ArticleId></ArticleIdList></Reference><Reference><Citation>Skupski DW Brady D Lowenwirt IP, et al. . Improvement in outcomes of major obstetric hemorrhage through systematic change. Obstet Gynecol. 2017;130:770&#x2013;777.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28885411</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin H Soylu Karapinar O Sahin EA, et al. . The effectiveness of the double B-lynch suture as a modification in the treatment of intractable postpartum haemorrhage. J Obstet Gynaecol. 2018;38:796&#x2013;799.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">29557226</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H Baba Y Usui R, et al. . Matsubara-Yano suture: a simple uterine compression suture for postpartum hemorrhage during cesarean section. Arch Gynecol Obstet. 2019;299:113&#x2013;121.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">30357496</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreu A Abgottspon F Baumann MU, et al. . Efficacy of pelvic artery embolisation for severe postpartum hemorrhage. Arch Gynecol Obstet. 2017;296:1117&#x2013;1124.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28993867</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinc G, O&#x11f;uz &#x15e;. The efficacy of pelvic arterial embolisation for the treatment in massive vaginal haemorrhage in obstetric and gynaecological emergencies: a single-centre experience. J Obstet Gynaecol. 2019;39:774&#x2013;781.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">31023116</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang PP Hu HY Gao JS, et al. . Evaluation of efficacy and safety of pelvic arterial embolization in women with primary postpartum hemorrhage. Zhonghua Fu Chan Ke Za Zhi. 2016;51:81&#x2013;86.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">26917474</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D Shamseer L Clarke M, et al. . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC4320440</ArticleId><ArticleId IdType=""pubmed"">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Vegas G Illescas T Mu&#xf1;oz M, et al. . Selective pelvic arterial embolization in the management of obstetric hemorrhage. Eur J Obstet Gynecol Reprod Biol. 2006;127:68&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">16229935</ArticleId></ArticleIdList></Reference><Reference><Citation>Dohan A Soyer P Subhani A, et al. . Postpartum hemorrhage resulting from pelvic pseudoaneurysm: a retrospective analysis of 588 consecutive cases treated by arterial embolization. Cardiovasc Intervent Radiol. 2013;36:1247&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23756881</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ Jeon GS Kim MD, et al. . Usefulness of pelvic artery embolization in cesarean section compared with vaginal delivery in 176 patients. J Vasc Interv Radiol. 2013;24:103&#x2013;109.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23273701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z Li X Pan J, et al. . Uterine artery embolization for management of primary postpartum hemorrhage associated with placenta accreta. Chin Med Sci J. 2016;31:228&#x2013;232.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28065219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SM Jeon GS Kim MD, et al. . Transcatheter arterial embolisation for the management of obstetric haemorrhage associated with placental abnormality in 40 cases. Eur Radiol. 2013;23:766&#x2013;773.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23300034</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y Zhou X Yang Z, et al. . Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. Int J Gynaecol Obstet. 2017;137:45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28098341</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert WM Moore TR Resnik R, et al. . Angiographic embolization in the management of hemorrhagic complications of pregnancy. Am J Obstet Gynecol. 1992;166:493&#x2013;497.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">1536217</ArticleId></ArticleIdList></Reference><Reference><Citation>Fargeaudou Y Morel O Soyer P, et al. . Persistent postpartum haemorrhage after failed arterial ligation: value of pelvic embolisation. Eur Radiol. 2010;20:1777&#x2013;1785.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">20309561</ArticleId></ArticleIdList></Reference><Reference><Citation>Cottier JP Fignon A Tranquart F, et al. . Uterine necrosis after arterial embolization for postpartum hemorrhage. Obstet Gynecol. 2002;100:1074&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">12423810</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohilla M Singh P Kaur J, et al. . Uterine necrosis and lumbosacral-plexopathy following pelvic vessel embolization for postpartum haemorrhage: report of two cases and review of literature. Arch Gynecol Obstet. 2014;290:819&#x2013;823.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">24947325</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KJ Shin JH Yoon HK, et al. . Postpartum hemorrhage from extravasation or pseudoaneurysm: efficacy of transcatheter arterial embolization using N-butyl cyanoacrylate and comparison with gelatin sponge particle. J Vasc Interv Radiol. 2015;26:154&#x2013;161.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">25454736</ArticleId></ArticleIdList></Reference><Reference><Citation>Obata S Kasai M Kasai J, et al. . Emergent uterine arterial embolization using N-butyl cyanoacrylate in postpartum hemorrhage with disseminated intravascular coagulation. Biomed Res Int. 2017;2017:1562432.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC5303842</ArticleId><ArticleId IdType=""pubmed"">28251148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hongsakul K, Songjamrat A, Rookkapan S. Transarterial embolization for the treatment of massive bleeding in gynecologic and obstetric emergencies: a single center experience. Emerg Radiol. 2014;21:333&#x2013;339.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">24522752</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellerin O Bats AS Di Primio M, et al. . Postpartum hemorrhage treated with Gelfoam slurry embolization using the superselective technique: immediate results and 1-month MRI follow-up. Cardiovasc Intervent Radiol. 2013;36:98&#x2013;104.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">22327604</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong JY Kong TW Son JH, et al. . Outcome of pelvic arterial embolization for postpartum hemorrhage: a retrospective review of 117 cases. Obstet Gynecol Sci. 2014;57:17&#x2013;27.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC3924745</ArticleId><ArticleId IdType=""pubmed"">24596814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang E, Liu L, Owen R. Pelvic artery embolization in the management of obstetrical hemorrhage: predictive factors for clinical outcomes. Cardiovasc Intervent Radiol. 2015;38:1477&#x2013;1486.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">25876518</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojala K Per&#xe4;l&#xe4; J Kariniemi J, et al. . Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand. 2005;84:1075&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">16232175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE So YH Kim BJ, et al. . Postpartum hemorrhage from non-uterine arteries: clinical importance of their detection and the results of selective embolization. Acta Radiol. 2018;59:932&#x2013;938.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">29065701</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar-Crespo A Morales-Rosell&#xf3; J S&#xe1;nchez-Ajenjo C, et al. . Postpartum hemorrhage with pelvic arterial embolization, study of 33 cases. J Matern Fetal Neonatal Med. 2019;32:573&#x2013;578.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;nvall M Tikkanen M Mets&#xe4;t&#xe4;hti M, et al. . Pelvic arterial embolization in severe obstetric hemorrhage. Acta Obstet Gynecol Scand. 2014;93:716&#x2013;719.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">24617830</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong TM Tseng HS Lee RC, et al. . Uterine artery embolization: an effective treatment for intractable obstetric haemorrhage. Clin Radiol. 2004;59:96&#x2013;101.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">14697382</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J Li X Kang C, et al. . Maternal mortality ratios in 2852 Chinese counties, 1996&#x2013;2015, and achievement of Millennium Development Goal 5 in China: a subnational analysis of the Global Burden of Disease Study 2016. Lancet. 2019;393:241&#x2013;252.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC6336935</ArticleId><ArticleId IdType=""pubmed"">30554785</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BJ Heaston DK Poulson AM, et al. . Uncontrollable postpartum bleeding: a new approach to hemostasis through angiographic arterial embolization. Obstet Gynecol. 1979;54:361&#x2013;365.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">314075</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayat E Resche-Rigon M Morel O, et al. . Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med. 2011;37:1816&#x2013;1825.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">21805157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansch E Chitkara U McAlpine J, et al. . Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol. 1999;180(6 Pt 1):1454&#x2013;1460.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">10368488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo TK So CH Yeung SW, et al. . Comparison of selective and non-selective internal iliac artery embolization for abnormal placentation with major postpartum hemorrhage. Int J Gynaecol Obstet. 2017;136:103&#x2013;104.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28099712</ArticleId></ArticleIdList></Reference><Reference><Citation>Soyer P Dohan A Dautry R, et al. . Transcatheter arterial embolization for postpartum hemorrhage: indications, technique, results, and complications. Cardiovasc Intervent Radiol. 2015;38:1068&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">25677130</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison JJ Galgon RE Jansen JO, et al. . A systematic review of the use of resuscitative endovascular balloon occlusion of the aorta in the management of hemorrhagic shock. J Trauma Acute Care Surg. 2016;80:324&#x2013;334.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">26816219</ArticleId></ArticleIdList></Reference><Reference><Citation>Stensaeth KH Sovik E Haig IN, et al. . Fluoroscopy-free Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for controlling life threatening postpartum hemorrhage. PLoS One. 2017;12:e0174520.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC5371310</ArticleId><ArticleId IdType=""pubmed"">28355242</ArticleId></ArticleIdList></Reference><Reference><Citation>Stannard A, Eliason JL, Rasmussen TE. Resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct for hemorrhagic shock. J Trauma. 2011;71:1869&#x2013;1872.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">22182896</ArticleId></ArticleIdList></Reference><Reference><Citation>Poujade O Ceccaldi PF Davitian C, et al. . Uterine necrosis following pelvic arterial embolization for post-partum hemorrhage: review of the literature. Eur J Obstet Gynecol Reprod Biol. 2013;170:309&#x2013;314.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23932304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sone M Osuga K Shimazu K, et al. . Porous gelatin particles for uterine artery embolization: an experimental study of intra-arterial distribution, uterine necrosis, and inflammation in a porcine model. Cardiovasc Intervent Radiol. 2010;33:1001&#x2013;1008.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">20632007</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyayama S Yamakado K Anai H, et al. . Guidelines on the use of gelatin sponge particles in embolotherapy. Jpn J Radiol. 2014;32:242&#x2013;250.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">24510242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentilhes L Gromez A Clavier E, et al. . Predictors of failed pelvic arterial embolization for severe postpartum hemorrhage. Obstet Gynecol. 2009;113:992&#x2013;999.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">19384113</ArticleId></ArticleIdList></Reference><Reference><Citation>Poujade O Zappa M Letendre I, et al. . Predictive factors for failure of pelvic arterial embolization for postpartum hemorrhage. Int J Gynaecol Obstet. 2012;117:119&#x2013;123.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">22361480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindquist JD, Vogelzang RL. Pelvic artery embolization for treatment of postpartum hemorrhage. Semin Intervent Radiol. 2018;35:41&#x2013;47.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC5886774</ArticleId><ArticleId IdType=""pubmed"">29628615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz Labarta FJ Pintado Recarte MP Alvarez Luque A, et al. . Outcomes of pelvic arterial embolization in the management of postpartum haemorrhage: a case series study and systematic review. Eur J Obstet Gynecol Reprod Biol. 2016;206:12&#x2013;21.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">27612214</ArticleId></ArticleIdList></Reference><Reference><Citation>Giurazza F Albano G Valentino L, et al. . Predelivery uterine arteries embolization in patients affected by placental implant anomalies. Radiol Med. 2018;123:71&#x2013;78.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">28756581</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur M Adekola HO Asaad R, et al. . Secondary postpartum hemorrhage due to spontaneous uterine artery rupture after normal vaginal delivery managed by selective arterial embolization. AJP Rep. 2016;6:e442&#x2013;e444.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC5201432</ArticleId><ArticleId IdType=""pubmed"">28050332</ArticleId></ArticleIdList></Reference><Reference><Citation>Gizzo S Saccardi C Patrelli TS, et al. . Fertility rate and subsequent pregnancy outcomes after conservative surgical techniques in postpartum hemorrhage: 15 years of literature. Fertil Steril. 2013;99:2097&#x2013;2107.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23498891</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsarrag SZ Forss AR Richman S, et al. . Acute ovarian insufficiency and uterine infarction following uterine artery embolization for postpartum hemorrhage. Clin Med Rev Case Rep. 2015;2:040.</Citation><ArticleIdList><ArticleId IdType=""pmc"">PMC4623578</ArticleId><ArticleId IdType=""pubmed"">26523290</ArticleId></ArticleIdList></Reference><Reference><Citation>Soro MP Denys A de Rham M, et al. . Short &amp; long term adverse outcomes after arterial embolisation for the treatment of postpartum haemorrhage: a systematic review. Eur Radiol. 2017;27:749&#x2013;762.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">27229338</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome J Martin JG Bercu Z, et al. . Postpartum hemorrhage. Tech Vasc Interv Radiol. 2017;20:266&#x2013;273.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">29224660</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YT Xu LF Sun HL, et al. . Clinical efficacy and safety of uterine artery chemoembolization in abnormal placental implantation complicated with postpartum hemorrhage. Zhonghua Fu Chan Ke Za Zhi. 2010;45:273&#x2013;277.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">20646539</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YJ Yoon CJ Seong NJ, et al. . Failed pelvic arterial embolization for postpartum hemorrhage: clinical outcomes and predictive factors. J Vasc Interv Radiol. 2013;24:703&#x2013;709.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">23622042</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidhu HK Prasad G Jain V, et al. . Pelvic artery embolization in the management of obstetric hemorrhage. Acta Obstet Gynecol Scand. 2010;89:1096&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">20397757</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushiyama D Yoshizato T Kora S, et al. . Predictive factors related to the efficacy of pelvic arterial embolization for postpartum hemorrhage: a retrospective analysis of 21 cases. Taiwan J Obstet Gynecol. 2014;53:366&#x2013;371.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">25286792</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon LJ de Tayrac R Castaigne-Meary V, et al. . Fertility and pregnancy outcome following pelvic arterial embolization for severe post-partum haemorrhage. A cohort study. Hum Reprod. 2003;18:849&#x2013;852.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">12660283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornan D White R Pollak J, et al. . Pelvic embolization for intractable postpartum hemorrhage: long-term follow-up and implications for fertility. Obstet Gynecol. 2003;102:904&#x2013;910.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">14672461</ArticleId></ArticleIdList></Reference><Reference><Citation>Poggi SH Yaeger A Wahdan Y, et al. . Outcome of pregnancies after pelvic artery embolization for postpartum hemorrhage: retrospective cohort study. Am J Obstet Gynecol. 2015;213:576.e1&#x2013;576.e5.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">26164697</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardeman S Decroisette E Marin B, et al. . Fertility after embolization of the uterine arteries to treat obstetrical hemorrhage: a review of 53 cases. Fertil Steril. 2010;94:2574&#x2013;2579.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">20381035</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiori O Deux JF Kambale JC, et al. . Impact of pelvic arterial embolization for intractable postpartum hemorrhage on fertility. Am J Obstet Gynecol. 2009;200:381.e1&#x2013;381.e4.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">19217597</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue S, Masuyama H, Hiramatsu Y. Efficacy of transarterial embolisation in the management of post-partum haemorrhage and its impact on subsequent pregnancies. Aust N Z J Obstet Gynaecol. 2014;54:541&#x2013;545.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">25350565</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan MK Paul N Mercuri M, et al. . Canadian Cardiovascular Society position statement on radiation exposure from cardiac imaging and interventional procedures. Can J Cardiol. 2013;29:1361&#x2013;1368.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">24035289</ArticleId></ArticleIdList></Reference><Reference><Citation>Niola R Cavaliere C Marcello L, et al. . Role of interventional radiology in treating obstetric haemorrhages. Radiol Med. 2014;119:607&#x2013;615.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">24408047</ArticleId></ArticleIdList></Reference><Reference><Citation>Minano JA Canis M Roldan JM, et al. . Patient radiation doses in uterine artery embolisation using Monte Carlo simulation. Radiat Prot Dosimetry. 2014;158:162&#x2013;169.</Citation><ArticleIdList><ArticleId IdType=""pubmed"">24030141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>'",2021
8,"BACKGROUND: Intrauterine balloon tamponade (IUBT) and compression sutures have been widely used in recent years in the management of postpartum hemorrhage (PPH). However, there is scant literature directly comparing the clinical scenarios that led to the discriminant selection of these management modalities and the direct clinical outcomes. The purpose of this study is to compare the patient characteristics and clinical risk factors that led to the use of IUBT and compression sutures in the management of major PPH as well as the immediate outcome in a retrospective cohort.
METHODS: Patients who had IUBT or compression sutures applied due to major PPH (>1000 ml) from 2014 to 2018 in a single obstetric unit were recruited. The patient characteristics and clinical outcome of the two groups were compared.
RESULTS: A total of 67 patients had IUBT and 29 patients had compression sutures applied as the first uterine sparing technique. Apart from more vaginal deliveries (25.4% vs. 3.5%) in the IUBT group compared to compression sutures, there were no significant differences between the two groups in terms of patient characteristics. The IUBT group had a slightly higher blood loss at the start of the uterine sparing procedure (239 ml, p = 0.049) and received more transfusions, despite no differences in the total blood loss, hemogloblin level, incidence of coagulopathy, and intensive care unit admission between the two groups. There was no significant difference in the overall success rate between IUBT and compression sutures to control PPH without additional surgical intervention or hysterectomy (73.1% vs. 55.1%, p = 0.15) or the success rate for PPH due to uterine atony (32.8% vs. 20.7%), though IUBT apparently performed better than compression sutures in cases of placenta praevia (77.3% vs. 16.7%, p = 0.01). Blood loss &gt; 1.5 l at the start of the procedure, presence of placenta accreta, and presence of coagulopathy were found to be significant poor prognostic factors for both procedures to control PPH.
CONCLUSIONS: There were no dominating patient characteristics that favoured the selection of either IUBT or compression sutures in the management of severe PPH except for the mode of delivery. Both procedures had equally high overall success rates to control PPH, but IUBT performed better in placenta praevia cases as compared to compression sutures.",Kong CW,KongCW,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018e99d750>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e968e50>]","['Kong CW', 'To WWK']",Kong CW; To WWK,,,,,,,,,,,,,,,{},Kong CW and To WWK. The Discriminant Use of Intrauterine Balloon Tamponade and Compression Sutures for Management of Major Postpartum Hemorrhage: Comparison of Patient Characteristics and Clinical Outcome. The Discriminant Use of Intrauterine Balloon Tamponade and Compression Sutures for Management of Major Postpartum Hemorrhage: Comparison of Patient Characteristics and Clinical Outcome. 2021; 2021:6648829. doi: 10.1155/2021/6648829,Kong CW and To WWK. The Discriminant Use of Intrauterine Balloon Tamponade and Compression Sutures for Management of Major Postpartum Hemorrhage: Comparison of Patient Characteristics and Clinical Outcome. The Discriminant Use of Intrauterine Balloon Tamponade and Compression Sutures for Management of Major Postpartum Hemorrhage: Comparison of Patient Characteristics and Clinical Outcome. 2021; 2021:6648829. doi: 10.1155/2021/6648829,<Element PubmedArticle at 0x7f018e99c700>,10.1155/2021/6648829,6648829.0,[],"{'received': datetime.datetime(2020, 10, 5, 0, 0), 'revised': datetime.datetime(2020, 12, 11, 0, 0), 'accepted': datetime.datetime(2020, 12, 15, 0, 0), 'entrez': datetime.datetime(2021, 1, 25, 0, 0), 'pubmed': datetime.datetime(2021, 1, 26, 0, 0), 'medline': datetime.datetime(2021, 5, 25, 0, 0), 'pmc-release': datetime.datetime(2021, 1, 2, 0, 0)}",2314-6141,,Biomed Res Int,,"{'D000328': {'descriptor_name': 'Adult', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D001778': {'descriptor_name': 'Blood Coagulation Disorders', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D036861': {'descriptor_name': 'Delivery, Obstetric', 'major_topic': False, 'qualifier_name': 'statistics & numerical data', 'qualifier_ui': 'Q000706'}, 'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D007044': {'descriptor_name': 'Hysterectomy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D010921': {'descriptor_name': 'Placenta Accreta', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D011183': {'descriptor_name': 'Postoperative Complications', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': True, 'qualifier_name': 'epidemiology', 'qualifier_ui': 'Q000453'}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D012189': {'descriptor_name': 'Retrospective Studies', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D012307': {'descriptor_name': 'Risk Factors', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D013537': {'descriptor_name': 'Sutures', 'major_topic': False, 'qualifier_name': 'statistics & numerical data', 'qualifier_ui': 'Q000706'}, 'D016896': {'descriptor_name': 'Treatment Outcome', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D058738': {'descriptor_name': 'Uterine Balloon Tamponade', 'major_topic': False, 'qualifier_name': 'statistics & numerical data', 'qualifier_ui': 'Q000706'}}",6648829,<function MetaPubObject.parse_xml at 0x7f01911c1120>,,7801069.0,33490275,,"{'D003160': 'Comparative Study', 'D016428': 'Journal Article'}",article,The Discriminant Use of Intrauterine Balloon Tamponade and Compression Sutures for Management of Major Postpartum Hemorrhage: Comparison of Patient Characteristics and Clinical Outcome.,<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018e930fd0>>,https://ncbi.nlm.nih.gov/pubmed/33490275,2021,2021,"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Manual""><PMID Version=""1"">33490275</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel=""Electronic-eCollection""><Journal><ISSN IssnType=""Electronic"">2314-6141</ISSN><JournalIssue CitedMedium=""Internet""><Volume>2021</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>The Discriminant Use of Intrauterine Balloon Tamponade and Compression Sutures for Management of Major Postpartum Hemorrhage: Comparison of Patient Characteristics and Clinical Outcome.</ArticleTitle><Pagination><StartPage>6648829</StartPage><MedlinePgn>6648829</MedlinePgn></Pagination><ELocationID EIdType=""pii"" ValidYN=""Y"">6648829</ELocationID><ELocationID EIdType=""doi"" ValidYN=""Y"">10.1155/2021/6648829</ELocationID><Abstract><AbstractText Label=""BACKGROUND"" NlmCategory=""BACKGROUND"">Intrauterine balloon tamponade (IUBT) and compression sutures have been widely used in recent years in the management of postpartum hemorrhage (PPH). However, there is scant literature directly comparing the clinical scenarios that led to the discriminant selection of these management modalities and the direct clinical outcomes. The purpose of this study is to compare the patient characteristics and clinical risk factors that led to the use of IUBT and compression sutures in the management of major PPH as well as the immediate outcome in a retrospective cohort.</AbstractText><AbstractText Label=""METHODS"" NlmCategory=""METHODS"">Patients who had IUBT or compression sutures applied due to major PPH (&gt;1000&#x2009;ml) from 2014 to 2018 in a single obstetric unit were recruited. The patient characteristics and clinical outcome of the two groups were compared.</AbstractText><AbstractText Label=""RESULTS"" NlmCategory=""RESULTS"">A total of 67 patients had IUBT and 29 patients had compression sutures applied as the first uterine sparing technique. Apart from more vaginal deliveries (25.4% vs. 3.5%) in the IUBT group compared to compression sutures, there were no significant differences between the two groups in terms of patient characteristics. The IUBT group had a slightly higher blood loss at the start of the uterine sparing procedure (239&#x2009;ml, <i>p</i> = 0.049) and received more transfusions, despite no differences in the total blood loss, hemogloblin level, incidence of coagulopathy, and intensive care unit admission between the two groups. There was no significant difference in the overall success rate between IUBT and compression sutures to control PPH without additional surgical intervention or hysterectomy (73.1% vs. 55.1%, <i>p</i> = 0.15) or the success rate for PPH due to uterine atony (32.8% vs. 20.7%), though IUBT apparently performed better than compression sutures in cases of placenta praevia (77.3% vs. 16.7%, <i>p</i> = 0.01). Blood&#x2009;loss &gt; 1.5&#x2009;l at the start of the procedure, presence of placenta accreta, and presence of coagulopathy were found to be significant poor prognostic factors for both procedures to control PPH.</AbstractText><AbstractText Label=""CONCLUSIONS"" NlmCategory=""CONCLUSIONS"">There were no dominating patient characteristics that favoured the selection of either IUBT or compression sutures in the management of severe PPH except for the mode of delivery. Both procedures had equally high overall success rates to control PPH, but IUBT performed better in placenta praevia cases as compared to compression sutures.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Choi Wah Kong and William Wing Kee To.</CopyrightInformation></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Kong</LastName><ForeName>Choi Wah</ForeName><Initials>CW</Initials><Identifier Source=""ORCID"">0000-0001-8889-4843</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, United Christian Hospital, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>To</LastName><ForeName>William Wing Kee</ForeName><Initials>WWK</Initials><Identifier Source=""ORCID"">0000-0001-9648-1256</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, United Christian Hospital, Hong Kong.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=""D003160"">Comparative Study</PublicationType><PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=""Electronic""><Year>2021</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D001778"" MajorTopicYN=""N"">Blood Coagulation Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D036861"" MajorTopicYN=""N"">Delivery, Obstetric</DescriptorName><QualifierName UI=""Q000706"" MajorTopicYN=""N"">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D007044"" MajorTopicYN=""N"">Hysterectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D010921"" MajorTopicYN=""N"">Placenta Accreta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D011183"" MajorTopicYN=""N"">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""Y"">Postpartum Hemorrhage</DescriptorName><QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName><QualifierName UI=""Q000601"" MajorTopicYN=""N"">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D012189"" MajorTopicYN=""N"">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D012307"" MajorTopicYN=""N"">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D013537"" MajorTopicYN=""N"">Sutures</DescriptorName><QualifierName UI=""Q000706"" MajorTopicYN=""Y"">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D016896"" MajorTopicYN=""N"">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D058738"" MajorTopicYN=""N"">Uterine Balloon Tamponade</DescriptorName><QualifierName UI=""Q000706"" MajorTopicYN=""Y"">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that there is no conflict of interest regarding the publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""received""><Year>2020</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=""revised""><Year>2020</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus=""accepted""><Year>2020</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=""entrez""><Year>2021</Year><Month>1</Month><Day>25</Day><Hour>5</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pubmed""><Year>2021</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""pmc-release""><Year>2021</Year><Month>1</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">33490275</ArticleId><ArticleId IdType=""pmc"">PMC7801069</ArticleId><ArticleId IdType=""doi"">10.1155/2021/6648829</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hayman R. G., Arulkumaran S., Steer P. J. Uterine compression sutures: surgical management of postpartum hemorrhage. Obstetrics and Gynecology. 2002;99(3):502&#x2013;506. doi: 10.1016/s0029-7844(01)01643-x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/s0029-7844(01)01643-x</ArticleId><ArticleId IdType=""pubmed"">11864681</ArticleId></ArticleIdList></Reference><Reference><Citation>Doumouchtsis S. K., Papageorghiou A. T., Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstetrical &amp; Gynecological Survey. 2007;62(8):540&#x2013;547. doi: 10.1097/01.ogx.0000271137.81361.93.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/01.ogx.0000271137.81361.93</ArticleId><ArticleId IdType=""pubmed"">17634155</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakri Y. N., Amri A., Abdul J. F. Tamponade-balloon for obstetrical bleeding. International Journal of Gynecology &amp; Obstetrics. 2001;74(2):139&#x2013;142. doi: 10.1016/S0020-7292(01)00395-2.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/S0020-7292(01)00395-2</ArticleId><ArticleId IdType=""pubmed"">11502292</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharajan L., Chandraharan E., Sutton J., Lowe V., Arulkumaran S. Outcome of the management of massive postpartum hemorrhage using the algorithm &#x201c;Hemostasis&#x201d;. International Journal of Gynecology &amp; Obstetrics. 2011;113(2):152&#x2013;154. doi: 10.1016/j.ijgo.2010.11.021.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijgo.2010.11.021</ArticleId><ArticleId IdType=""pubmed"">21396642</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnarwyler B., Passweg D., von Castelberg B. Erfolgreiche behandlung einer medikament&#xf6;s refrakt&#xe4;ren uterusatonie durch funduskompressionsn&#xe4;hte. Geburtshilfe und Frauenheilkunde. 1996;56(3):151&#x2013;153. doi: 10.1055/s-2007-1022282.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1055/s-2007-1022282</ArticleId><ArticleId IdType=""pubmed"">8674962</ArticleId></ArticleIdList></Reference><Reference><Citation>B-Lynch C., Coker A., Lawal A. H., Abu J., Cowen M. J. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. British Journal of Obstetrics and Gynaecology. 1997;104(3):372&#x2013;375. doi: 10.1111/j.1471-0528.1997.tb11471.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.1997.tb11471.x</ArticleId><ArticleId IdType=""pubmed"">9091019</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubara S., Yano H., Ohkuchi A., Kuwata T., Usui R., Suzuki M. Uterine compression sutures for postpartum hemorrhage: an overview. Acta Obstetricia et Gynecologica Scandinavica. 2013;92(4):378&#x2013;385. doi: 10.1111/aogs.12077.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/aogs.12077</ArticleId><ArticleId IdType=""pubmed"">23330882</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG : An International Journal of Obstetrics and Gynaecology. 2009;116(6):748&#x2013;757. doi: 10.1111/j.1471-0528.2009.02113.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.2009.02113.x</ArticleId><ArticleId IdType=""pubmed"">19432563</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya B., Guralp O., Tuten A., Unal O., Celik M. O., Dogan A. Which uterine sparing technique should be used for uterine atony during cesarean section? The Bakri balloon or the B-Lynch suture? Archives of Gynecology and Obstetrics. 2016;294(3):511&#x2013;517. doi: 10.1007/s00404-016-4015-z.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1007/s00404-016-4015-z</ArticleId><ArticleId IdType=""pubmed"">26781261</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;etin B. A., Aydogan Mathyk B., Atis Aydin A., et al. Comparing success rates of the Hayman compression suture and the Bakri balloon tamponade. The Journal of Maternal-Fetal &amp; Neonatal Medicine. 2019;32(18):3034&#x2013;3038. doi: 10.1080/14767058.2018.1455184.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1080/14767058.2018.1455184</ArticleId><ArticleId IdType=""pubmed"">29558231</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios-Jaraquemada J. M. Efficacy of surgical techniques to control obstetric hemorrhage: analysis of 539 cases. Acta Obstetricia et Gynecologica Scandinavica. 2011;90(9):1036&#x2013;1042. doi: 10.1111/j.1600-0412.2011.01176.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1600-0412.2011.01176.x</ArticleId><ArticleId IdType=""pubmed"">21564024</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallappa Saroja C. S., Nankani A., El-Hamamy E. Uterine compression sutures, an update: review of efficacy, safety and complications of B-Lynch suture and other uterine compression techniques for postpartum haemorrhage. Archives of Gynecology and Obstetrics. 2010;281(4):581&#x2013;588. doi: 10.1007/s00404-009-1249-z.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1007/s00404-009-1249-z</ArticleId><ArticleId IdType=""pubmed"">19834719</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwu Y. M., Chen C. P., Chen H. S., Su T. H. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. BJOG : An International Journal of Obstetrics and Gynaecology. 2005;112(10):1420&#x2013;1423. doi: 10.1111/j.1471-0528.2005.00666.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.2005.00666.x</ArticleId><ArticleId IdType=""pubmed"">16167948</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G.-T., Li X.-F., Wu B., Li G. Longitudinal parallel compression suture to control postopartum hemorrhage due to placenta previa and accrete. Taiwanese Journal of Obstetrics &amp; Gynecology. 2016;55(2):193&#x2013;197. doi: 10.1016/j.tjog.2016.02.008.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.tjog.2016.02.008</ArticleId><ArticleId IdType=""pubmed"">27125401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratiu A. C., Crisan D. C. A prospective evaluation and management of different types of placenta praevia using parallel vertical compression suture to preserve uterus. Medicine. 2018;97(46, article e13253) doi: 10.1097/md.0000000000013253.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1097/md.0000000000013253</ArticleId><ArticleId IdType=""pmc"">PMC6257590</ArticleId><ArticleId IdType=""pubmed"">30431609</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabelea V., Schultze P. M., McDuffie R. S., Jr. Intrauterine balloon tamponade in the management of postpartum hemorrhage. American Journal of Perinatology. 2007;24(6):359&#x2013;364. doi: 10.1055/s-2007-984402.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1055/s-2007-984402</ArticleId><ArticleId IdType=""pubmed"">17566947</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown H., Okeyo S., Mabeya H., Wilkinson J., Schmitt J. The Bakri tamponade balloon as an adjunct treatment for refractory postpartum hemorrhage. International Journal of Gynecology &amp; Obstetrics. 2016;135(3):276&#x2013;280. doi: 10.1016/j.ijgo.2016.06.021.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijgo.2016.06.021</ArticleId><ArticleId IdType=""pubmed"">27612530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson W. L., O&#x2019;Brien J. M. The uterine sandwich for persistent uterine atony: combining the B-Lynch compression suture and an intrauterine Bakri balloon. American Journal of Obstetrics and Gynecology. 2007;196(5):e9&#x2013;10. doi: 10.1016/j.ajog.2006.10.887.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ajog.2006.10.887</ArticleId><ArticleId IdType=""pubmed"">17466689</ArticleId></ArticleIdList></Reference><Reference><Citation>Diemert A., Ortmeyer G., Hollwitz B., et al. The combination of intrauterine balloon tamponade and the B-Lynch procedure for the treatment of severe postpartum hemorrhage. American Journal of Obstetrics and Gynecology. 2012;206(1):65.e1&#x2013;65.e4. doi: 10.1016/j.ajog.2011.07.041.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ajog.2011.07.041</ArticleId><ArticleId IdType=""pubmed"">22000893</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi V. M., Shrivastava M. Partial ischemic necrosis of the uterus following a uterine brace compression suture. British Journal of Obstetrics and Gynaecology. 2004;111(3):279&#x2013;280. doi: 10.1111/j.1471-0528.2004.00056.x.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/j.1471-0528.2004.00056.x</ArticleId><ArticleId IdType=""pubmed"">14961893</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentilhes L., Gromez A., Razzouk K., Resch B., Verspyck E., Marpeau L. B-Lynch suture for massive persistent postpartum hemorrhage following stepwise uterine devascularization. Acta Obstetricia et Gynecologica Scandinavica. 2008;87(10):1020&#x2013;1026. doi: 10.1080/00016340802380750.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1080/00016340802380750</ArticleId><ArticleId IdType=""pubmed"">18927949</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Mathur M., Tagore S. Complications and pregnancy outcome following uterine compression suture for postpartum haemorrhage: a single centre experience. Journal of Obstetrics and Gynaecology. 2014;34(5):383&#x2013;386. doi: 10.3109/01443615.2014.895309.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.3109/01443615.2014.895309</ArticleId><ArticleId IdType=""pubmed"">24678816</ArticleId></ArticleIdList></Reference><Reference><Citation>Gezgin&#xe7; K., Yazici F., Koyuncu T. Results of hysterosalpingogram in women with previous B-Lynch suture. International Journal of Gynaecology and Obstetrics. 2011;115(1):68&#x2013;69. doi: 10.1016/j.ijgo.2011.02.026.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijgo.2011.02.026</ArticleId><ArticleId IdType=""pubmed"">21767836</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadakawa M., Sugawara J., Saito M., et al. Fertility and pregnancy outcomes following B-Lynch sutures for post-partum hemorrhage. The Journal of Obstetrics and Gynaecology Research. 2015;41(4):559&#x2013;564. doi: 10.1111/jog.12590.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/jog.12590</ArticleId><ArticleId IdType=""pubmed"">25331482</ArticleId></ArticleIdList></Reference><Reference><Citation>Goojha C. A., Case A., Pierson R. Development of Asherman syndrome after conservative surgical management of intractable postpartum hemorrhage. Fertility and Sterility. 2010;94(3):1098.e1&#x2013;1098.e5. doi: 10.1016/j.fertnstert.2010.01.078.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.fertnstert.2010.01.078</ArticleId><ArticleId IdType=""pmc"">PMC3035637</ArticleId><ArticleId IdType=""pubmed"">20347081</ArticleId></ArticleIdList></Reference><Reference><Citation>Leparco S., Viot A., Benachi A., Deffieux X. Migration of Bakri balloon through an unsuspected uterine perforation during the treatment of secondary postpartum hemorrhage. American Journal of Obstetrics and Gynecology. 2013;208(6):e6&#x2013;e7. doi: 10.1016/j.ajog.2013.02.052.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ajog.2013.02.052</ArticleId><ArticleId IdType=""pubmed"">23470856</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong C. W., To W. W. K. Menstrual and reproductive outcomes after use of balloon tamponade for severe postpartum hemorrhage. BMC Pregnancy and Childbirth. 2018;18(1):p. 451. doi: 10.1186/s12884-018-2085-6.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1186/s12884-018-2085-6</ArticleId><ArticleId IdType=""pmc"">PMC6249747</ArticleId><ArticleId IdType=""pubmed"">30463522</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodhi W., Golara M., Karangaokar V., Yoong W. Uterine necrosis following application of combined uterine compression suture with intrauterine balloon tamponade. Journal of Obstetrics and Gynaecology. 2011;32(1):30&#x2013;31. doi: 10.3109/01443615.2011.614972.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.3109/01443615.2011.614972</ArticleId><ArticleId IdType=""pubmed"">22185530</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckmann M. M., Chaplin J. Bakri balloon during cesarean delivery for placenta previa. International Journal of Gynaecology and Obstetrics. 2014;124(2):118&#x2013;122. doi: 10.1016/j.ijgo.2013.08.010.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1016/j.ijgo.2013.08.010</ArticleId><ArticleId IdType=""pubmed"">24262684</ArticleId></ArticleIdList></Reference><Reference><Citation>Vintejoux E., Ulrich D., Mousty E., et al. Success factors for Bakri&#x2122; balloon usage secondary to uterine atony: a retrospective, multicentre study. The Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology. 2015;55(6):572&#x2013;577. doi: 10.1111/ajo.12376.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1111/ajo.12376</ArticleId><ArticleId IdType=""pubmed"">26223852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong C. W., To W. W. Prognostic factors for the use of intrauterine balloon tamponade in the management of severe postpartum hemorrhage. International Journal of Gynaecology and Obstetrics. 2018;142(1):48&#x2013;53. doi: 10.1002/ijgo.12498.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1002/ijgo.12498</ArticleId><ArticleId IdType=""pubmed"">29603742</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H. Y., Park Y. W., Kim Y. H., Jung I., Kwon J. Y. Efficacy of intrauterine Bakri balloon tamponade in cesarean section for placenta previa patients. PLoS One. 2015;10(8, article e0134282) doi: 10.1371/journal.pone.0134282.</Citation><ArticleIdList><ArticleId IdType=""doi"">10.1371/journal.pone.0134282</ArticleId><ArticleId IdType=""pmc"">PMC4532486</ArticleId><ArticleId IdType=""pubmed"">26263014</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>'",2021
9,"Intrauterine balloon tamponade (IUBT) is an established fertility-sparing and life-saving treatment for postpartum haemorrhage. However, high-level evidence is lacking for specific aspects of its use. Our aim was to evaluate a large case series of IUBT to inform evidence-based clinical practice. 296 cases of IUBT over a three-year period at a tertiary obstetric referral centre were identified and reviewed. Demographic, clinical, and procedural outcome measures were collected; including rates of success and failure of IUBT, duration of tamponade, and complications. IUBT was successful in 265 (90%) of women and failed in 18 (6%). All failures occurred within six hours of balloon insertion. Once deemed stable and successful at six hours, no women required return to theatre or further intervention. The mean duration of intrauterine balloon tamponade was 18.5 hours. A large variance in clinical practice exists including duration of intrauterine balloon tamponade, and method and timing of removal. A number of changes informed by the results will be introduced and prospectively audited to improve IUBT use.Impact statementWhat is already known on this subject? Intrauterine balloon tamponade (IUBT) is an important second-line treatment option in severe postpartum haemorrhage (PPH). IUBT is easy to use, is effective especially in the setting of uterine atony, and is associated with minimal complications.What the results of this study add? This study confirms the high rate of success for IUBT in controlling PPH. We found that after six hours, if deemed successful, it is rare that further intervention is required. In addition, tamponade beyond 12 hours, gradual or incremental deflation of the balloon, and antibiotic cover beyond the duration of tamponade are unlikely to yield any further safety benefit.What the implications are of these findings for clinical practice and/or further research? Our findings suggest that women should not be required to fast for balloon removal; removal of the balloon should occur by 12 hours if deemed stable and adequately resuscitated; deflation and removal of the balloon can occur at once; and antibiotics should be ceased after balloon removal. These will allow women to mobilise and recover sooner, and improve flow and throughput in our high-acuity care areas.",Dorkham MC,DorkhamMC,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018e999990>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e987790>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e984f50>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e985b90>]","['Dorkham MC', 'Epee-Bekima MJ', 'Sylvester HC', 'White SW']",Dorkham MC; Epee-Bekima MJ; Sylvester HC; White SW,,,,,,,,,,,,,,,{},"Dorkham MC, et al. Experience of Bakri balloon tamponade at a single tertiary centre: a retrospective case series. Experience of Bakri balloon tamponade at a single tertiary centre: a retrospective case series. 2021; 41:854-859. doi: 10.1080/01443615.2020.1799341","Dorkham MC, <i>et al</i>. Experience of Bakri balloon tamponade at a single tertiary centre: a retrospective case series. Experience of Bakri balloon tamponade at a single tertiary centre: a retrospective case series. 2021; 41:854-859. doi: 10.1080/01443615.2020.1799341",<Element PubmedArticle at 0x7f018e99ac40>,10.1080/01443615.2020.1799341,854.0,[],"{'pubmed': datetime.datetime(2020, 10, 17, 0, 0), 'medline': datetime.datetime(2021, 12, 1, 0, 0), 'entrez': datetime.datetime(2020, 10, 16, 0, 0)}",1364-6893,6,J Obstet Gynaecol,,"{'D000328': {'descriptor_name': 'Adult', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D036861': {'descriptor_name': 'Delivery, Obstetric', 'major_topic': False, 'qualifier_name': 'adverse effects', 'qualifier_ui': 'Q000009'}, 'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D059247': {'descriptor_name': 'Fertility Preservation', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': False, 'qualifier_name': 'etiology', 'qualifier_ui': 'Q000209'}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D012189': {'descriptor_name': 'Retrospective Studies', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D062606': {'descriptor_name': 'Tertiary Care Centers', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D016896': {'descriptor_name': 'Treatment Outcome', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D058738': {'descriptor_name': 'Uterine Balloon Tamponade', 'major_topic': False, 'qualifier_name': 'statistics & numerical data', 'qualifier_ui': 'Q000706'}, 'D014593': {'descriptor_name': 'Uterine Inertia', 'major_topic': False, 'qualifier_name': 'therapy', 'qualifier_ui': 'Q000628'}}",854-859,<function MetaPubObject.parse_xml at 0x7f01911c1120>,,,33063565,,"{'D023362': 'Evaluation Study', 'D016428': 'Journal Article'}",article,Experience of Bakri balloon tamponade at a single tertiary centre: a retrospective case series.,<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018e99b7d0>>,https://ncbi.nlm.nih.gov/pubmed/33063565,41,41(6),"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Manual""><PMID Version=""1"">33063565</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel=""Print-Electronic""><Journal><ISSN IssnType=""Electronic"">1364-6893</ISSN><JournalIssue CitedMedium=""Internet""><Volume>41</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology</Title><ISOAbbreviation>J Obstet Gynaecol</ISOAbbreviation></Journal><ArticleTitle>Experience of Bakri balloon tamponade at a single tertiary centre: a retrospective case series.</ArticleTitle><Pagination><StartPage>854</StartPage><EndPage>859</EndPage><MedlinePgn>854-859</MedlinePgn></Pagination><ELocationID EIdType=""doi"" ValidYN=""Y"">10.1080/01443615.2020.1799341</ELocationID><Abstract><AbstractText>Intrauterine balloon tamponade (IUBT) is an established fertility-sparing and life-saving treatment for postpartum haemorrhage. However, high-level evidence is lacking for specific aspects of its use. Our aim was to evaluate a large case series of IUBT to inform evidence-based clinical practice. 296 cases of IUBT over a three-year period at a tertiary obstetric referral centre were identified and reviewed. Demographic, clinical, and procedural outcome measures were collected; including rates of success and failure of IUBT, duration of tamponade, and complications. IUBT was successful in 265 (90%) of women and failed in 18 (6%). All failures occurred within six hours of balloon insertion. Once deemed stable and successful at six hours, no women required return to theatre or further intervention. The mean duration of intrauterine balloon tamponade was 18.5&#x2009;hours. A large variance in clinical practice exists including duration of intrauterine balloon tamponade, and method and timing of removal. A number of changes informed by the results will be introduced and prospectively audited to improve IUBT use.Impact statement<b>What is already known on this subject?</b> Intrauterine balloon tamponade (IUBT) is an important second-line treatment option in severe postpartum haemorrhage (PPH). IUBT is easy to use, is effective especially in the setting of uterine atony, and is associated with minimal complications.<b>What the results of this study add?</b> This study confirms the high rate of success for IUBT in controlling PPH. We found that after six hours, if deemed successful, it is rare that further intervention is required. In addition, tamponade beyond 12&#x2009;hours, gradual or incremental deflation of the balloon, and antibiotic cover beyond the duration of tamponade are unlikely to yield any further safety benefit.<b>What the implications are of these findings for clinical practice and/or further research?</b> Our findings suggest that women should not be required to fast for balloon removal; removal of the balloon should occur by 12&#x2009;hours if deemed stable and adequately resuscitated; deflation and removal of the balloon can occur at once; and antibiotics should be ceased after balloon removal. These will allow women to mobilise and recover sooner, and improve flow and throughput in our high-acuity care areas.</AbstractText></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Dorkham</LastName><ForeName>Mariana C</ForeName><Initials>MC</Initials><Identifier Source=""ORCID"">0000-0003-3599-6410</Identifier><AffiliationInfo><Affiliation>Division of Obstetrics, Gynaecology and Imaging Directorate, King Edward Memorial Hospital, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Epee-Bekima</LastName><ForeName>Mathias J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Obstetrics, Gynaecology and Imaging Directorate, King Edward Memorial Hospital, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Sylvester</LastName><ForeName>Hannah C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Division of Obstetrics, Gynaecology and Imaging Directorate, King Edward Memorial Hospital, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>White</LastName><ForeName>Scott W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Division of Obstetrics, Gynaecology and Imaging Directorate, King Edward Memorial Hospital, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Obstetrics &amp; Gynaecology, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=""D023362"">Evaluation Study</PublicationType><PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=""Electronic""><Year>2020</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Obstet Gynaecol</MedlineTA><NlmUniqueID>8309140</NlmUniqueID><ISSNLinking>0144-3615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D036861"" MajorTopicYN=""N"">Delivery, Obstetric</DescriptorName><QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D059247"" MajorTopicYN=""N"">Fertility Preservation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""N"">Postpartum Hemorrhage</DescriptorName><QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName><QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D012189"" MajorTopicYN=""N"">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D062606"" MajorTopicYN=""N"">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D016896"" MajorTopicYN=""N"">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D058738"" MajorTopicYN=""N"">Uterine Balloon Tamponade</DescriptorName><QualifierName UI=""Q000706"" MajorTopicYN=""Y"">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D014593"" MajorTopicYN=""N"">Uterine Inertia</DescriptorName><QualifierName UI=""Q000628"" MajorTopicYN=""N"">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=""NOTNLM""><Keyword MajorTopicYN=""N"">Bakri balloon</Keyword><Keyword MajorTopicYN=""N"">Postpartum haemorrhage</Keyword><Keyword MajorTopicYN=""N"">conservative management</Keyword><Keyword MajorTopicYN=""N"">intrauterine balloon tamponade</Keyword><Keyword MajorTopicYN=""N"">obstetric haemorrhage</Keyword><Keyword MajorTopicYN=""N"">quality improvement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""pubmed""><Year>2020</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2021</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""entrez""><Year>2020</Year><Month>10</Month><Day>16</Day><Hour>8</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">33063565</ArticleId><ArticleId IdType=""doi"">10.1080/01443615.2020.1799341</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>'",2021
10,"INTRODUCTION: Postpartum haemorrhage is still the main cause of maternal morbidity and mortality. Many treatments are available, but they may threaten fertility potential. As a uterine sparing procedure, we aimed to review uterine compression sutures in order to better understand when they should represent an appropriate option.
MATERIAL AND METHODS: A comprehensive search in MEDLINE and PubMed databases including the terms 'postpartum haemorrhage' and 'uterine compression sutures' was performed. Results were revised and articles reviewing or presenting case reports of uterine compression sutures to treat postpartum haemorrhage were included.
RESULTS: The first description of uterine compression sutures to control postpartum haemorrhage was published in 1997, by B-Lynch et al. After this publication, many others have reported successful management of postpartum haemorrhage with different suturing techniques. Most of them describe success rates above 75% and the possibility of fertility preservation, with cases of uneventful pregnancy after uterine compression sutures already published. Complications associated with each technique are rare.
DISCUSSION: Reports of use of uterine compression sutures include small series of cases or even single case reports which limits the quality of existing evidence to support one technique over another. Nevertheless, uterine compression sutures are recognized as an effective surgical conservative strategy to control postpartum haemorrhage due to uterine atony and its use is recommended, if possible, prior to hysterectomy.
CONCLUSION: Uterine compression sutures are effective, safe and simple to perform in an emergent situation and preserve fertility potential in cases of postpartum haemorrhage.",Moleiro ML,MoleiroML,"[<metapub.pubmedauthor.PubMedAuthor object at 0x7f018fac2890>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e984550>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e986b90>, <metapub.pubmedauthor.PubMedAuthor object at 0x7f018e97c610>]","['Moleiro ML', 'Braga J', 'Machado MJ', 'Guedes-Martins L']",Moleiro ML; Braga J; Machado MJ; Guedes-Martins L,,,,,,,,,,,,,,,{},"Moleiro ML, et al. Uterine Compression Sutures in Controlling Postpartum Haemorrhage: A Narrative Review. Uterine Compression Sutures in Controlling Postpartum Haemorrhage: A Narrative Review. 2022; 35:51-58. doi: 10.20344/amp.11987","Moleiro ML, <i>et al</i>. Uterine Compression Sutures in Controlling Postpartum Haemorrhage: A Narrative Review. Uterine Compression Sutures in Controlling Postpartum Haemorrhage: A Narrative Review. 2022; 35:51-58. doi: 10.20344/amp.11987",<Element PubmedArticle at 0x7f018e900040>,10.20344/amp.11987,51.0,[],"{'received': datetime.datetime(2019, 3, 1, 0, 0), 'accepted': datetime.datetime(2019, 10, 7, 0, 0), 'revised': datetime.datetime(2019, 10, 6, 0, 0), 'pubmed': datetime.datetime(2020, 3, 26, 0, 0), 'medline': datetime.datetime(2022, 1, 6, 0, 0), 'entrez': datetime.datetime(2020, 3, 26, 0, 0)}",1646-0758,1,Acta Med Port,,"{'D005260': {'descriptor_name': 'Female', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006801': {'descriptor_name': 'Humans', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D006473': {'descriptor_name': 'Postpartum Hemorrhage', 'major_topic': True, 'qualifier_name': 'prevention & control', 'qualifier_ui': 'Q000517'}, 'D011247': {'descriptor_name': 'Pregnancy', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D013536': {'descriptor_name': 'Suture Techniques', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D013537': {'descriptor_name': 'Sutures', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}, 'D014593': {'descriptor_name': 'Uterine Inertia', 'major_topic': True, 'qualifier_name': 'surgery', 'qualifier_ui': 'Q000601'}, 'D014599': {'descriptor_name': 'Uterus', 'major_topic': False, 'qualifier_name': None, 'qualifier_ui': None}}",51-58,<function MetaPubObject.parse_xml at 0x7f01911c1120>,,,32208130,,"{'D016428': 'Journal Article', 'D016454': 'Review'}",article,Uterine Compression Sutures in Controlling Postpartum Haemorrhage: A Narrative Review.,<bound method PubMedArticle.to_dict of <metapub.pubmedarticle.PubMedArticle object at 0x7f018e902010>>,https://ncbi.nlm.nih.gov/pubmed/32208130,35,35(1),"b'<?xml version=""1.0"" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC ""-//NLM//DTD PubMedArticle, 1st January 2025//EN"" ""https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd"">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=""MEDLINE"" Owner=""NLM"" IndexingMethod=""Automated""><PMID Version=""1"">32208130</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel=""Print-Electronic""><Journal><ISSN IssnType=""Electronic"">1646-0758</ISSN><JournalIssue CitedMedium=""Internet""><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>03</Day></PubDate></JournalIssue><Title>Acta medica portuguesa</Title><ISOAbbreviation>Acta Med Port</ISOAbbreviation></Journal><ArticleTitle>Uterine Compression Sutures in Controlling Postpartum Haemorrhage: A Narrative Review.</ArticleTitle><Pagination><StartPage>51</StartPage><EndPage>58</EndPage><MedlinePgn>51-58</MedlinePgn></Pagination><ELocationID EIdType=""doi"" ValidYN=""Y"">10.20344/amp.11987</ELocationID><Abstract><AbstractText Label=""INTRODUCTION"" NlmCategory=""BACKGROUND"">Postpartum haemorrhage is still the main cause of maternal morbidity and mortality. Many treatments are available, but&#xa0;they may threaten fertility potential. As a uterine sparing procedure, we aimed to review uterine compression sutures in order to better&#xa0;understand when they should represent an appropriate option.</AbstractText><AbstractText Label=""MATERIAL AND METHODS"" NlmCategory=""METHODS"">A comprehensive search in MEDLINE and PubMed databases including the terms \'postpartum haemorrhage\'&#xa0;and \'uterine compression sutures\' was performed. Results were revised and articles reviewing or presenting case reports of uterine&#xa0;compression sutures to treat postpartum haemorrhage were included.</AbstractText><AbstractText Label=""RESULTS"" NlmCategory=""RESULTS"">The first description of uterine compression sutures to control postpartum haemorrhage was published in 1997, by B-Lynch et&#xa0;al. After this publication, many others have reported successful management of postpartum haemorrhage with different suturing techniques.&#xa0;Most of them describe success rates above 75% and the possibility of fertility preservation, with cases of uneventful pregnancy&#xa0;after uterine compression sutures already published. Complications associated with each technique are rare.</AbstractText><AbstractText Label=""DISCUSSION"" NlmCategory=""CONCLUSIONS"">Reports of use of uterine compression sutures include small series of cases or even single case reports which limits the&#xa0;quality of existing evidence to support one technique over another. Nevertheless, uterine compression sutures are recognized as an&#xa0;effective surgical conservative strategy to control postpartum haemorrhage due to uterine atony and its use is recommended, if possible,&#xa0;prior to hysterectomy.</AbstractText><AbstractText Label=""CONCLUSION"" NlmCategory=""CONCLUSIONS"">Uterine compression sutures are effective, safe and simple to perform in an emergent situation and preserve fertility&#xa0;potential in cases of postpartum haemorrhage.</AbstractText></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Moleiro</LastName><ForeName>Maria L&#xfa;cia</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Departamento da Mulher e da Medicina Reprodutiva. Centro Materno Infantil do Norte. Centro Hospitalar Universit&#xe1;rio do Porto. Porto. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Braga</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departamento da Mulher e da Medicina Reprodutiva. Centro Materno Infantil do Norte. Centro Hospitalar Universit&#xe1;rio do Porto. Porto. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Machado</LastName><ForeName>Maria Jo&#xe3;o</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Neurocirurgia. Hospital de Braga. Braga. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Guedes-Martins</LastName><ForeName>Lu&#xed;s</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Departamento da Mulher e da Medicina Reprodutiva. Centro Materno Infantil do Norte. Centro Hospitalar Universit&#xe1;rio do Porto. Porto. Unidade de Investiga&#xe7;&#xe3;o e Forma&#xe7;&#xe3;o. Centro Materno Infantil do Norte. Centro Hospitalar Universit&#xe1;rio do Porto. Porto. Instituto de Investiga&#xe7;&#xe3;o e Inova&#xe7;&#xe3;o em Sa&#xfa;de. Universidade do Porto. Porto. Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=""D016428"">Journal Article</PublicationType><PublicationType UI=""D016454"">Review</PublicationType></PublicationTypeList><ArticleDate DateType=""Electronic""><Year>2019</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Portugal</Country><MedlineTA>Acta Med Port</MedlineTA><NlmUniqueID>7906803</NlmUniqueID><ISSNLinking>0870-399X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D006473"" MajorTopicYN=""Y"">Postpartum Hemorrhage</DescriptorName><QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName><QualifierName UI=""Q000601"" MajorTopicYN=""N"">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D013536"" MajorTopicYN=""N"">Suture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D013537"" MajorTopicYN=""N"">Sutures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=""D014593"" MajorTopicYN=""Y"">Uterine Inertia</DescriptorName><QualifierName UI=""Q000601"" MajorTopicYN=""N"">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=""D014599"" MajorTopicYN=""N"">Uterus</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type=""Publisher"" Language=""por""><AbstractText>Introdu&#xe7;&#xe3;o: A hemorragia p&#xf3;s-parto &#xe9; a principal causa de morbimortalidade materna. Apesar dos tratamentos dispon&#xed;veis, o potencial f&#xe9;rtil da mulher pode ser colocado em causa. As suturas uterinas de compress&#xe3;o representam uma terap&#xea;utica conservadora do &#xfa;tero. Assim, revimos os tipos de suturas uterinas de compress&#xe3;o para compreender quando devem ser uma op&#xe7;&#xe3;o terap&#xea;utica. Material e M&#xe9;todos: Foi realizada pesquisa na MEDLINE e PubMed com os termos &#x2018;postpartum haemorrhage&#x2019; e &#x2018;uterine compression sutures&#x2019; separados e em conjunto. Os resultados foram revistos e os artigos de revis&#xe3;o ou descrevendo casos cl&#xed;nicos de suturas uterinas de compress&#xe3;o foram selecionados. Resultados: Em 1997, B-Lynch et al descreveu pela primeira vez as suturas uterinas de compress&#xe3;o para tratamento da hemorragia p&#xf3;s-parto. Desde a&#xed;, publica&#xe7;&#xf5;es de diferentes tipos de suturas uterinas de compress&#xe3;o, com registo de casos bem-sucedidos, t&#xea;m sido publicadas. A maioria reporta taxas de sucesso acima de 75%, com preserva&#xe7;&#xe3;o da fertilidade, existindo v&#xe1;rios casos de bom desfecho obst&#xe9;trico posteriormente descritos. As complica&#xe7;&#xf5;es associadas s&#xe3;o raras. Discuss&#xe3;o: A evid&#xea;ncia acerca do uso de suturas uterinas de compress&#xe3;o &#xe9; limitada pela qualidade dos artigos existentes que incluem apenas pequenas s&#xe9;ries de casos ou descri&#xe7;&#xf5;es de casos isolados. Apesar disso, tem sido reconhecido o seu potencial enquanto estrat&#xe9;gia conservadora no controlo da hemorragia p&#xf3;s-parto devido a atonia uterina, sendo recomendado o seu uso, se poss&#xed;vel, antes de realizar histerectomia. Conclus&#xe3;o: Em situa&#xe7;&#xf5;es de hemorragia p&#xf3;s-parto, as suturas uterinas de compress&#xe3;o s&#xe3;o eficazes, seguras e simples de realizar, preservando o potencial reprodutivo.</AbstractText></OtherAbstract><KeywordList Owner=""NOTNLM""><Keyword MajorTopicYN=""N"">Hysterectomy</Keyword><Keyword MajorTopicYN=""N"">Obstetric Labour Complications</Keyword><Keyword MajorTopicYN=""N"">Postpartum Hemorrhage</Keyword><Keyword MajorTopicYN=""N"">Sutures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=""received""><Year>2019</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=""accepted""><Year>2019</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=""revised""><Year>2019</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=""pubmed""><Year>2020</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""medline""><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=""entrez""><Year>2020</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=""pubmed"">32208130</ArticleId><ArticleId IdType=""doi"">10.20344/amp.11987</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>'",2022
